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Abstract 
In Eastern Europe, cardiovascular disease (CVD) mortality is high, but the causes of 
this remain poorly understood. Metabolic syndrome (MetS) is a risk factor for CVD 
and is thought to be partly determined by diet. However, few studies have examined 
the prevalence of MetS and the associations between dietary quality and MetS in 
Eastern European populations. 
This cross-sectional study used data from the baseline wave of HAPIEE study—
21519 randomly selected adults aged 45-69 years. MetS was defined using the ATP 
III definition. Healthy Diet Indicator (HDI) was derived using WHO 2003 
recommendations: each component was scored from 0 (worst) to 10 (best adherence) 
and the total score ranged from 0 (worst) to 70 (best dietary quality). Anthropometric 
data and blood samples were collected during clinic visits.  
Prevalence of MetS was high in the Czech Republic (men: 37.1%, women: 35.7%), 
Russia (20.8%, 36.3%), and Poland (27.9%, 28.6%). In logistic regression, adherence 
to total HDI score was not associated with risk of MetS (P>0.05), but higher HDI was 
associated with lower risk of having raised blood pressure in the pooled sample (OR 
per 10 unit increase in HDI=0.82, 95% CI: 0.72-0.94). A better adherence to 
recommended protein intake was consistently associated with lower risk of having 
high blood glucose in three countries (Czech Republic: OR per 1 unit increase in 
protein score=0.87, 95% CI: 0.80-0.94; Russia: 0.93, 0.88-0.99; Poland: 0.82, 0.75-
0.89), and also associated with lower risk of MetS (0.92, 0.86-0.98) and central 
obesity (0.90, 0.84-0.96) in Poland.  
Findings showed that MetS prevalence was high and diet quality was moderate to 
poor. Findings also provide some support for the beneficial role of diet quality 
(especially moderate protein intake) in lowering MetS prevalence. Future longitudinal 
studies should examine whether higher adherence to HDI reduces the risk of MetS 
and CVD. 
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Chapter 1  Introduction  
The term metabolic syndrome (also called as Syndrome X or the Deadly quartet) 
refers to a cluster of conditions which occur more commonly among individuals with 
insulin resistance, and it was first put forward by Reaven in 1988.1;2 The conditions 
include abdominal obesity, hyperglycaemia, high blood pressure, and dyslipidaemia. 
Metabolic syndrome has been shown to be a risk factor for cardiovascular disease 
and type 2 diabetes, and is also related to other metabolic abnormalities and 
diseases.3-5 Over the past three decades, the prevalence of metabolic syndrome 
increased worldwide, and its definitions and pathophysiology have been widely 
discussed.3-6 
The prevalence of metabolic syndrome is relatively high worldwide. In Europe, about 
25% of adults are thought to have metabolic syndrome;7 while in the United States 
(U.S.) and Latin America, the prevalence is higher—among older adults (>60 years) 
its prevalence is thought to be over 40% in the U.S.8 In addition, the prevalence of 
metabolic syndrome is believed to be increasing worldwide in parallel with the rising 
prevalence of obesity and type 2 diabetes.7;9 Most metabolic syndrome patients are 
thought to be at higher risk of having cardiovascular disease, because the clinical 
features of metabolic syndrome are also cardiovascular disease risk factors.10 A 
systematic review and meta-analysis found that metabolic syndrome is associated 
with an 80% increased risk of cardiovascular disease events and mortality;11 
moreover, metabolic syndrome is also associated with increased total mortality.12 
Therefore, in order to prevent various adverse life events, tackling metabolic 
syndrome is an important global public health issue.  
Despite reductions in premature mortality in Western Europe, total and cardiovascular 
disease mortality increased in Central and Eastern Europe between 1970s to 1980s, 
and cardiovascular disease accounted for almost 60% of the gap in life-expectancy 
between Western Europe and Central and Eastern Europe.13 Since the dissolution of 
Soviet Union, and the start of social and political transformation in Central and Eastern 
Europe after 1989, cardiovascular disease mortality decreased dramatically in the 
Czech Republic and Poland in early 1990s, but not in Russia.14 It has been 
hypothesised that changes in diet are one reason for this reduction.14;15 Since the late 
1990s to early 2000s, cardiovascular mortality in the Czech Republic and Poland 
continued to fall and further reduced the gap with Western Europe, but the incidence 
in Russia has remained far above the European average.16;17 However, few 
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population studies have investigated the reasons for the differences between these 
countries in cardiovascular mortality trends. The HAPIEE (Health, Alcohol and 
Psychosocial factors in Eastern Europe) study was set up at the start of 2000s to 
investigate the wider determinants of cardiovascular disease and other chronic 
conditions in the Czech Republic, Russia, and Poland.18 Metabolic syndrome, as a 
risk factor for cardiovascular disease, has been examined in some studies in this 
region. A few studies have investigated the prevalence of metabolic syndrome in the 
Czech Republic, Russia, and Poland.19-25 Despite the limited research and non-unified 
definition used in previous studies, prevalence of metabolic syndrome (and its 
components) was estimated to be high in this region. For example, one previous 
report using HAPIEE data estimated that over 70%  individuals aged ≥45 years were 
overweight or obese (BMI>25kg/m2) in the Czech Republic, Russia, and Poland.26 
Since obesity is one of the underlying risk factors for metabolic syndrome, the 
prevalence of metabolic syndrome is also likely to be high in Central and Eastern 
Europe, but it is still not well described. Thus, metabolic syndrome, as well as its 
related risk factors, needs further examination in the Central and Eastern Europe. 
Metabolic syndrome and some of its components (central obesity and insulin 
resistance) are thought to be associated with demographic factors (age, sex), 
socioeconomic position, lifestyle behaviours (diet, physical activity), and genetic 
factors.27;28 Some of these, such as dietary factors, are modifiable. In addition, it is 
believed that the prevalence of central obesity, insulin resistance, and metabolic 
syndrome can be reduced by interventions targeting physical inactivity and unhealthy 
diet, and such interventions have been found to have short-term success in clinical 
trials with both intensive and less intensive procedures.29-34 
High energy intake is not the only link between diet and metabolic disorders, and 
some food groups and nutrients might be particularly important for preventing 
metabolic syndrome and its components. For example, fruit and vegetable intake was 
found to have protective effects on inflammation markers due to the combination of 
antioxidants and minerals, and it could further prevent cardiovascular risk factors.35;36 
Therefore, examining components of diet rather than energy intake alone is important 
in understanding the relationship between diet and metabolic syndrome. 
Previous work, including one from the HAPIEE study,37 showed that the intake of 
saturated fatty acids, sugar, and protein is very high in the Czech Republic, Russia, 
and Poland, whilst the consumption of fruits and vegetables and fibres is low.38 High 
intake of saturated fatty acids and protein is associated with increased risk of 
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metabolic syndrome,39;40 and high intakes in fruits and vegetables, fibre and whole 
grain are associated with decreased risk of metabolic syndrome.41-46 However, there 
are a number of limitations of examining how single nutrients relate to health 
outcomes. In recent years, dietary pattern research has been increasingly used to 
overcome these limitations.47;48 However, to the author’s knowledge, no study has 
investigated associations between dietary factors/patterns and metabolic syndrome 
in the Czech Republic, Russia, and Poland. 
The main aim of this thesis is thus to at least partly fill this gap and to investigate the 
prevalence of metabolic syndrome in the HAPIEE study populations (in the Czech 
Republic, Russia, and Poland), to explore the dietary patterns using Healthy Diet 
Indicator (HDI, described in detail in Chapter 4) in these populations, and to examine 
the association between HDI and the risk of metabolic syndrome and its components. 
The findings of this thesis will contribute to scarce research on health in Central and 
Eastern Europe, and potentially contribute to policies which ultimately aim at reducing 
diet-related non-communicable diseases.  
The thesis is structured as follows: Chapter 2 provides a literature review on the 
history and prevalence of metabolic syndrome, and describes its pathophysiology, 
main debates, and its risk factors. It then provides an extensive literature review of 
studies examining how dietary patterns relate to metabolic syndrome. In Chapter 3, 
the aims and objectives of this thesis are presented; in Chapter 4, the study design, 
statistical power, and analytical methods used in this thesis are explained in detail, 
followed by the results of the study in Chapter 5. In Chapter 6, methodological issues, 
comparisons with previous studies, potential explanations of findings and their 
implications are discussed. Finally in Chapter 7 the final conclusions of this thesis are 
presented. 
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Chapter 2  Literature review 
2.1 Historical background of metabolic syndrome 
As early as the beginning of the 20th century, scientists have been trying to describe 
a very common coexistence of several metabolic disorders, which we know today as 
metabolic syndrome. 
The first descriptions of the clustering of various components of the metabolic 
syndrome trace back to the 1920s and 1930s when Banting and Best discovered 
insulin.49 During the First World War, some physicians started to believe that there 
was a relationship between blood pressure and diabetes mellitus among adults, and 
began to explore the mechanisms of such a relationship.50 In 1936, Himsworth first 
divided patients with diabetes mellitus into insulin-sensitive and insulin-resistant 
groups. This could be seen as a milestone in metabolic research history.51 After about 
20 years, Vague was the first person who distinguished android obesity (where fat is 
localised around the waist and in the upper body, commonly seen in men) from 
gynaecoid obesity (obesity where fat is localised in the lower half of the body, 
commonly seen in women).52 He also believed that there was a connection between 
android obesity and the development of diabetes, hypertension, gout and 
atherosclerosis; moreover, he suggested that android obesity plays an important role 
in cardiovascular disease. At the same time, other researchers also emphasised how 
android obesity related to the development of dyslipidaemia and hyperglycaemia.53 
Sarafidis and Nilsson reported that since 1960s, researchers have published their 
findings on a variety of multifaceted metabolic disorders using different names: 
metabolic trisyndrome, plurimetabolic syndrome, syndrome of affluence, metabolic 
syndrome, syndrome X, deadly quartet, and insulin resistance syndrome.54 In 1981, 
based on epidemiological and pathophysiological data, Hanefeld and Leonards 
(1981), as summarised by Sarafidis (2006), described a ‘metabolic syndrome’ which 
included type 2 diabetes mellitus, hyperinsulinaemia, obesity, hypertension, 
hyperlipidaemia, gout and thrombophilia. They also hypothesised that the ‘metabolic 
syndrome’ was caused by both genetic and environment factors (eg lack of physical 
exercise).54 
In 1988, Reaven raised the profile of metabolic syndrome by naming it ‘syndrome X’.1 
Based on observations of hospital patients, he believed that insulin resistance was 
the common aetiological factor for impaired glucose tolerance (IGT), 
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hyperinsulinaemia, high levels of very low-density lipoprotein, high level of 
triglycerides, low levels of high-density lipoprotein cholesterol (HDL-C) and 
hypertension. He also claimed that individuals with ‘syndrome X’ have a high risk of 
developing atherosclerosis. Moreover, he emphasised the important role of genetic 
and environmental factors in relation to the severity of insulin resistance. Later, Kaplan 
added central adiposity to ‘syndrome X’, and claimed that a group of disorders 
including central adiposity, IGT, hypertriglyceridaemia, and hypertension, played a 
critical role in development of cardiovascular disease and named it as ‘the Deadly 
Quartet’.55 From the 1990s onwards, the terms ‘insulin resistance syndrome’, 
‘metabolic syndrome’, and ‘syndrome X’, were the most commonly used to describe 
this group of disorders, and the term metabolic syndrome becoming widely accepted. 
In the next section, the most commonly used definitions of metabolic syndrome in 
practice and research will be described in detail.  
2.2 Definitions of metabolic syndrome  
Several definitions of metabolic syndrome have been proposed during the past 15 
years by organisations including the World Health Organisation (WHO), the European 
Group for the Study of Insulin Resistance (EGIR), the National Cholesterol Education 
Program Expert Panel on Detection, Evaluation, and Treatment of High Blood 
cholesterol in Adults (ATP III), the American Heart Association/National Heart, Lung, 
and Blood Institute (AHA/NHLBI), and the International Diabetes Federation (IDF) 
(see Table 1). 
In 1998, the WHO consultation proposed a working definition of metabolic syndrome, 
and in 1999 published a finalised definition by changing the systolic blood pressure 
cut-off point from 160mmHg to 140 mmHg (see Table 1).56 According to the WHO 
definition, a patient with insulin resistance plus two additional metabolic abnormalities 
(obesity, hypertension, dyslipidaemia, or microalbuminuria) could be diagnosed as 
having metabolic syndrome. In the same year, EGIR published a modified definition 
(see Table 1).57 EGIR agreed with WHO that insulin resistance is likely to be the major 
cause of metabolic syndrome, and they suggested to use the term ‘insulin resistance 
syndrome’ instead of ‘metabolic syndrome’, because it contains non-metabolic 
components (eg, blood pressure). They defined insulin resistance as being in the top 
quartile of fasting insulin among the non-diabetic population; this was used in order to 
20 
 
avoid the need for expensive and burdensome euglycaemic clampi measures used in 
the WHO definition. In addition, two more abnormal features are required among 
central obesity, high blood pressure, and dyslipidaemia, and fasting plasma glucose. 
However, the EGIR definition is only suitable for non-diabetic populations. The cut-
points for triglycerides and HDL-C were modified, since the report from the Second 
Joint Task Force of European and other Societies on Coronary Prevention suggested 
that the fasting triglycerides >2.0mmol/L and/or an HDL-C<1.0mmol/L could predict 
higher risk of coronary heart disease.59  In their definition, central obesity was an 
important component of the diagnosis criteria, and it was measured using waist 
circumference instead of waist-hip ratio, because it was much easier to measure and 
better correlated with intra-abdominal visceral adipose tissue accumulation and 
metabolic abnormalities.60 EGIR removed the microalbuminuria criteria from the list, 
because it has not been universally shown to be linked with insulin concentrations.61;62 
Finally, EGIR suggested that a minimum number of abnormalities in the syndrome is 
practical for most epidemiological research use, which lead the further thoughts from 
other institutions. In 2001, the National Cholesterol Education Program (NCEP) 
produced a third version of clinical updates on cholesterol management (ATP III). 
Unlike previous versions, ATP III maintains the attention of the intensive treatment for 
patients with coronary heart disease, but also emphasises the focus on the prevention 
of coronary heart disease among people with multiple metabolic risk factors. 
Subsequently a definition of metabolic syndrome was proposed by ATP III.63 The 
purpose of ATP III was to identify the risk factors for coronary heart disease—
consequently, it does not have a prerequisite of insulin resistance. The ATP III 
diagnosis of metabolic syndrome required three out of five components believed to 
be the major components of metabolic syndrome (central obesity, 
hypertriglyceridaemia, low HDL-C, hypertension, and elevated fasting glucose). It was 
still believed that central obesity was an important component, and the cut-points were 
modified by using National Institutes of Health clinical guidelines of obesity.64 ATP III 
revised the definition of high blood pressure and changed the cut-points for 
triglycerides back to the WHO 1999 definition and allowed for the diagnosis of the 
metabolic syndrome among diabetes patients. NCEP acknowledged racial and ethnic 
differences in risk factors for coronary heart disease, but suggested that the observed 
                                               
i  During the procedure, the plasma insulin concentration is acutely raised and 
maintained at 100 μU/ml by a continuous infusion of insulin. Meanwhile, the plasma 
glucose concentration is held constantly at basal levels by a variable glucose infusion. 
When the steady-state is achieved, the glucose infusion rate equals glucose uptake 
by all the tissues in the body and is therefore a measure of tissue insulin sensitivity. 
The hyperinsulinemic clamps are often used to measure insulin resistane..58 
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evidence was not sufficient for changing the general guidelines. Therefore, the ATP 
III definition of metabolic syndrome is thought to be more suitable for Caucasian 
compared with other ethnic groups (see Table 1).  
In 2005, AHA/NHLBI and IDF proposed revised definitions of metabolic syndrome.65;66 
The AHA/NHLBI definition, central obesity was not required as an obligatory criteria, 
and it only modified the ATP III criteria slightly (fasting plasma glucose ≥5.6 mmol/L). 
These two modified versions are quite similar to ATP III version. Specifically, the IDF 
definition made central obesity (high waist circumference) an obligatory component 
in the definition, and first proposed that different ethnic cut-points of waist 
circumference are needed, but other requirements are exactly the same as ATP III. 
In addition, the cut-points of central obesity are different between IDF and AHA/NHLBI 
(see Table 1). 
In 2009, AHA/NHLBI and IDF agreed on a unified definition of metabolic syndrome.3 
They reached an agreement that central obesity would not be an obligatory 
component of metabolic syndrome but emphasised ethnic differences of central 
obesity, and kept the ATP III requirement of three abnormal findings out of five for a 
person to qualify for the metabolic syndrome (see Table 1). 
There are also some other definitions suggested by different institutions. For example, 
in 2003, American Association of Clinical Endocrinologists (AACE) proposed a 
modified definition called as ‘insulin resistance syndrome’.67 Components of this 
definition included impaired glucose tolerance, elevated triglycerides, reduced HDL-
C, elevated blood pressure, and obesity. However, no specified number of factors 
was stipulated for the diagnosis, but specific clinical judgement was required (this 
definition has not been showed in Table 1). 
Both WHO and EGIR definition included the measurement of insulin resistance as a 
prerequisite component of metabolic syndrome, but these measurements are not 
routinely available in clinical practice, especially in population studies. Moreover, 
studies have shown that ATP III and AHA/NHLBI definitions are stronger predictors 
of cardiovascular disease risk than other definitions, and ATP III is the most commonly 
used definition in research. By considering the above aspects, the ATP III definition 
is by far the most practical definition in population health studies, and it was therefore 
used in this thesis.68;69 
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Table 1 Definitions of metabolic syndrome 
Risk factors WHO(1999)56 EGIR(1999)57* ATP III(2001)63 AHA/NHLBI(2005)65 IDF(2005)66 Unified AHA/NHLBI & 
IDF(2009)3 
Insulin resistance T2DM,IFG,IGT, or 
lowered insulin 
sensitivity[1] 
Plus any 2 of the 
following 
 
Top quartile of 
fasting  insulin 
values among  
the nondiabetic 
population 
Plus any 2 of the 
following 
None 
Any 3 of the 
following 5 
components 
None 
Any 3 of the 
following 5 
components 
None  None 
Any 3 of the following 5 
components 
 
 
 
 
 
Body weight waist:hip ratio 
>0.90(male), > 
0.85 (female) 
or BMI> 30 kg/m2 
WC ≥ 94 cm 
(male) or ≥ 80 cm 
(female). 
WC ≥ 102 cm 
(male) or ≥ 88 
cm (female) 
WC ≥ 102cm 
(male), ≥ 88 cm 
(female) 
WC ≥ 94cm 
(male), or 80cm  
(female) 
or BMI is >30 
kg/m² [2] 
Plus any 2 of the 
following 4 
components 
 
WC- population/country 
specific definitions  [4] 
Blood pressure ≥140/90 mmHg  ≥ 140/90 mmHg 
or treated for 
hypertension 
≥ 130/85 mmHg ≥ 130/85 mmHg, or 
on antihypertensive 
drug treatment in a 
patient with a 
history of 
hypertension 
≥ 130/85 mm 
Hg, or treated for 
hypertension. 
 
 
 
 
≥ 130/85 mm Hg, or 
treated for 
hypertension. 
Dyslipidaemia  TG≥1.695 mmol/L 
or HDL-C≤ 0.9 
mmol/L (male), ≤ 
1.0 mmol/L 
(female) 
TG > 2.0 mmol/L  
or HDL-
cholesterol 
< 1.0 mmol/L 
TG ≥ 1.7 mmol/L  
 
TG ≥ 1.7 mmol/L or 
on drug treatment 
for elevated TG 
 
TG ≥1.7 mmol/L, 
or specific 
treatment for this 
lipid abnormality. 
 
TG ≥1.7 mmol/L, or 
specific treatment for 
this lipid abnormality. 
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Risk factors WHO(1999)56 EGIR(1999)57* ATP III(2001)63 AHA/NHLBI(2005)65 IDF(2005)66 Unified AHA/NHLBI & 
IDF(2009)3 
or treated for 
dyslipidaemia 
HDL-C < 1.03 
mmol/L (male) or 
< 1.29 mmol/L 
(female) 
 
HDL-C < 1.03 
mmol/L (male) or 
<1.29 mmol/L 
(female)  
Or on drug 
treatment for 
reduced HDL-C 
HDL-C: < 1.03 
mmol/L (male), 
or < 1.29 mmol/L 
(female), or 
specific 
treatment for this 
lipid abnormality 
 
HDL-C: < 1.03 mmol/L 
(male), or < 1.29 
mmol/L (female), or 
specific treatment for 
this lipid abnormality 
 
Fasting plasma 
glucose 
-- ≥ 6.1 mmol/L ≥ 6.1 mmol/L 
(including 
diabetes) 
≥ 5.6 mmol/L or on 
drug treatment for 
elevated glucose 
≥ 5.6 mmol/L, or 
previously 
diagnosed T2DM  
≥ 5.6 mmol/L, or 
previously diagnosed 
T2DM 
Other  Microalbuminuria[3]  -- -- -- -- -- 
 
Abbreviation: T2DM- type 2 diabetes mellitus, IFG- impaired fasting glucose, IGT- impaired glucose tolerance, BMI- body mass index, TG- 
triglycerides, HDL-C- high density lipoprotein cholesterol, WC- waist circumference 
[1] Insulin sensitivity measured under hyperinsulinaemic and euglycaemic conditions, glucose uptake in the lowest quartile for the back ground 
population under investigation. 
[2] When BMI is >30 kg/m², central obesity can be assumed and waist circumference does not need to be measured  
[3] Microalbuminuria: urinary albumin excretion ratio ≥ 20 µg/min or albumin:creatinine ratio ≥ 30 mg/g 
[4] It is recommended that the IDF cut points be used for non-Europeans and either the IDF or AHA/NHLBI cut points used for people of European 
origin until more data are available 
*Unlike all other definitions restricted to non-diabetic persons 
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2.3 Prevalence of metabolic syndrome  
The lack of diagnostic concordance among metabolic syndrome definitions and its 
individual components makes it difficult to compare metabolic syndrome prevalence 
across different studies and different countries. In the following sections, the 
estimated prevalence of metabolic syndrome worldwide will be discussed first, then 
in the countries studied in HAPIEE: the Czech Republic, Russia, and Poland.  
2.3.1 Worldwide prevalence of metabolic syndrome using different definitions 
In 2004, Cameron, Shaw, and Zimmet summarised the prevalence of metabolic 
syndrome in different populations using three definitions: WHO, ATP III, and EGIR 
(see Figures 1 and 2).70 
Figure 1 displays the data on prevalence of metabolic syndrome defined by ATP III 
and WHO definitions in selected countries in the 2000s. The prevalence varies from 
11% to 35% depending on the definition and population used. Prevalence was higher 
in men than in women using the WHO definition, but this gender difference was not 
seen when using ATP III definition. In addition, the prevalence in men was higher 
when using WHO definition compared to ATP III.  
Figure 2 shows the comparison of metabolic syndrome prevalence using EGIR and 
WHO definitions. Firstly, similar to the WHO definition, the prevalence of metabolic 
syndrome was higher in men than in women when using EGIR definition. Secondly, 
the prevalence in both men and women are higher when using the WHO definition 
than EGIR; however, in some studies, one or more components of metabolic 
syndrome in either EGIR or WHO definition were not included in the used definition, 
which made these estimates less comparable. For example, in the study among 22-
73 years men and women conducted in Italy, the waist-hip ratio component was not 
included in the WHO definition and waist circumference was not included in the EGIR 
definition, these could both reduce the true prevalence using both definitions and 
making it difficult to predict the difference of the distribution.  
In addition, one study in Mauritius showed the prevalence of metabolic syndrome 
using all three definitions. The prevalence of metabolic syndrome was the highest 
using the WHO definition in both men and women (20.9% and 17.6% respectively), 
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compared with ATP III (men: 10.6%; women: 14.7%) and EGIR (men: 9.0%; women: 
10.2%).70 
Ko et al examined the prevalence of metabolic syndrome among Hong Kong Chinese 
using WHO, ATP III, and EGIR definitions.71 Of 1513 participants aged 18-66 years, 
the prevalence was highest when using the WHO definition (13.4%), followed by ATP 
III (9.6%) and EGIR (8.9%). This confirmed the findings from Cameron et al.70 
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Figure 1  Prevalence of metabolic syndrome using ATP III and WHO definitions (adapted from Cameron, Shaw, Zimmet70) 
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Figure 2  Prevalence of metabolic syndrome using EGIR and WHO definitions (adapted from Cameron, Shaw, Zimmet70) 
†This value is not comparable due to one or more components of the metabolic syndrome not being measured for the WHO criteria. 
‡Obesity was omitted from the definition of metabolic syndrome in the EGIR criteria. 
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Since 2005, several new definitions of metabolic syndrome have been proposed, and 
they are AHA/NHLBI, IDF, and Unified AHA/NHLBI & IDF as aforementioned (see 
Table 1). These definitions kept the five basic components of metabolic syndrome as 
ATPIII for its simplicity and practical advantage, but modified the cut-points of some 
components. For example, AHA/NHLBI modified the glucose level in response to the 
updates from American Diabetes Association criteria.65 The IDF writing group 
suggested that central obesity and insulin resistance are highly correlated, and that 
central obesity could be used instead, with specific ethnic threshold.66 Later, both 
AHA/NHLBI and IDF groups agreed not to have central obesity as a prerequisite 
component in the unified definition in order to resolve the differences in definitions.3 
These new definitions have been compared with each other and with ATP III definition 
in the U.S., Sweden, Germany, and Greece.   
In the National Health and Nutrition Examination Survey (NHANES) 1999-2002, 
among a total of 3601 people aged ≥20 years, Ford found that the age-adjusted 
prevalence of metabolic syndrome in men was 34.4%, and 34.5% in women when 
using ATP III definition, while the prevalence increased slightly when using IDF 
definition (40.7% in men and 37.1% in women).72  
Nilsson, Engstrom and Hedblad found that among 5,047 Swedish people aged 46 to 
68 years who enrolled in the Malmo Diet and Cancer (MDC) study between 1991 and 
1994, the prevalence of metabolic syndrome was the highest when using IDF 
definition (21.9%), followed by 20.7% when using ATP III and 18.8% when using 
EGIR.73 
In the German Metabolic and Cardiovascular Risk Project (GEMCAS) which 
conducted in 2005, Moebus et al compared prevalence of metabolic syndrome using 
ATP III, AHA/NHLBI 2005, and IDF definitions; among 35,869 primary care patients 
aged 18-99 years.74  The age-standardised prevalence was the lowest when using 
ATP III definition (18.7%) and the highest when using IDF definition (30.7%).  
Another similar comparison study was conducted in a Mediterranean population in 
Greece between 2003 and 2004.69 Athyros et al compared the metabolic syndrome 
prevalence using four different definitions (ATP III, AHA/NHLBI 2005, IDF, and Unified 
AHA/NHLBI & IDF) among a total of 9,669 Greek adults aged ≥18 years. The age-
adjusted prevalence of metabolic syndrome was similar when using ATP III and 
AHA/NHLBI 2005 (24.5% and 26.3% respectively), and the prevalence were higher 
when using IDF and Unified AHA/NHLBI and IDF (43.4% and 45.7% respectively).  
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The evidence above showed that the prevalence of metabolic syndrome is high 
worldwide, although the estimates vary by populations and definition. Moreover, the 
prevalence is higher when using WHO and IDF definition in the same population 
compared with other definitions.  
2.3.2 Prevalence of metabolic syndrome and its components in the Czech 
Republic, Russia, and Poland 
Recently several studies have examined prevalence in the Central and Eastern 
Europe, for example in Hungary,75 Slovakia,76 and Croatia.77. Studies have suggested 
that the prevalence of metabolic syndrome is high (>24%) in these countries. 
However, studies on the prevalence of metabolic syndrome are still scarce in Central 
and Eastern European population. In the following section, the studies on the 
prevalence of metabolic syndrome in the countries in which HAPIEE study was 
conducted are summarised.  
The Czech MONICA (MONItoring trends and determinants in CArdiovascular 
disease) study showed 24.4% of women had metabolic syndrome and 32.0% of men 
aged between 25 and 64 years.19;25 Another study conducted among 805 aged 
between 18 and 65 years in three regions of the Czech Republic showed that 22.9% 
of women and 32.5% of men had metabolic syndrome when using the IDF definition.25 
Other studies among Czech population have focused on the prevalence of 
components of metabolic syndrome. From 1985 to 2007/8, among men, BMI 
increased from 27.0 to 28.5kg/m2; among both men and women, the mean systolic 
blood pressure decreased (in men: 135.8 to 132.5mmHg; in women: 131.6 to 
126.6mmHg), as well as the mean diastolic pressure (in men: 85.9 to 84.4mmHg; in 
women: 82.5 to 80.6mmHg); further, the prevalence of hypertension (defined as 
systolic blood pressure≥140mmHg, and/or diastolic blood pressure≥90mmHg) 
decreased in total population from 47.1% to 43.6% and from 42.5% to 37.3% in 
women, however, there was no change among men. In the study, blood pressure was 
measured by standard mercury sphygmomanometers, and the first and fifth Korotkoff 
sounds were recorded as systolic blood pressure and diastolic blood pressure to the 
nearest 2mmHg. Final blood pressure was recorded as the average of the first two 
readings. However, the blood pressure readings may be biased by differences in 
investigator technique. Moreover, there was a mild decline for mean HDL-C level in 
men (from 1.35 to 1.30mmol/L) but no change in women; the high prevalence of 
dyslipidaemia (defined as total cholesterol≥5mmol/L or HDL-C <1mmol/L in men and 
<1.2mmol/L in women or use of lipid-lowering drug) was observed throughout the 
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surveys, and it decreased in both men (from 87.5% to 73.8%) and women (85.2% to 
62.9%).78 
Few studies have examined metabolic syndrome prevalence in Russia. Jones et al 
examined the prevalence of metabolic syndrome among a sample of 146 people aged 
25-89 years in Kuzmolovsky, Russia.20 They found the prevalence of metabolic 
syndrome was 54.1% using ATP III definition; however, the sample size was small 
and the sample was not representative because it was selected in the only one clinic 
in a local area by inviting patients who came to the clinic, which introduced substantial 
selection bias by including unhealthy participants only. Several years later, a cross-
sectional study of 3555 participants aged 18-90 years was conducted in Arkhangelsk, 
Northwest Russia, and investigated the prevalence of metabolic syndrome using IDF 
definition.21 The prevalence was 9.5% in men and 23.5% in women. However, the 
prevalence could have been underestimated because of using HbA1c (≥6.1%) 
instead of plasma glucose (≥6.1mmol/L) as the hyperglycaemia criteria. A level of 
≥6.1% in HbA1c is equivalent to a level of plasma glucose level ≥7.1mmol/L;79 
therefore, the cut-point used for HbA1c underestimated the prevalence of 
hyperglycaemia and metabolic syndrome. In the same year, Sidorenkov et al 
investigated the prevalence of metabolic syndrome by comparing three definitions – 
ATP III, IDF, and AHA/NHLBI – in the same study sample.22 The age-standardised 
prevalence was highest among women by using IDF definition (23.1%), followed by 
AHA/NHLBI (20.6%) and ATP III (19.8%), while in men the prevalence was highest 
by using AHA/NHLBI (13.7%), followed by ATP III (11.5%) and IDF (11.0%). However, 
in this latter study, the prevalence of the metabolic syndrome may have been 
underestimated since the glucose level was measured by serum glucose instead of 
plasma glucose.  
In Poland, the prevalence of metabolic syndrome was also investigated in several 
studies. Szurkowska and colleagues found that the prevalence of metabolic syndrome 
among 40989 Poles aged 25-97 years was 16.2% in men and 20.9% in women when 
using the ATP III definition.23 In the Polish Norwegian Study (PONS), researchers 
found that among 3862 people, the prevalence of metabolic syndrome was 49.9% in 
men and 34.3% in women when using the Unified AHA/NHLBI & IDF definition; central 
obesity was the most common abnormality with a prevalence of 75.1%, followed by 
high blood pressure (71%), glucose intolerance (37.3%), high triglycerides (21.2%), 
and low HDL-C (15.9%).80 In a study of 8006 men and 10577 women aged 40 and 50 
years from Wroclaw, Poland, Ilow and colleagues found that the prevalence of 
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metabolic syndrome was 35.9% in men and 22.9% in women when using the Unified 
AHA/NHLBI and IDF definition.24 They also found that metabolic syndrome was 
significantly more common in men than women, and among older group (=50 years 
old) than younger group (=40 years old). The most frequent components of metabolic 
syndrome among 40 years old women was central obesity (36.1%) and high blood 
pressure (27.3%), while in the 50 years old group, the prevalence was 62.6% and 
55.3% respectively. In this study, researchers also compared the prevalence of 
metabolic syndrome using two definitions- IDF and Unified AHA/NHLBI & IDF. The 
prevalence of metabolic syndrome and its components was significantly lower when 
using IDF definition compared to the Unified definition.  
The Czech Republic, Russia, and Poland are the countries included in the HAPIEE 
study as well as this thesis. The literature above showed the prevalence of metabolic 
syndrome to vary considerably, suggesting that assessment of prevalence of 
metabolic syndrome in these countries using a multi-centre study, such as HAPIEE 
study, with representative samples, standardised data collection procedures, and 
well-designed laboratory measures, will considerably advance understanding of the 
metabolic syndrome in the region.  
The evidence in both section 2.3.1 and 2.3.2 showed that the prevalence of metabolic 
syndrome varies between populations and criteria used. Comparing prevalence 
between definitions, IDF and Unified AHA/NHLBI & IDF showed a higher prevalence 
of metabolic syndrome compared to other definitions. Ford tested the agreement of 
metabolic syndrome diagnosis using IDF and ATP III and the percent agreement was 
high in both men (89.8%) and women (96.0%); moreover, when using IDF definition, 
5.8% of the participants had been diagnosed with metabolic syndrome but not when 
using ATP III definition. The prevalence difference between two definitions could be 
explained by the obligatory of central obesity in IDF and the lower threshold of waist 
circumference in IDF (≥90cm for men and ≥80 for women) compared to ATP III 
(≥102cm for men and ≥88cm for women).72 Moebus et al found that the largest 
disagreement among definitions was between ATP III and IDF.74 Despite the large 
disagreement between IDF and most commonly used definition (ATP III), the 
prediction level of different definitions on other chronic disease has been described. 
A study from Greece reported that the use of the IDF definition resulted in increased 
labelling of elderly subjects with the diagnosis of metabolic syndrome without 
identifying more subjects at high risk for stroke.81 Athyros et al found that metabolic 
syndrome by the use of ATP III definition predicted cardiovascular disease better than 
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the use of other definitions.69 Also, in the Malmo Diet and Cancer study, better 
prediction of cardiovascular disease event by metabolic syndrome was found using 
the ATP III definition.73 In summary, by comparing the agreement and predicted level 
of other chronic diseases with definitions, the ATP III definition is potentially more 
suitable for disease detection at the population level.  
2.4 Concepts and debates of metabolic syndrome 
Metabolic syndrome, as a constellation of risk factors for cardiovascular diseases and 
type 2 diabetes, has been discussed in studies for decades.82 However, the 
pathogenesis of metabolic syndrome is still not fully understood. There are two 
essential research aspects related to the pathophysiology of metabolic syndrome: 1), 
whether insulin resistance is the major underlying risk factor for the metabolic 
syndrome; and 2) whether obesity is the main cause of multiple metabolic disorders 
which constitutes the metabolic syndrome.5 Furthermore, there has been important 
debate on whether metabolic syndrome has some additional predictive effect in 
comparison to its individual components. The literature related to these three issues 
will be summarised below.  
2.4.1 Insulin resistance in the aetiology of the metabolic syndrome  
The metabolic interaction between glucose and fatty acids is thought to be important 
for development of insulin resistance and metabolic syndrome.83 In adipose tissue, 
when the glucose circulation increases, the pancreas secretes more insulin in order 
to maintain euglycaemia; meanwhile, insulin suppresses fatty acid release from 
adipose tissue. Therefore, a high glucose level normally leads to a low non-esterified 
fatty acids level in plasma. In muscle, when more glucose becomes available, muscle 
tissue utilises glucose rather than fatty acids. In between meals, the glucose level falls, 
the pancreas secrets less insulin, but the non-esterified fatty acid level increases. At 
this point, fatty acids in muscle are oxidised in order to suppress the uptake and 
oxidation of glucose, which could preserve the glucose for other tissue use (eg, brain). 
In insulin resistant subjects, glucose uptake is not stimulated by insulin as normal, 
leading to hyperinsulinaemia. Normally, insulin inhibits gluconeogenesis in the liver 
when the glucose level is high (eg, after meals). But among insulin resistant subjects, 
the inhibiting function by insulin is not effective, which results in a further increase of 
glucose level by gluconeogenesis. The impaired insulin function will also result in the 
failure of suppressing fatty acids release from the adipose tissue. 
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It has been proposed that insulin resistance is a physiological adaptation to obesity 
that limits fat deposition and leads to weight stabilisation.84Insulin resistance is one of 
the components of metabolic syndrome,1 and it is the most accepted hypothesis of 
the pathophysiology of the metabolic syndrome.82 Some researchers proposed that 
insulin resistant syndrome is the same as metabolic syndrome,67 because they 
believed that insulin resistance is the root cause of metabolic syndrome. To some 
extent, this view is supported. According to the Framingham Offspring studies, most 
metabolic syndrome patients were insulin resistant.85 Reaven believed that a defect 
in insulin function can further cause several other abnormalities. Specifically, it can 
lead to an increased level of triglyceride, a decreased level of HDL-C, and elevated 
blood pressure.86 According to DeFronzo and Ferrannini, insulin resistance has two 
main stages which are obesity and type 2 diabetes, and both of these stages are the 
components of metabolic syndrome.87 It is believed that insulin resistance can cause 
metabolic disorders, such as high level of triglycerides and blood glucose. It is a major 
component of metabolic syndrome; however, there is still a lack of evidence to show 
if insulin resistance is the major cause of every component of metabolic syndrome.  
2.4.2 Obesity in the aetiology of the metabolic syndrome 
The worldwide rising prevalence of obesity paralleled the increasing prevalence of 
metabolic syndrome.88 Obesity is associated with risk of cardiovascular disease, 
premature mortality, and some metabolic disorders, such as type 2 diabetes, 
hypertension, and dyslipidaemia.89 Researchers have found that it is the products, 
released by adipose tissue, that play important roles in metabolic disorders. One of 
the products released by adipose tissue is non-esterified fatty acid. Insulin can 
suppress the activity of hormone-sensitive lipase. When insulin level is low, the 
enzyme hormone-sensitive lipase can enhance the hydrolysis of triglycerides, and 
release more non-esterified fatty acid. Among obese people, their tissue is resistant 
to insulin actions, which leads to surprisingly high levels of non-esterified fatty acid 
levels.90 In this way, insulin resistance and obesity are connected.  
One of the components of metabolic syndrome is central obesity (abdominal obesity). 
One study showed that central obesity was more strongly associated with metabolic 
syndrome than the whole body obesity, but the reasons for this were not understood.91 
Moreover, studies show a strong relationship between central obesity and metabolic 
risk factors.92-96 Pouliot and colleagues found that centrally obese men are more likely 
to have atherogenic metabolic traits, and they also suggested that central obesity 
especially the measurement of waist circumference is a strong predictor of metabolic 
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complications.60;97 According to Lemieux and colleagues, around 80% of men who 
were centrally obese had elevated triglycerides level, and they also suggested that a 
hypertriglyceridaemic waist can predict metabolic abnormalities.98 Also, central 
obesity is thought to be one of the causes of insulin resistance because a high 
percentage of body fat can decrease insulin sensitivity.99 Consequently central 
obesity may be one of the causes of metabolic syndrome.  
2.4.3 Controversies surrounding metabolic syndrome 
Debates on metabolic syndrome have been continuing for decades. The major issues 
include the validity of its naming and its utility as a practical clinical tool, these have 
been discussed in previous sections (see Section 2.1 and 2.2); mostly important, is 
its predictive value. Researchers question whether metabolic syndrome can forecast 
cardiovascular events, diabetes or disease progression any better than its 
components.88 
Three meta-analyses conducted in 2006, 2007, and 2010, showed that metabolic 
syndrome is an important risk factor for cardiovascular disease, and that metabolic 
syndrome was associated with increased cardiovascular and all-cause 
mortality.11;100;101 However, comparison of the effects of metabolic syndrome and its 
components has not been discussed systematically. Scatter and colleagues found 
that metabolic syndrome and its components are associated with risk of type 2 
diabetes, but no association was found in relation to vascular risk.102 Reaven recently 
suggested that metabolic syndrome should no longer to be used.103 He argued that it 
is simply the additive effect of several adverse factors together (under the heading 
‘metabolic syndrome’) that predict higher risk of cardiovascular disease rather than 
any additional effect associated with the clustering of conditions together—he argued 
that there is no evidence for metabolic syndrome effect above its additive value. The 
debate still continues and more research is needed to justify whether metabolic 
syndrome should still be used and whether it has additional value compared with the 
sum of its individual components—central obesity, high blood pressure, high 
triglycerides, low HDL-C, and high plasma glucose. 
However, metabolic syndrome still has its unique value in clinical diagnosis. One of 
the most important reasons of introducing metabolic syndrome into medical research 
and practice is to amplify the awareness of the increased risk associated with obesity 
and to target the sedentary life-styles and unhealthy diets in modern society.5 
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Therefore, metabolic syndrome might still be important as a clinical tool, and as a 
predictor of adverse life events.  
2.5 Risk factors for metabolic syndrome 
Identifying risk factors for metabolic syndrome is important to ultimately prevent and 
reverse metabolic syndrome. In addition to diet, the main focus of this thesis, there 
are other risk factors for metabolic syndrome which may affect the association 
between diet and metabolic syndrome. These factors will be used as the covariates 
in the analysis of the association between diet and metabolic syndrome in this thesis, 
and the existing evidence of their association with metabolic syndrome and its 
components will be briefly discussed in the following sections. These factors are 
gender, age, socioeconomic position, health behaviours, BMI and weight gain, 
hormones change, family history, and other diseases. 
2.5.1 Gender 
Gender differences in several components of metabolic syndrome, namely central 
obesity, lipid concentration, and hypertension, have been often discussed in 
published studies. It is well known that menopause is a critical point of cardiovascular 
health among women compared with men.104;105 Before menopause, women tend to 
accumulate more fat in the lower body gluteal area (thighs and bottom), while later 
they tend to accumulate more fat in upper body area (centrally obese).106;107  
Moreover, women tend to store fat subcutaneously, while men tend to store fat 
viscerally, and this gender difference may be due to a greater amount of fatty acid 
uptake in the visceral area in men compared with women after eating.108 However, 
after menopause, women start having increasing risk of metabolic abnormalities, such 
as central obesity and hypertension. Among postmenopausal women, body fat 
distribution shifts to a more male pattern with fat stored viscerally.107;109 Post-
menopausal women have also been found to have higher risk of hypertension 
compared to their pre-menopausal counterparts.110 Dallongeville et al compared the 
importance of components of metabolic syndrome in men and women, they found that 
high waist circumference and low HDL-C were the most important contributor to 
metabolic syndrome in women, while raised blood pressure was the most important 
contributor to metabolic syndrome in men.111 Furthermore, NHANES also showed a 
higher increase of prevalence of metabolic syndrome in women (23.5%) than among 
men (2.2%) in 10 years time.112  
36 
 
2.5.2 Age 
Older age is a risk factor for many health outcomes, and as well as metabolic 
syndrome and its components. According to researchers in the United States, the 
prevalence of metabolic syndrome increases by age.8;27 Among men, the prevalence 
of metabolic syndrome reached a peak at 60 years of age, while in women at the age 
of 70 years. In both men and women, the dramatic increase in metabolic syndrome 
prevalence from age 30-40 years old is paralleled with the increase of prevalence in 
overweight and obesity. Carnethon and colleagues found that the risk of metabolic 
syndrome increased with age in the Coronary Artery Risk Development in Young 
Adults study during the 15-year follow-up.113 In addition, with the increasing age, 
insulin resistance, hypertension, other hormonal alterations, and visceral adipose 
tissue become more common among adults, which is the other important 
pathogenesis of developing metabolic syndrome.27;114-116  
2.5.3 Socioeconomic position 
Low socioeconomic position (SEP) is another risk factor for metabolic syndrome. 
Occupation, income, education and wealth across the life (from childhood to 
adulthood) are the most commonly used measures of SEP in relation to metabolic 
syndrome.  
Childhood socioeconomic position 
One of the commonly used measures of childhood SEP is father’s occupation. The 
British Regional Heart Study, Medical Research Council National Survey of Health 
and Development, and Whitehall II study showed that lower father’s occupation in 
childhood was associated with higher risk of metabolic syndrome.117-119 However, 
neither of the latter two studies showed a significant association between father’s 
occupation and metabolic syndrome among men. 
Apart from father’s occupation, other predictors of childhood SEP have been used, 
such as housing condition. Researchers using data from the Newcastle Thousand 
Families Study found that poor housing conditions at age 5 and 10 years were not 
associated with metabolic syndrome score among adults aged 49-51.120;121 Another 
predictor is parental possessions. A study based on Chinese Guangzhou Biobank 
Cohort Study suggested that parental possessions were inversely associated with 
metabolic syndrome risk among Chinese women aged over 50 years.122 
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In the United States, researchers derived a cumulative score in the Atherosclerosis 
Risk in Communities study by summing up the values of parental education at the 
time of birth, parental occupation, parental occupational role, and parental home 
ownership. They showed that low childhood SEP predicted higher risk of metabolic 
syndrome among 45-64 years old women but not among men.123;124 
Adulthood socioeconomic position  
Education is one of the main indicators for adulthood SEP. The Medical Research 
Council National Survey of Health and Development study, World Health Organization 
Monitoring Trends and Determinants in Cardiovascular Disease population survey, 
and another Finnish study, all consistently showed that lower education was 
associated with higher risk of metabolic syndrome.118;125;126 In addition, this social 
gradient is much stronger among women than men.122;127-131 However, some studies 
found that there was no association between educational level and metabolic 
syndrome among men nor women.27;119 
Income is used in several different forms as a measure of SEP, specifically, poverty 
income ratio, personal income, and household income. Poverty income ratio is the 
ratio of family income to federal poverty line. It is believed to be a better measure than 
income by some researchers because it takes family size and inflation into account.132 
A study based on NHANES showed that women aged between 46 and 65 years with 
income level below the poverty line (poverty income ratio less than 1) have almost 5 
times higher risk of having metabolic syndrome compared with their counterparts in 
the top poverty income ratio group, but the similar association was not found in 
men.128 The relationship between personal income, household income, and metabolic 
syndrome is similar to the one of education. Specifically, income level is inversely 
associated with risk of metabolic syndrome, and the association is more common in 
women rather in men.27;119;125;130;133  
Other measures of adulthood SEP include employment grade and house ownership. 
The association between employment grade and house ownership, and household 
wealth, and metabolic syndrome showed similar results as the association of 
education and income.117;119;125;127;134-136 
In summary, a variety of predictors of childhood SEP and adulthood SEP have been 
used. Generally, there was a social gradient in relation to risk of metabolic syndrome 
and SEP—the higher the SEP, the lower the risk of having metabolic syndrome. 
Moreover, this gradient was much stronger among women than men.  
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2.5.4 Health behaviours 
Health behaviours are thought to be related to many chronic diseases, such as 
cardiovascular disease, diabetes, as well as metabolic syndrome. It is argued that 
physical inactivity, smoking and sleeping duration are all risk factors for metabolic 
syndrome.  
Physical inactivity 
Physical inactivity is reported to be a risk factor for metabolic syndrome. According to 
NHANES study, men with a sedentary lifestyle have 50% higher risk of metabolic 
syndrome compared to their peers who were physically active.27 Another study 
showed that having 3 hours/week of moderate or vigorous leisure time physical 
activity could halve the risk of metabolic syndrome compared to having a sedentary 
lifestyle among men.137 Another study showed that participants having no moderate 
or vigorous physical activity during leisure time had about two-fold of higher risk of 
having metabolic syndrome compared to their peers with 150 min/week physical 
activity, however, the analyses in this study were not adjusted for BMI.138 Several 
other studies showed consistent results that increased physical activity can be a 
protective factor for metabolic syndrome and other risk factors of cardiovascular 
disease, although the analyses were not adjusted for BMI in the models; instead, 
some of them included dietary intakes (eg, fat intake, alcohol intake, energy intake) 
as covariates in the analyses.113;139-141 
Smoking 
Smoking is another risk factor for metabolic syndrome. A Taiwanese study showed 
that former (35.3%) or current smokers (34.6%) had higher prevalence of metabolic 
syndrome than never smokers (10.8%).142 A Japanese study showed that smoking 
increased the risk of metabolic syndrome, central obesity, raised triglycerides, and 
low HDL-C.143 A Chinese study found that current smokers have increased incidence 
of raised triglycerides and low HDL-C compared to non-smokers; furthermore, ex-
smokers who had quitted smoking for more than 13 years ago had decreased risk of 
having new metabolic syndrome event.144 Furthermore, Slagter et al also found that 
current smokers had higher risk of having metabolic syndrome in Dutch men and 
women. Wilsqaard and Jacobsen found that smoking more than 20 cigarettes/day 
was associated with increased risk of having metabolic syndrome among men and 
women in a Norwegian longitudinal study.145  
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Sleeping duration 
Both short and long sleeping duration have been related to metabolic syndrome. 
Researchers from The Nurses Health Study suggested that restriction of sleeping 
hours may be a risk factor of diabetes.146 In NHANES I, less than 5 hours sleep and 
more than 9 hours sleep was also associated with higher risk of having diabetes after 
a 10 years follow-up.147 Moreover, lack of sleep was also found associated with 
obesity and hypertension.148-150 However, it was argued that the association between 
lack of sleep and higher risk of obesity was overestimated; instead, daytime 
sleepiness (due to lack of sleep) and physical inactivity result in a lower energy 
expenditure than energy intake.151 Horne suggested that an intervention of 10 minutes 
of exercise per day could obtain the same effect as sleeping for one or more hours in 
reducing body fat among children.152 In 2013, Ju and Choi conducted a systematic 
review and meta-analysis on sleep duration and metabolic syndrome risk among 
adults.153  They suggested that less than 6 hours/day sleepers had higher risk of 
having metabolic syndrome among 12 cross-sectional and 3 cohort studies, while 
more than 8 hours/day sleepers also had higher risk of having metabolic syndrome 
among 11 cross-sectional studies, and 2 cohort studies. However, the associations 
between sleep duration and metabolic syndrome (and its components) are moderate; 
and it could be confounded by other lifestyle factors, such as, physical activity, energy 
intake/expenditure.153 Furthermore, lack of sleep may also impair immunity and 
further leads to inflammatory response and metabolic syndrome.154 Therefore, the 
effect of sleeping duration on metabolic syndrome and its components still needs 
further investigation.  
2.5.5 BMI and weight gain 
Studies showed that higher BMI and weight gain over time are associated with the 
risk of having some components of metabolic syndrome—high blood pressure, high 
triglycerides, and high blood glucose.155;156  
Atlantis et al found that weight gain was associated with higher risk of metabolic 
syndrome in an Australian longitudinal study.157 Also in the Coronary Artery Risk 
Development in Young Adults study, BMI was a significant predictor of metabolic 
syndrome risk in all sex and race groups (black and white).113 Weight gain was 
associated with increased risk of metabolic syndrome in the study. Moreover, the 
strong predictive value of BMI and weight gain over 15 years on metabolic syndrome 
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did not change when excluding central obesity as a component of metabolic 
syndrome.  
2.5.6 Hormones changes 
Imbalanced sex hormones may represent a risk factor for metabolic syndrome. 
Specifically, during menopause, reduction of estrogen production leads to some 
metabolic disorders. According to a meta-analysis by Neugarten and colleagues, 
menopause was associated with all the components of metabolic syndrome.158   
In addition, polycystic ovary syndrome (PCOS) is one of the most common female 
endocrine disorders. The PCOS also can result in obesity, type 2 diabetes, and high 
cholesterol levels which are the components of metabolic syndrome. Because PCOS 
and metabolic syndrome share insulin resistance as an important element in their 
pathophysiology, it may explain some of the gender differences in metabolic 
syndrome over time.159 Glueck and colleagues found the surprising result that the 
incidence of metabolic syndrome in newly diagnosed PCOS patients to be 46%, which 
indicates a higher overlap among metabolic syndrome and PCOS patients.160 Nestler 
et al found the prevalence of the metabolic syndrome was 43% among PCOS patients 
diagnosed after a 3-year period and it was nearly twofold higher than the age-adjusted 
prevalence rate of 24% in women in the general population.161 
Studies also showed that low testosterone level also associated with increased 
prevalence of metabolic syndrome components, such as hypertension in 
men.158;162;163  
2.5.7 Family history 
Family history may through both genetic and environmental pathways be important in 
the prevention of metabolic syndrome. A study used family history of diabetes and 
cardiovascular disease and childhood BMI to predict metabolic syndrome in 
adulthood.164 Results showed that after adding family history to BMI, the predicted 
probability of adult metabolic syndrome rose from 29% to 52% among adults who 
were overweight as children. In addition, another study in the U.S. showed that people 
with moderate and high familial diabetes risk had higher risk of having metabolic 
syndrome compared to the average familial risk (Odds ratios: 1.41-1.62, 1.58-1.79, 
respectively; the strata of the familial risk was determined by how close and how many 
relatives were not well).165  
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2.5.8 Other health conditions 
There are some other health conditions which are considered as risk factors for 
metabolic syndrome. For example, obstructive sleep apnoea was independently 
associated with risk of metabolic syndrome, and non-alcoholic fatty liver disease was 
seen as a feature of metabolic syndrome;166;167 however, the link and pathogenesis 
between these health conditions and metabolic syndrome still need to be investigated 
further.168;169  
Apart from the risk factors discussed above, diet is another factor thought to be an 
important underlying risk factor for metabolic syndrome, and it is also the main 
exposure of this thesis. In the following section, nutrition in health research, dietary 
patterns in health research, dietary patterns in relation to metabolic syndrome and its 
components will be described and existing evidence will be summarised.  
2.6 The history of nutrition in health research 
For hundreds of years, the possible effects of nutrition on health have been 
considered important in society. In L’Orange’s book in 2002, a note from Hippocrates 
said, ‘Leave your drugs in the chemist’s pot if you can cure the patient with food’.170 
This quote shows that the importance of food and nutrition in health has been 
discussed throughout history.  
During Medieval and Tudor periods, eating fresh fruit was not recommended because 
it was thought to cause fever.171 Pregnant women were described as having a 
‘sickness’ of craving for fresh fruits, which could be explained by the bodies 
physiological need of vitamin C. Another vitamin deficiency was discovered by the 
Newfoundland fishermen. Fishermen reporting ‘night blind’, now known as a symptom 
of vitamin A deficiency, were instructed to immediately cook and eat cod liver (which 
contains high levels of vitamin A).  
In the 16th and 17th century, the recommended remedy of scurvy was a mix of oranges, 
lemons, and scurvy grass, but the cause of it was still unknown.171 Until 1795, lemon-
juice was introduced as a scurvy remedy, and deaths from scurvy dropped 
dramatically from 1,754 in 1760 to 1 in 1806 in a naval hospital. Drummond estimated 
the diet records of a working man’s family (north of England) in the 18th century and 
suggested the family was well nourished.172 He also suggested that the South-Eastern 
European diet (consisted of little meat, whole-grain bread, think vegetable stews, and 
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goat’s cheese) at the time provided local people sufficient nutrients (eg, calcium, iron, 
vitamins) for a healthy and strong body.  
The first official recorded dietary recommendation was the lemon juice requirement in 
the rations of British sailors in 1835 to prevent scurvy.173;174 Subsequently, in 1862, 
Smith estimated that a 3000kcal of energy from food and 80g of protein per day could 
prevent starvation in response to the British Government as referred by Harper.173 In 
the following 50–60 years, some dietary recommendations based on observing 
protein or energy intake were proposed, and scientists increasingly realised that some 
food are protective and especially important for certain population (eg, infants and 
children). In 19th century, nutrition science was more advanced than former times.171 
Scientists investigated nitrogen, and began realising that protein was an important 
nutrient for human health.175 Moreover, scurvy was accepted as a deficiency disease 
of certain dietary factors, and experiments were implemented on animals for other 
nutrient deficiency diseases. 
From the early 20th century, there was a big improvement in scientific knowledge on 
vitamins.176 For example, scientists for the first time found that rickets was associated 
with lack of vitamin D intake and exposure to sunlight.  Moreover, vitamin A, carotene, 
vitamin E, and vitamin K were first discovered; essential fatty acids were first related 
to early development in experimental studies of rats. Drummond suggested that a 
“basic intake of essential protective foods” for the population should be ensured, and 
suggested a food pattern comprised of wholemeal bread, sufficient vegetables and 
potatoes, and dairy products (cheese or milk).172 
During World War II, the rationing run by the UK government was designed to ensure 
a fair supply of food in all strata of the population.177 The government also introduced 
some special measures in order to meet the specific dietary requirements, such as in 
deficiencies of thiamine and calcium. There were also some food policies for 
population with special needs. For example, the National Milk Scheme operated from 
1940, which provided pregnant woman and children from birth to age five with one 
pint of milk at a reduced price or free of charge; the Vitamin Scheme entitled pregnant 
women to a daily concentrated orange juice (contained 25mg of vitamin C) and cod 
liver oil or supplement tablets (containing 4000IU vitamin A, 800IU vitamin D, and 
250mg calcium phosphate). Moreover, the nutritional status of the UK population was 
under close observation by the Ministry of Health via running food surveys, clinical 
surveys, and adult body weight surveys.177 
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In 1943, the full report of Recommended Dietary Allowances (RDAs) was published 
by the American Dietetic Association.178 RDAs was one of the first dietary guidelines 
aimed at preventing diseases and improving dietary quality in the entire population. 
Since then, organisations proposed different dietary recommendations to improve 
people’s health. From the second half of the 20th century, the affluent diet was doubted 
to be healthy for the first time.179 It was suggested that after World War II, people in 
affluent countries were at higher risk of chronic diseases at middle-age. Furthermore, 
scientists began to compare fat intake and ischaemic heart disease mortality in 
different countries.179 
In the early 1990s, Popkin proposed the nutrition transition concept.180 He believed 
that nutrition patterns had shifted and would shift in the future in parallel with 
economic, demographic, and epidemiological changes. He suggested that nutrition 
transition affects and is affected by two other historic transitions: demographic and 
epidemiological transitions. The demographic transition indicates the shift from a 
pattern of high fertility and high mortality to a pattern of low fertility and low mortality, 
while the epidemiological transition is the shift from a pattern of high prevalence of 
infectious diseases associated with malnutrition, famine, and poor sanitation, to a 
pattern of high prevalence of chronic diseases associated with modern lifestyle. In 
addition, five nutrition patterns are summarised by Popkin in chronological order, but 
any pattern is not specifically restricted to a certain historical period and could be the 
characteristic of any geographic or socioeconomic subpopulations: Pattern 1 is 
collecting food, which was characterised by a diet with  high intake of carbohydrates 
and fibre but low in saturated fat among hunter-gatherer populations; Pattern 2 is 
famine, characterised by scarcity of food; Pattern 3 is receding famine, characterised 
by increasing intake of fruits, vegetables, and animal protein while starchy foods (eg, 
potatoes) become less important; Pattern 4 is nutrition related non-communicable 
diseases, characterised with a diet high in total fat, cholesterol, sugar and other 
refined carbohydrates and low in polyunsaturated fatty acids and fibre, also 
accompanied by an increasingly sedentary life; Pattern 5 is behavioural change, and 
it is the result of changes in diet in order to prevent degenerative diseases and prolong 
health. Western high-income countries, such as the U.S., the United Kingdom, and 
other Western European countries, have changed from a receding famine to 
degenerative diseases pattern, then to the behavioural change with health conscious 
pattern among at least some subpopulations (eg, higher educated population). In 
Eastern Europe, the intake of saturated fats accounted for 25% of the energy intake, 
which could be explained by moving from receding famine to nutrition related non-
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communicable diseases pattern. This is because saturated fats impairs plasma 
cholesterol levels, which may result in the development of metabolic disorders,181 For 
example, in Russia, between 1970s and 1990s, the consumption of starchy food (eg, 
potatoes) and cereals declined while the consumption of sugar and red meat 
increased a lot.182 In addition, the change of diet also accompanied increasing obesity 
prevalence. The nutrition transition has occurred worldwide, and it will likely continue 
in different populations accompanying economic changes.  
The development of nutritional epidemiology as a discipline was influenced by both 
the nutritional and epidemiological transitions. It is originally based on the influential 
role of diet on disease occurrence.183 Until 1980s, scientists still mostly focused on 
sanitation and nutrients deficiencies in the general population in the last 3 decades, 
the focus moved to the prevention of chronic diseases in the developed world, as well 
as some developing countries.183    
Studies have since found that some particular foods (eg, fruits and vegetables, 
cereals) or nutrients (eg, fat) are associated with the risk of some non-communicable 
diseases, such as cardiovascular diseases, type 2 diabetes, and cancer.184-189 For 
example, a systematic review of cohort studies showed that increased intake of 
monounsaturated fatty acids was associated with lower risk of coronary heart disease, 
while the increased intake of trans fatty acids was associated with higher risk of 
coronary heart disease.185 A systematic review and meta-analysis showed that the 
increased consumption of green leafy vegetables was associated with lower risk of 
having type 2 diabetes.186 Another systematic review and dose-response meta-
analysis showed that for an increase of three servings of daily whole grain intake, the 
risk of developing colorectal cancer decreased.187  
Apart from examining the association between a single/specific foods or nutrient 
consumption and health, the relationship between a combination of foods—so called 
‘dietary patterns’—and health outcomes has also been investigated. Dietary patterns 
account for the fact that people eat meals containing multiple components instead of 
a single food or nutrient. In the next section, dietary pattern research will be discussed.  
2.7 Dietary patterns in health research 
Dietary pattern research has become popular in recent years due to some limitations 
of traditional methodology (ie, examining association between single or a few 
nutrients and health outcomes) in nutritional epidemiology. First, people eat meals 
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rather than single nutrients, and the interactions between the components of a diet 
and certain disease risk can be ignored when only examining a single nutrient or food 
study. For example, non-haem ferric iron (Fe3+) is not easily absorbed in the human 
body; instead, it needs to be reduced to Fe2+ before absorption in the intestine; while 
vitamin C from food helps with the transformation from Fe3+ to Fe2+.190 Second, some 
nutrients are highly intercorrelated (eg, when magnesium is low in the body, 
potassium is also low), which makes it difficult to examine their separate effects 
because the degree of independent variation of the nutrients is markedly reduced 
when they are entered into a model simultaneously. Also, the effect of a single nutrient 
may be too small to detect, but the cumulative effects of several nutrients (eg, some 
minerals and fibres are often consumed together) may be sufficiently large to be 
detectable.48;191 
Because of its advantages, studying dietary patterns has received considerable 
attention in the past three decades. In general, dietary pattern studies can be divided 
into two categories: a priori and a posteriori dietary pattern studies. ‘A priori’ studies 
evaluate the adherence to a pre-defined dietary patterns or dietary guidelines (also 
known as score-based), while ‘a posteriori’ studies involve statistical methods to 
derive patterns within different populations (also known as post-hoc).  
2.7.1 A priori dietary patterns  
A priori dietary patterns approaches are often based on dietary recommendations of 
foods and/or nutrients. There are many different a priori dietary scores, however, there 
are four main dietary quality scores which are commonly used and modified in 
nutrition studies: the Healthy Eating Index, the Dietary Quality Index, the 
Mediterranean Diet Score, and the Healthy Diet Indicator.192  The Healthy Eating 
Index, the Dietary Quality Index, and the Healthy Diet Indicator are created based on 
dietary guidelines or recommendations on a daily basis, while the Mediterranean Diet 
Score was inspired by the low risk of coronary heart diseases and cancer in 
Mediterranean regions. These four dietary quality scores will be described below in 
detail. 
Healthy Eating Index 
The Healthy Eating Index was proposed by Kennedy and colleagues in 1995.193 Ten 
components were included in the original index: components 1 to 5 are five major food 
groups based on the daily serving recommendations from the U.S. Department of 
Agriculture Food Guide Pyramid—grains, vegetables, fruits, milk, meat; Component 
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6 and 7 are daily total fat and saturated fat intake as percentage of total energy intake; 
Component 8 and 9 are cholesterol and sodium intake per day; and component 10 is 
based on food variety over a 3-day period. Each component has a score ranging from 
0 to 10 and a total score ranges from 0 to 100 (see Table 2). A higher score in Healthy 
Eating Index represents a better dietary quality. In 2005, a new version of Healthy 
Eating Index was developed to reflect the emphasis on increasingly important aspects 
of diet. The Healthy Eating Index-2005 (new version of Healthy Eating Index) included 
9 adequacy components (ie, intake of certain food should be enough in order to 
provide the nutrients that the body needs): total fruit (score 0-5), whole fruit (score 0-
5), total vegetables (score 0-5), dark green and orange vegetables and legumes 
(score 0-5), total grains (score 0-5), whole grains (score 0-5), milk (score 0-10), meat 
and beans (score 0-10), and oils (score 0-10); also it included 3 moderation 
components (ie, certain nutrients are recommended to have a limited intake): 
saturated  fat (score 0-10), sodium (score 0-10),  and calories from solid fat, alcohol, 
and added sugars (score 0-20) (see Table 3). The total score of Healthy Eating Index-
2005 still ranges from 0 to 100.194;195 In April 2013, a new update of Healthy Eating 
Index-2010 was published to reflect the new release of Dietary Guidelines for 
Americans-2010 and revised the United States Department of Agriculture Food 
Patterns to emphasize the importance of seafood intake and limitations of refined 
grains.196 In the Healthy Eating Index-2010, total fruits, whole fruit, total vegetables, 
total grains, sodium, milk, and meat and beans were carried forward from Healthy 
Eating Index-2005, only the milk was renamed to dairy and meat and beans was 
renamed to total protein foods. In the Healthy Eating Index-2010, the “Empty Calories” 
was used instead of “Calories from solid fats, alcohol, and added sugars”; dark green 
and orange vegetables and legumes was modified to “greens and beans”; seafood 
and plant proteins were newly added; fatty acids replaced saturated fats and oils; and 
total grains was replaced by refined grains (see Table 4).  
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Table 2 Healthy Eating Index-1995193 
Components Score range Highest score 
(daily) 
Lowest score 
(daily) 
Grains 0-10 6-11servings=10 0 serving=0 
Vegetables 0-10 3-5 servings=10 0 serving=0 
Fruits 0-10 2-4 servings=10 0 serving=0 
Milk 0-10 2-3 servings=10 0 serving=0 
Meat 0-10 2-3 servings=10 0 serving=0 
Total fat 0-10 ≤30% =10 ≥45% =0 
Saturated fat 0-10 <10% =10 ≥15%=0 
Cholesterol 0-10 <300mg=10 ≥450mg=0 
Sodium 0-10 <2400mg=10 ≥4800mg=0 
Variety 0-10 16 kinds of food 
items over 3-day 
period=10 
≤6 food items over a 
3-day period=0 
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Table 3 Healthy Eating Index-2005194;195 
 Components Score range Highest score Other scores  Lowest score 
Adequacy Total fruit (include100% juice) 0-5 ≥0.8 cup eq/1000 kcal=5 
The score was calculated 
proportionately 
No fruit 
 Whole fruit (except juice) 0-5 ≥0.4 cup eq/1000 kcal=5 No whole fruit 
 Total vegetables 0-5 ≥1.1 cup eq/1000 kcal=5 No vegetables 
 
Dark green and orange 
vegetables and legumes 
0-5 ≥0.4 cup eq/1000 kcal=5 
No dark green or 
orange vegetables or 
legumes 
 Total grains 0-5 ≥3.0 oz eq/1000 kcal=5 No grains 
 Whole grains 0-5 ≥1.5 oz eq/1000 kcal=5 No whole grains 
 Milk 0-10 ≥1.3 cup eq/1000 kcal=10 No milk 
 Meat and beans 0-10 ≥2.5 oz eq/1000 kcal=10 No meat or beans 
 Oils 0-10 ≥12 g/1000 kcal=10 No oil 
Moderation Saturated fat 0-10 
≤7% of the energy intake 
=10 
=10%=8 (other scores are 
calculated proportionally) 
≥15% of energy=0 
 Sodium 0-10 ≤0.7g /1000 kcal 
=1.1g/1000 kcal=8 (other 
scores are calculated 
proportionally) 
≥2.0g /1000 kcal 
 
Calories from solid fats, 
alcoholic beverages, and 
added sugars 
0-20 ≤20% of energy calculated proportionally ≥50% of energy 
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Table 4 Healthy Eating Index-2010196 
 Components Score range Highest score Lowest score 
Adequacy Total fruit (include100% juice) 0-5 ≥0.8 cup eq/1000 kcal=5 No fruit 
 Whole fruit (except juice) 0-5 ≥0.4 cup eq/1000 kcal=5 No whole fruit 
 Total vegetables 0-5 ≥1.1 cup eq/1000 kcal=5 No vegetables 
 Greens and beans 0-5 ≥0.2 cup eq/1000 kcal=5 No dark green vegetables or beans and peas 
 Whole grains 0-10 ≥1.5 oz eq/1000 kcal=5 No whole grains 
 Dairy 0-10 ≥1.3 cup eq/1000 kcal=10 No dairy 
 Total protein foods 0-5 ≥2.5 oz eq/1000 kcal=5 No protein foods 
 Seafood and plant proteins 0-5 ≥0.8 oz eq/1000 kcal=5 No seafood or plant proteins 
 Fatty acids 0-10 (PUFAs + MUFAs)/SFA>2.5 (PUFAs + MUFAs)/SFA≤1.2 
Moderation Refined grains 0-10 ≤1.8 oz eq/1000 kcal ≥4.3 oz eq/1000 kcal 
 Sodium 0-10 ≤1.1g /1000 kcal ≥2.0g/1000 kcal 
 Empty calories 0-20 19% of energy ≥50% of energy 
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Dietary Quality Index 
The Dietary Quality Index was developed by Patterson and colleagues in 1994 and 
aimed to measure overall diet related to chronic diseases using dietary 
recommendations from the American Committee on Diet and Health.197;198 Eight 
dietary elements were included: intake of total fat, saturated fatty acid, cholesterol, 
fruit and vegetables, grains and legume, protein, sodium, and calcium. For each 
element, score 0, 1, and 2 was assigned: 0 was assigned to participants who achieved 
the nutrition goal, while a 2 score was assigned when they have not achieved it. The 
total index score ranges from 0 to 16, where a lower score represent a better dietary 
quality (see Table 5). In 1999, a revised Diet Quality Index was proposed by Haines, 
Siega-riz, and Popkin.199 The Diet Quality Index Revised version aimed at reflecting 
current dietary guidance and incorporates improved methods of estimating food 
servings. Iron intake was newly added in the revised Diet Quality Index. Moreover, 
two new scores—dietary diversity and dietary moderation—were also added in order 
to measure the dietary structure. The dietary diversity score was developed to capture 
the consumption of 4 different food groups: grains, vegetables, fruits, and meat/dairy. 
The dietary moderation score was developed based on four dietary elements: added 
sugar, discretionary fat, sodium intake, and alcohol intake (see Table 6).  
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Table 5 Diet Quality Index-1994198 
Components Highest score Score range Lowest score 
Total fat >40%=2 0-2 ≤30%=0 
Saturated fatty acid >13%=2 0-2 <10%=0 
Cholesterol >400mg=2 0-2 <300mg=0 
Fruits and vegetables 0-2 servings=2 0-2 ≥5 servings=0 
Breads, cereals, and 
legumes 
0-3 servings=2 0-2 ≥6 servings=0 
Protein >150% RDA=2 0-2 ≤100% RDA=0 
Sodium >3400mg=2 0-2 ≤2400mg=0 
Calcium <2/3 DRI*=2 0-2 ≥DRI=0 
*DRI: dietary reference intake   
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Table 6 Diet Quality Index Revised-1999199 
Components Score range Highest score Other score Lowest score 
Total fat 0-10 ≤30%=10 
>30,≤40%=5 
 
>40%=0 
Saturated fatty acid 0-10 
≤10%=10 
 
>10, ≤13%=5 
 
>13%=0 
Cholesterol 0-10 ≤300mg=10 
>300, ≤400mg=5 
 
>400mg=0 
Fruit 0-10 2-4 servings 
Calculated proportionally according to the 
recommended intake 
Vegetables 0-10 3-5 servings 
Grains 0-10 6-11 servings 
Calcium 0-10 
% adequate intake 
value for age 
Iron 0-10 % 1989 RDA for age 
Dietary diversity score 0-10 
Any food group out of 4 has a maximum point of 2.5(out of 10 in total). 
The score was calculated proportionally. 
Dietary moderation 
score 
0-10 
Any component out of 4 has a maximum point of 2.5 (out of 10 in total). 
Each component has score cut-points at 2.5, 1.5, 1.0, and 0. 
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Mediterranean Diet Score 
The Mediterranean diet has been supported by institutions since early 1990s due to 
its suspected beneficial effects in certain populations.200 The highest life expectancy 
and the lowest prevalence of coronary heart disease, certain cancers, and some other 
diet-related chronic diseases in 1960s were observed in Crete, most of Greece, and 
southern Italy. Moreover, studies showed that some dietary patterns which share the 
similarities with Mediterranean diet have been associated with low risk of some 
chronic diseases. In 1995, Trichopoulou proposed the Mediterranean Diet Score 
based on a traditional Mediterranean diet which is characterised by a high intake of 
fruits and vegetables, legumes and nuts, cereals, fish, and olive oil (as the main 
source of fat), but a low intake of saturated fats, a low-to-moderate intake of dairy 
products, a low red meat intake, and a regular and moderate alcohol intake during 
meals.201 The Mediterranean Diet was revised in 2003 and now included nine 
components: vegetables, legumes, fruits and nuts, fish, meat, poultry, dairy products, 
ethanol, and ratio of monounsaturated lipids to saturated lipids.202 As beneficial 
components, vegetables, legumes, fruits and nuts, fish, and ratio of monounsaturated 
lipids to saturated lipids, a score of 1 was assigned to participants who have a 
consumption at or above the median intake, while score of 0 was assigned to those 
whose consumption was below the median intake; as detrimental components, meat, 
poultry, and dairy products, a score of 1 was assigned to participants who have a 
consumption below the median intake, while score of 0 was assigned to whom have 
a consumption at or above the median intake.  For ethanol, a score of 1 was assigned 
to men who have a consumption between 10 and 50 gram per day, and women who 
have a consumption between 5 and 25 gram per day, otherwise a 0 score was 
assigned. In total, the Mediterranean Diet Score ranges from 0 to 9, with a high score 
representing a better quality diet (see Table 7).  
54 
 
 
 
Table 7 Mediterranean Diet Score-2003202 
Components Score range Highest score Lowest score 
Vegetables 0-1 
Beneficial 
components: if a 
person’s 
consumption is 
above the median, a 
score 1 is assigned. 
If a person’s 
consumption is 
below the median, a 
score 0 is assigned. 
Legumes 0-1 
Fruits and nuts 0-1 
Fish 0-1 
Monosaturated 
lipds:saturated lipids 
0-1 
Meat 0-1 Detrimental 
components: if a 
person’s 
consumption is 
below the median, a 
score 1is assigned. 
If a person’s 
consumption is 
above the median, a 
score 0 is assigned. 
Poultry 0-1 
Dairy products 0-1 
Ethanol 0-1 
Men: 10-50g/day= 1 
Women: 5-
25g/day=1 
Men: <10 or 
>50g/day=0 
Women: <5 or 
25g/day=0 
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Healthy Diet Indicator 
The Healthy Diet Indicator was first developed by Huijbregts and colleagues in 
1997.203 The Healthy Diet Indicator was developed based on World Health 
Organisation (WHO) daily dietary guidelines for the prevention of chronic diseases.204 
There are nine components in the Healthy Diet Indicator: saturated fatty acids, 
polyunsaturated fatty acids, protein, complex carbohydrates, dietary fibre, fruits and 
vegetables, pulses/nuts/seeds, monosaccharides and disaccharides, and cholesterol. 
Each component was generated into a dichotomous variable: a score of 1 was 
assigned to participants who have daily consumption of food within the recommended 
range, otherwise a score of 0 was assigned. The total score of Healthy Diet Indicator 
ranges from 0 to 9 (see Table 8). In 2003, WHO updated the daily dietary guidelines 
for the prevention of chronic disease, and 15 dietary factors were included in the 
guidelines: total fat, saturated fatty acids, polyunsaturated fatty acids, n-6 
polyunsaturated fatty acids, n-3 polyunsaturated fatty acids, trans fatty acids, 
monounsaturated fatty acids, total carbohydrate, free sugars, protein, cholesterol, 
sodium chloride, fruits and vegetables, total dietary fibre, non-starch 
polysaccharides.205 In Table 9, the HDI score adapted to the updated WHO guidelines 
is shown.  
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Table 8 Healthy Diet Indicator-1997203 
Components Score range 
Highest score 
(daily) 
Lowest score 
(daily) 
Saturated fatty acids 0-1 
0-10% of energy 
intake 
>10% 
Polyunsaturated fatty acids 0-1 3-7% <3% or >7% 
Protein 0-1 10-15% <10% or >15% 
Complex carbohydrates 0-1 50-70% <50% or >70% 
Dietary fibre (g) 0-1 27-40g <27g or >40g 
Fruits and vegetables (g) 0-1 ≥400g <400g 
Pulses, nuts, seeds (g) 0-1 ≥30g <30g 
Monosaccharides and 
disaccharides 
0-1 0-10% >10% 
Cholesterol (mg) 0-1 0-300mg >300mg 
 
 
Table 9 Healthy Diet Indicator adapted to updated WHO guidelines-2003 
 
Components 
Score 
range 
Highest score 
(daily) 
Lowest score 
(daily) 
Saturated fatty acids 0-1 
0-10% of energy 
intake 
>10% 
Polyunsaturated fatty acids 0-1 6-10% <6% or >10% 
Protein 0-1 10-15% <10% or >15% 
Complex carbohydrates 0-1 50-70% <50% or >70% 
Dietary fibre (g) 0-1 27-40g <27g or >40g 
Fruits and vegetables (g) 0-1 ≥400g <400g 
Pulses, nuts, seeds (g) 0-1 ≥30g <30g 
Monosaccharides and 
disaccharides 
0-1 0-10% >10% 
Cholesterol (mg) 0-1 0-300mg >300mg 
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The above four most popular ‘a priori’ dietary patterns vary in both their components 
and score system. The Healthy Eating Index, Diet Quality Index, and Healthy Diet 
Indicator include a mix of components in both nutrients and foods, while the 
Mediterranean Diet Score includes foods and a ratio of monosaturated lipids and 
saturated lipids.  
Although the components in these dietary indices and patterns are different from each 
other, there are still some specific foods/nutrients included in all patterns; they are 
fruits, vegetables, cholesterol, sodium, and saturated/unsaturated fatty acids. In the 
Healthy Eating Index, Diet Quality Index, and Healthy Diet Indicator, the scoring is 
based on dietary guidelines to set certain cut-points for each component, while the 
Mediterranean Diet Scale used the group median as the cut-points for each dietary 
component (except for ethanol). The disadvantages of using the median as cut-points 
have been widely discussed.206  Since the median is not based on any scientific 
guidelines, the value of the cut-point does not necessarily reflect a healthy cut-off 
value; moreover, the median would differ in different populations and studies, which 
makes comparison between studies difficult. The Healthy Diet Indicator, defined by 
Huijbregts203 in 1997 and adapted it to WHO 2003 guidelines,205 is the main 
explanatory variable used in this thesis, and its use in health research to date is 
summarised in the section 2.8. 
2.7.2 A posteriori dietary patterns 
A posteriori dietary patterns are derived using statistical methods, and are not based 
on any predefined dietary guidelines. The statistical methods included so far in 
population studies are factor analysis, principal components analysis, cluster 
analysis, and reduced rank regression. Although these three methods share the same 
aim in dietary pattern research, they are different in some ways. Factor analysis and 
principal component analysis are essentially dealing with the same problems in the 
data, however, factor analyses analyse covariance while principal component analyse 
variance. In addition, principal component analysis assumes that the components 
derived depend on the observed measures, while factor analysis has a reversed 
direction- observed measures are based on latent factors. Reduced rank regression 
is very different from the aforementioned two methods, it accounts for a priori 
information on the pathways between predictors (dietary factors) and responses 
(health outcome).207  The summary of literature on posteriori dietary patterns and 
metabolic syndrome will be discussed in section 2.10. 
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2.7.3 Strengths and limitations of a priori and a posteriori dietary patterns 
The strengths and limitations of a priori and a posteriori dietary patterns have been 
discussed for the past two decades. A priori dietary patterns and a posteriori including 
nutrients, food group, or a mix of both could represent total diet in study population; 
moreover, both methods can be used to examine the association between dietary 
patterns and health outcomes. Apart from this, there are some more advantages of 
using a priori dietary patterns in research. First, a priori dietary patterns are score-
based indices which are typically easier to calculate and interpret. Second, a priori 
dietary patterns are based on dietary guidelines which made it easy to reproduce the 
dietary patterns in different population (eg, different countries) and to compare the 
dietary intake status between different studies. The advantages of using a posteriori 
dietary patterns in research are: first, the patterns can describe the variation in food 
intake based on the correlation between different food intakes; second, in cluster 
analysis, people with similar dietary intake patterns are separated to same group; 
third, in reduced rank regression, it also helps understand the pathways between diet 
and health outcomes.  
Both a priori and a posteriori methods have limitations. A priori dietary pattern 
methods are often dichotomise/categorised dietary data, therefore lose potentially 
valuable information; second, the different food groups are typically equally weighted 
partitions (eg, fruit group, nut group), this assumes that certain components in diet are 
equally important. A posteriori dietary patterns differ in different datasets, which 
makes it difficult to make comparison between studies; secondly, there are subjective 
decisions to make while deriving dietary patterns using statistical methods—for 
example, grouping the dietary factors (eg, including potato in the vegetable group or 
not), the forms of the input variables (eg, portions/grams/percentage of energy 
intake), selecting the final patterns (eg, using eigenvalue>1). 
2.8 Healthy Diet Indicator and health outcomes 
Since the Healthy Diet Indicator (HDI) was proposed in 1997, over the past two 
decades, its association with a variety of different health outcomes has examined, 
such as mortality, cognitive function, and cancer risks. The characteristics of 
epidemiological studies using HDI as a dietary exposure are summarised in Table 10.  
The association between HDI and mortality was first examined in western European 
populations, and later in other populations.203;208-210 Huijbregts and colleagues found 
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that people with higher adherence to HDI (in Finland, the Netherlands, and Italy) had 
13% less risk of all-cause death compared with those with lower adherence to HDI 
after 20 years follow-up (RR=0.87, 95%CI: 0.77-0.98).203 Knoops and colleagues 
examined the association between HDI and 10-year mortality in HALE project 
(Healthy Ageing: a Longitudinal study in Europe).208 They also showed a mild inverse 
association between high HDI score and all-cause mortality (HR=0.89, 95%CI: 0.81-
0.98). However, in some small population studies, the mild protective effect of high 
HDI score on mortality was not found. Sjogren and colleagues found no association 
between HDI score and all-cause mortality or cardiovascular disease mortality in a 
Swedish population sample.209 A Polish study showed that women aged 75-80 years 
with lower HDI score had 39% lower of the risk of all-cause death, but the association 
was not found among men.210   
The association between HDI and cognitive function was also investigated in several 
studies. Huijbregts et al found that an increased HDI score was associated with lower 
prevalence of mild cognitive impairment (OR=0.87, 95%CI: 0.77-0.99).211 Correa 
Leite  et al also found that a better HDI score was associated with a lower prevalence 
of cognitive deficit (OR=0.85, 95%CI: 0.77-0.93).212 
Cade et al and Berentzen et al investigated HDI score in relation to cancer risks.213;214 
Cade et al did not find that HDI score was associated with breast cancer risk after 9-
year follow-up.213 In addition, Berentzen et al’s study showed that the adherence to 
HDI was not associated with overall cancer risk, smoking-related cancer risk, or 
alcohol-related cancer risk.214 
Apart from the aforementioned health outcomes, some studies also focused on the 
association between HDI and biomarkers. In the Framingham Heart Study and 
SENECA (Survey in Europe on Nutrition and the Elderly: a Concerted Action) study, 
Haveman-Nies and colleagues showed that people with HDI score greater than 3 had 
smaller waist circumference and lower body mass index than people with HDI score 
less than 3.215 
Other studies have investigated HDI and health outcomes using specific population 
group, such as diabetes patients and children.216-218 In addition, Rodrigues et al and 
Cade et al investigated the association between HDI and socioeconomic status.219;220 
The details of these studies are presented in Table 10.  
Since 1997, the effect of HDI on health has not been investigated in Central and 
Eastern European Countries. Apart from the aforementioned mortality study in 
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Poland, to the author’s knowledge, there is only one study focused on the dietary 
adherence on HDI in the Czech Republic, Russia, and Poland.37 Using data from 
HAPIEE study, Boylan et al showed a low adherence to HDI in the above regions with 
mean HDI score ranging from 1.0 to 1.7 out of a total score of 7. Few participants met 
HDI guidelines on complex carbohydrates, pulses or nuts, and the intake of saturated 
fatty acids, sugar, and protein exceeded the WHO’s recommendation limits.  
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Table 10  Healthy diet indicator in health research 
Authors 
(year) 
Study type Follow-
up time  
Country  Sample 
characteristics  
Outcome 
/exposure  
Dietary 
assessment 
method 
Exposure (HDI forms) Results  
Huijbregts 
et al. 
(1997)203 
Cohort 
study 
20 
years 
Finland, Italy, the 
Netherlands (5 
cohorts) 
Sample size: 
3045  
Age: 50-70yrs 
Sex: Men 
Mortality Cross check 
dietary history  
Based on WHO 
guideline 1990.  
9 components: SFA, 
PUFA, protein, complex 
carbohydrates, dietary 
fibre, fruits and 
vegetables, 
pulses/nuts/seeds, 
monosaccharides and 
disaccharides, 
cholesterol.  
HDI was associated 
with increased risk of 
mortality.  
Huijbregts 
et al. 
(1998)211 
Cross-
sectional 
study 
 n/a Finland, The 
Netherlands, and 
Italy  
Sample 
size:1049 
Age: 70-91yrs  
Sex: men. 
Cognitive 
function (Mini-
Mental State 
Examination), a 
score of 23 or 
lower was used 
to indicate 
cognitive 
impairment 
Cross check 
dietary history 
Same Huijbregts et al. 
(1997) 
HDI score was 
inversely associated 
with mild cognitive 
impairment. 
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Authors 
(year) 
Study type Follow-
up time  
Country  Sample 
characteristics  
Outcome 
/exposure  
Dietary 
assessment 
method 
Exposure (HDI forms) Results  
Cade et al. 
(1999)221 
Cross-
sectional 
study 
n/a UK Sample 
size:15191 
Age: 35-69yrs 
Sex: women 
Same Huijbregts 
et al. (1997) 
excluded 
cholesterol 
FFQ Direct costs and indirect 
costs 
Increased costs was 
associated with higher 
dietary score  
Correa 
Leite et al. 
(2001)212 
Cross-
sectional 
study  
 n/a Italy Sample size: 
1651  
Age : >=65 yrs  
Sex: men and 
women 
Cognitive 
function 
(cognitive deficit) 
FFQ Same Huijbregts et al. 
(1997) 
HDI score was 
associated with lower 
prevalence of cognitive 
deficit.  
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Authors 
(year) 
Study type Follow-
up time  
Country  Sample 
characteristics  
Outcome 
/exposure  
Dietary 
assessment 
method 
Exposure (HDI forms) Results  
Haveman-
Nies A et al. 
(2001)215 
Cross-
sectional 
study (multi-
centred) 
n/a  U.S., Belgium, 
Denmark, Italy, 
The Netherlands, 
Portugal, Spain, 
Switzerland 
Sample 
size:1110    
Age: 70-77yrs     
Sex: men and 
women   
Serum albumin, 
haemoglobin, 
BMI, waist 
circumference 
FFQ & dietary 
history method 
Same Huijbregts et al. 
(1997)  
Waist circumference 
and BMI were 
significant lower in 
people with high HDI 
score (>3) compared to 
the low HDI 
counterparts (≤3). 
Knoops et 
al. (2006)208 
Cohort 
study (multi-
centred) 
10 
years 
Belgium, 
Denmark, France, 
Greece, Italy, The 
Netherlands, 
Portugal, Spain, 
Switzerland, 
Finland  
Sample size: 
3093 
Age: 70-90 yrs 
Sex: men and 
women 
All-cause 
mortality 
Dietary history  Same Huijbregts et al. 
(1997) 
HDI score was 
inversely associated 
with mortality. SFA 
intake was positively 
associated with 
mortality. The intake of 
fibres and fruits and 
vegetables was 
inversely associated 
with mortality. 
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Authors 
(year) 
Study type Follow-
up time  
Country  Sample 
characteristics  
Outcome 
/exposure  
Dietary 
assessment 
method 
Exposure (HDI forms) Results  
Rodrigues 
et al. 
(2008)220 
Cohort 
study 
10 
years 
Portugal Sample size: 
10020 
households 
Age: all 
Sex: men and 
women  
Education, 
urbanisation, 
household 
income, 
expenditures on 
outside home 
food 
Data food 
networking 
(food 
availability 
from surveys) 
Revised version of HDI: 
added sodium and 
alcohol in the HDI. Also, 
they revised the cut-
points of PUFA, and fibre 
in accordance with the 
new 2003 WHO/FAO 
guidelines.  
Households whose 
head had higher 
education, living in 
more urbanised areas, 
from the Azores region, 
and with higher income 
or higher expenditure 
on outside home food 
were more likely to 
have a low-quality diet 
(either low HDIr or 
Mediterranean 
Adequacy Index score) 
Sjogren et 
al. (2010)209 
Cohort 10 
years 
Sweden Sample 
size:1221  
Age:70yrs  
Sex: men 
All-cause 
mortality and 
CVD mortality 
7-day dietary 
record 
Based on WHO 2003. 
HDI was modified under 
the guidelines advocated 
by the Swedish 
recommendations (-1-8 
scores). HDI includes 
SFA, PUFA, protein, 
total carbohydrates, 
sucrose, fibre, fruit and 
vegetables, cholesterol, 
fish (9 components)  
No association 
between HDI and all-
cause or CVD mortality 
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Authors 
(year) 
Study type Follow-
up time  
Country  Sample 
characteristics  
Outcome 
/exposure  
Dietary 
assessment 
method 
Exposure (HDI forms) Results  
Frackiewicz 
et al (2010) 
Cohort 
study 
Not 
clear 
 
Poland(Warsaw) 
 
Sample size: 411  
Age: 75-80 yrs  
Sex: men and 
women 
 
All-cause 
mortality 
 
3-day food 
intake 
 
Same Huijbregts et al. 
(1997) 
the risk of all-cause 
mortality was 
statistically significantly 
lower in women with 
lower HDI and DQI-R 
compared to women 
with higher quality of 
diet. A similar tendency 
was shown for MDS 
indicator.  
 
Cade et al 
(2011) 
 
Cohort 
study 
 
9yrs UK 
 
Sample size: 
33731  
Age:35-69 yrs at 
baseline  
Sex: women 
 
Breast cancer FFQ HDI was based on WHO 
2003 10 components: 
total fatty acids, 
saturated fatty acids, 
polyunsaturated fatty 
acids, total 
carbohydrates, non-
starch polysaccharides, 
fruits and vegetables, 
protein, cholesterol, 
salts. 
HDI was not associated 
with breast cancer risk 
 
Jennings et 
al (2011) 
 
cross-
sectional 
study 
 
n/a UK 
 
Sample size: 
1700  
Age: 9-10 yrs  
Sex: boys and 
girls 
 
Weight status 
 
4-day food 
diary 
HDI score were modified 
to be reflective of 
children's diets 
 
High HDI score was 
associated with 
improved weight status. 
Comparing extreme 
quintiles of HDI scores 
were associated with 
lower waist 
circumference and 
lower body fat.  
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Authors 
(year) 
Study type Follow-
up time  
Country  Sample 
characteristics  
Outcome 
/exposure  
Dietary 
assessment 
method 
Exposure (HDI forms) Results  
Berentzen 
et al 2013 
 
Cohort 
study 
 
12.7 yrs 
 
The Netherlands 
 
Sample size: 
35555  
Age: 20-65 yrs at 
baseline  
Sex: men and 
women 
 
Overall Cancer 
Risk, smoking 
related cancer, 
alcohol-related 
cancer 
 
FFQ Based on WHO 2003. 7 
components: SFA, 
PUFA, cholesterol, 
protein, dietary fibre, 
fruits and vegetables, 
free sugars. 
 
Adherence to the HDI 
was not associated with 
reduced overall cancer 
risk or smoking-related 
cancer, or alcohol-
related cancer 
 
Kim et al 
(2013) 
 
cross-
sectional 
study 
 
 Korea 
 
Sample size: 110 
consecutive 
outpatients with 
type 2 diabetes. 
Age:  mean age 
55 yrs  
Sex: men and 
women 
 
HbA1C, fasting 
plasma glucose, 
postprandial 2-h 
glucose  
 
24h dietary 
recall 
Same Huijbregts et al. 
(1997) 
HDI was correlated with 
HbA1c, fasting plasma 
glucose, and 
postprandial 2h glucose 
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Authors 
(year) 
Study type Follow-
up time  
Country  Sample 
characteristics  
Outcome 
/exposure  
Dietary 
assessment 
method 
Exposure (HDI forms) Results  
Murray et al 
(2013) 
 
cross-
sectional 
study 
 
n/a Ireland 
 
Sample size: 111 
Caucasian 
adults(65 with 
type 2 diabetes).  
Age: 30-75 yrs 
Sex: men and 
women  
 
n/a 
 
3-day dietary 
diary 
 
Same Huijbregts et al. 
(1997) 
HDI was significantly 
lower among people 
with type 2 diabetes 
compared to people 
without. 
 
Atkins et al 
(2014)222 
Cohort 
study 
11.3 
years 
UK Sample size: 
3328 
Age: 60-79 years 
Sex: men 
CVD and all-
cause mortality, 
CVD and CHD 
events 
FFQ Same Huijbregts et al. 
(1997) but modified 
PUFA, fibre, and 
fruits/vegetable intake.  
HDI score was not 
associated with any 
outcome of interest. But 
higher HDI score  was 
associated with lower 
HDL-C, less chance 
being smokers, heavy 
drinkers, manual social 
class or obese, and 
had lower energy 
intake, and C-reactive 
protein level. Following 
the cholesterol 
guidelines was 
associated with lower 
risk of CVD mortality.  
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Authors 
(year) 
Study type Follow-
up time  
Country  Sample 
characteristics  
Outcome 
/exposure  
Dietary 
assessment 
method 
Exposure (HDI forms) Results  
Santos et al 
(2014)223 
Cross-
sectional 
studies 
(Household 
Budget 
Surveys) 
n/a Portugal  Sample size*: 
1990:3733 
1995:3588 
2000:4003 
2005:4294 
Age: >18years  
Sex: men and 
women 
Education level, 
family income, 
eating out 
expense, region, 
urbanisation 
level 
An open 
questionnaire 
and 
subsequently 
recorded into 
500 codes 
Same as Rodrigues et 
al. (2008) 
Education level, eating 
out expenses were 
inversely associated 
with HDI score, only 
among the solitary 
men, education level 
was positively 
associated with HDI 
score. 
 
*Household surveys including years of 1990, 1995, 2000, and 2005. 
Abbreviations: WHO- World Health Organisation; HDI- Healthy Diet Indicator; SFA- saturated fatty acids; PUFA- polyunsaturated fatty acids; FFQ- 
food frequency questionnaire; CVD- cardiovascular disease 
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2.9 HDI in relation to metabolic syndrome and its components   
In this section, the literature on HDI and its dietary components in relation to metabolic 
syndrome will be discussed first; then the literature on HDI and its dietary components 
in relation to components of metabolic syndrome will be discussed. Finally, some 
literature on other a priori dietary patterns (Healthy Eating Index, Diet Quality Index, 
and Mediterranean Diet Score) in relation to metabolic syndrome will be discussed.  
2.9.1 HDI, components of HDI and metabolic syndrome 
To the author’s knowledge, there is only one study examining HDI and metabolic 
syndrome. Alkerwi et al conducted a cross-sectional study among 1349 Europid 
adults aged 18-69 years in Luxembourg to examine the relationship between dietary 
factors and metabolic syndrome risk.224 The dietary score developed by the authors 
was called as Diet Quality Index according to WHO dietary recommendations on 
prevention of chronic diseases—the dietary reference base of the HDI.205 In Alkerwi 
et al’s study, the HDI was consisted of 13 components: saturated fatty acids, 
polyunsaturated fatty acids, monounsaturated fatty acids, overall fat consumption, n-
6:n3 fatty acids, cholesterol, total carbohydrates, simple sugars, total daily energy 
intake, Na, fruits and vegetables, total fibre, and soluble fibre. However, no 
association was found between HDI and metabolic syndrome risk (unified 
AHA/NHLBI&IDF definition).  
Apart from this study on HDI and metabolic syndrome, some studies have examined 
the association between dietary components of HDI and metabolic syndrome. In the 
following sections, the intake of saturated fatty acids, polyunsaturated fatty acids, 
protein, complex carbohydrate, dietary fibre, fruits and vegetables, pulses/nuts/seeds, 
and monosaccharides/disaccharides in relation to metabolic syndrome risk will be 
discussed.  
Saturated fatty acids 
Two studies have examined the association between saturated fatty acids intake and 
metabolic syndrome risk. Hosseini-Esfahani et al found that the high intake of 
saturated fatty acids was associated with increased risk of metabolic syndrome 
(modified ATPIII definition- waist circumference≥95cm in both sexes) among 2510 
Iranian adults aged 19 to 70 years.225 De Oliveira et al also found that high saturated 
fatty acids intake (more than 10% of the daily total energy intake) was associated with 
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twofold risk of having metabolic syndrome (modified ATP III definition- 
glucose≥100mg/dL) compared to their counterparts among 305 Brazilian adults.46 
Polyunsaturated fatty acids 
Only one study has been found on polyunsaturated fatty acids intake and metabolic 
syndrome. Alkerwi et al found no association between polyunsaturated fatty acid 
intake (preferable intake: 6-10% of total energy intake) and metabolic syndrome risk 
among 1349 Europid adults aged 18-69 years in Luxembourg.224 
Protein 
Two studies have examined protein intake in relation to metabolic syndrome risk. 
Damiao et al examined dietary intakes and metabolic syndrome risk among 151 
Japanese-Brazilians aged 40-79 years at the baseline.226 After 7 years follow-up, they 
found that the protein intake was higher among men with metabolic syndrome 
compared to those without; moreover, the study also showed that people with higher 
red meat intake (mostly protein and fat) was associated with 4.7 folds higher risk of 
having metabolic syndrome compared to those with lower intake, however, the 
association disappeared after adjusting for saturated fatty acids and protein. In 
addition, Alkerwi et al found that the protein intake lower than 10% or higher than 15% 
of total energy intake was significantly associated with 56% higher risk of having 
metabolic syndrome among 1349 Europid adults aged 18-69 years in Luxembourg.224 
Complex carbohydrate  
Four studies have examined the carbohydrate intake in relation to metabolic 
syndrome. Kim et al conducted a study among 910 middle-aged Korean adults and 
found that high intake of dietary carbohydrate was associated with increased risk of 
metabolic syndrome in women but not in men.227 In another Korean study, similar 
results were found. Song et al examined the association between carbohydrate intake 
and metabolic syndrome risk among 6845 Korean adults aged 30-65 years in the 
Fourth Korea National Health and Nutrition Examination Survey (KNHANES 2007-
2009).228 They found that high energy intake from carbohydrate was associated with 
increased risk of metabolic syndrome (modified ATP III definition) among men, but 
the association was not found among women. Moreover, high intake of refined grains 
and white rice were associated with increased risk of metabolic syndrome in women 
but not in men.  
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However, Kouki et al found no association between white bread intake and risk of 
metabolic syndrome among either men or women aged 57-78 years in Dose 
Responses to Exercise Training study.45 In addition, Alkerwi et al also found no 
association between total carbohydrates intake (preferable intake: 55-75% of energy 
intake) and metabolic syndrome risk among 1349 Europid adults aged 18-69 years in 
Luxembourg.224 
Dietary fibre 
Three studies have examined the dietary fibre intake and metabolic syndrome risk. 
McKeown et al examined the association between dietary factors and the prevalence 
of metabolic syndrome among 2834 subjects aged 26-82 years in the Framingham 
Offspring Study.44 They found that people with higher cereal fibre intake were 38% 
less likely to have metabolic syndrome compared to those with lower intake. Hosseini-
Esfahani et al also found that the low intake of dietary fibre was associated with high 
risk of metabolic syndrome among 2510 Iranian adults aged between 19 and 70 
years.225 
However, Alkerwi et al found no association between total fibre intake or soluble fibre 
intake (preferable intake: >25g/day and >10g/day respectively) and metabolic 
syndrome risk among 1349 Europid adults aged 18-69 years in Luxembourg.224 
Fruits and vegetables 
Seven studies have examined the fruits and vegetable intake in relation to metabolic 
syndrome. Esmaillzadeh et al found that people with higher consumption of fruits was 
associated with 34% lower risk of having metabolic syndrome (ATP III definition), and 
people with higher consumption of vegetables was associated with 30% lower risk of 
having metabolic syndrome compared to their counterparts among 486 Iranian female 
teachers aged 40-60 years.42 De Oliveira et al also found that people having more 
than 3 servings of fruits per day was associated with 48% less risk of having metabolic 
syndrome (modified ATP III definition- glucose≥100mg/dL) compared to people have 
less than 3 servings in a Brazilian study consisted of 305 adults aged ≥35 years.46 In 
addition, Kouki et al found that high intake of vegetables was associated with 
decreased risk of metabolic syndrome (ATP III definition) among women (n=671) and 
men (n=673) aged 57-78 years after adjusting for age, alcohol consumption and 
smoking in the Dose Responses to Exercise Training study.45 However, after adding 
education and maximal oxygen uptake in the model, no association between 
vegetable intake and risk of metabolic syndrome was found. The similar results were 
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found between non-root vegetables and metabolic syndrome risk. Moreover, the 
study also showed that high berries intake was associated with decreased risk of 
metabolic syndrome among men, but this association was not found in women. Also, 
Yoo et al found that people with no metabolic syndrome component (ATP III definition) 
have much higher fruit and vegetables intake compared to those with 1-2 components 
of metabolic syndrome among 1181 adults aged 19-38 years in the Bogalusa Heart 
Study.229 
However, some studies found no association between fruit/vegetables intake and 
metabolic syndrome risk. Alkerwi et al found no association between fruits and 
vegetables intake (preferable intake: ≥400g/day) and metabolic syndrome risk among 
1349 Europid adults aged 18-69 years in Luxembourg.224 Moreover, Lutsey et al found 
no association between fruit and vegetable intake and metabolic syndrome 
(AHA/NHLBI definition) risk among 9514 adults (mean age was 54 at baseline) in the 
Atherosclerosis Risk in Communities Study after 9 years follow-up.230 Another Iranian 
study also showed the similar results.225  
Pulses, nuts, and seeds 
In total, four studies examined the associations between pulses/nuts/seeds intake and 
metabolic syndrome risk. Kouki et al found that people with high intake of legumes 
and nuts was associated with 40% less risk of having metabolic syndrome compared 
to those with lower intake among men (n=673) aged 57-78 years, but the association 
was not found in women (n=671).45 O’Neil et al found that tree nut consumers had a 
lower prevalence of metabolic syndrome compared to the non-consumers among 
13292 adults aged ≥19 years in the 1999-2004 NHANES.231  Fernandez-Montero et 
al examined the association between tree nut consumption and risk of metabolic 
syndrome (Unified AHA/NHLBI & IDF definition) among 9887 adults (mean age from 
37-41 years) in the Seguimiento Universidad de Navarra, University of Navarra 
Follow-up (SUN) cohort.232 They found that women who had ≥2 servings/week of nut 
had 69% less risk of having metabolic syndrome compared to the non-consumers, 
but the association was not found among men. In the study, they also stratified the 
sample by health professionals. Among health professionals, higher consumption of 
nuts was associated with lower risk of metabolic syndrome, but this association was 
not found in non-health professionals. Ibarrola-Jurado et al also found that high nut 
intake was associated with decreased risk of metabolic syndrome (Unified 
AHA/NHLBI & IDF definition) among 7210 participants with mean age of 67 years in 
the PREvencion con DIeta Mediterranea (PREDIMED) study.233  
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Monosaccharides and disaccharides 
Two studies examined the association between sugar intake and metabolic syndrome 
risk. For example, Alkerwi et al found that sugar intake higher than 10% of the total 
daily energy intake (preferable intake: <10% of energy intake) was associated with 
73% less risk of having metabolic syndrome among 1349 Europid adults aged 18-69 
years in Luxembourg.224 Also, Kouki et al found that high sugar intake was associated 
with decreased risk of metabolic syndrome among men aged 57-78 years in Dose 
Responses to Exercise Training (DR’s EXTRA) study, and the association 
disappeared after adjusting for education and maximal oxygen consumption.45 
Cholesterol  
Only one study was found on cholesterol intake and metabolic syndrome risk. Alkerwi 
et al found no association between cholesterol intake (preferable intake: <300mg/day) 
and metabolic syndrome risk among 1349 Europid adults aged 18-69 years in 
Luxembourg.224 
In the following section, the relationship between HDI and components of metabolic 
will be discussed. 
2.9.2 HDI and components of metabolic syndrome 
To the author’s knowledge, there are few studies examined HDI and components of 
metabolic syndrome. For example, a cross-sectional study conducted in the U.S., 
Belgium, Denmark, Italy, the Netherlands, Portugal, Spain, and Switzerland among 
1110 men and women aged between 70 and 77 years showed that waist 
circumference was significant lower among people with high HDI score compared to 
those with low HDI score;215 moreover, Kim et al found that high HDI score was 
associated with low fasting plasma glucose among 110 consecutive middle aged 
outpatients with type 2 diabetes.216 
In the next section, other a priori dietary patterns (Healthy Eating Index, Diet Quality 
Index, and Mediterranean Diet Score) in relation to metabolic syndrome and its 
components will be discussed.  
2.9.3 Other a priori dietary patterns and metabolic syndrome 
Three studies have examined the association between Healthy Eating Index and 
metabolic syndrome risk. For example, Nicklas and colleagues investigated the 
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association between Healthy Eating Index-2005 and cardiovascular risk factors in 
NHANES 2001-2008 data.234 They found that participants with the highest dietary 
quality of Healthy Eating Index-2005 were 35% less likely to have metabolic syndrome 
(ATP III definition) compared to those with the lowest dietary quality among 18,988 
people aged ≥19 years. Silva and colleagues have compared the Healthy Eating 
Index score between individuals with metabolic syndrome (ATPIII definition) and 
those without among 246 Brazilian.235 Results showed that people without metabolic 
syndrome had higher score in total Healthy Eating Index score, total fat score, and 
diet variety score. In addition, the Whitehall II study showed that the adherence to 
Alternative Healthy Eating index (a revision of Healthy Eating Index) was associated 
with metabolic syndrome reversion after 5 years follow-up among 339 metabolic 
syndrome patients.236 
Two studies have examined the association between Diet Quality Index and metabolic 
syndrome risk. Gregory and colleagues examined Dietary Quality Index- International 
(a revision of Dietary Quality Index) in relation to metabolic syndrome (Unified 
AHA/NHLBI definition) among 1,220 Guatemalan young adults (mean age: 32 
years).237 However, they found no association between Dietary Quality Index-
International and metabolic syndrome. The similar results were found in a Mexican 
study.238 Ramirez-Vargas et al found no protective effect of high Dietary Quality Index 
score on metabolic syndrome among 325 Mexican aged 35-65 years.  
In 2010, a meta-analysis was conducted by Kastorini and colleagues on 50 studies 
relating Mediterranean diet to metabolic syndrome. It suggested that adherence to a 
Mediterranean diet was associated with a 50% reduction in the metabolic 
syndrome.239 In 2013, Esposito and colleagues conducted an updated systematic 
review on Mediterranean diet and metabolic syndrome. They confirmed that the 
adherence to Mediterranean diet was associated with decreased risk of metabolic 
syndrome, and Mediterranean diet should be provoked worldwide.240 
Kouki et al examined reaching dietary recommendations including the vegetables 
intake more than 400g/day, fish more than 2 servings/week, fibre more 14g/1000 kcal, 
saturated fatty acids less than  10% of daily total energy intake in relation to metabolic 
syndrome (ATP III definition) risk.241 A 5-points dietary score was constructed based 
on the adherence to the above dietary factors. They found that high score was 
associated with decreased risk of metabolic syndrome.  
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The above studies showed that better adherence to the Healthy Eating Index, and 
Mediterranean diet were associated with lower metabolic syndrome risk. However, 
the studies reported no association between adherence to Dietary Quality Index and 
metabolic syndrome but they were small studies and the inconclusive results could 
be due to insufficient study power. In the next section, literature on the relationship 
between a priori dietary patterns and components of metabolic syndrome will be 
summarised.  
2.9.4 Other a priori dietary patterns and components of metabolic syndrome 
Many studies have investigated the association between Healthy Eating Index and 
components of metabolic syndrome. For example, Nicklas et al found that participants 
with the highest dietary quality in Healthy Eating Index-2005 were 35% less likely to 
have high waist circumference, 26% less likely to have elevated blood pressure, and 
21% less likely to have decreased HDL-C, compared to those with lowest dietary 
quality in the NHANES 2001-2008 among 18,988 individuals aged ≥19. No 
association was found between Healthy Eating Index-2005 and triglycerides or blood 
glucose.234 Tande et al investigated the relationship between Healthy Eating Index 
and central obesity among 15,658 US adults aged ≥20 years.242 They found that each 
10-unit increase in Healthy Eating Index was associated with 8.3% lower risk of 
central obesity in women and 14.5% lower risk in men. However, Asghari found no 
association between Health Eating Index-2005 and waist circumference.243 In an 
Iranian study consisted of 9568 adults aged ≥19 years, women with higher Healthy 
Eating Index  scores had lower values of systolic blood pressure.244 A French study 
consisted of 5081 men and women aged 35-61 years showed that higher Healthy 
Eating Index score was associated with lower blood pressure among men.245  
Some studies have examined the Diet Quality Index and components of metabolic 
syndrome. For example, Zamora and colleagues found that better adherence to 
Dietary Quality Index was associated with greater increase in HDL-C among 4,381 
people in Coronary Artery Risk Development in Young Adults study.246 Gregory et al 
examined Dietary Quality Index- International (a revision of Dietary Quality Index) in 
relation to metabolic syndrome (Unified AHA/NHLBI definition) among 1220 
Guatemalan young adults(mean age: 32 years).237 However, they found that high 
score in Dietary Quality Index-International was associated with increasing waist 
circumference.  
76 
 
An increasing body of evidence has showed the protective effect of Mediterranean 
diet on metabolic syndrome components. For example, Kastorini et al conducted a 
systematic review and meta-analysis on Mediterranean diet and components of 
metabolic syndrome.239 This study showed that high adherence to Mediterranean diet 
was associated with low waist circumference, high HDL-C, low diastolic blood 
pressure, and low blood glucose. Mediterranean diet score was inversely associated 
with waist circumference.247 Some recent studies have also confirmed the results from 
the previous meta-analysis.247;248  
2.9.5 Summary of the role of a priori dietary measures and their role on 
metabolic syndrome 
Based on a small number of studies on HDI and metabolic syndrome risk, high HDI 
was associated with smaller waist circumference and lower blood glucose level, but 
was not associated with metabolic syndrome risk. More studies have examined the 
separate dietary components of HDI score in relation to metabolic syndrome. High 
saturated fatty acid, carbohydrate intake and low fibre intake were associated with 
increased risk of metabolic syndrome; both low protein and high protein intake was 
associated with increased risk of metabolic syndrome; high intake of fruits, 
vegetables, nuts, and sugar was associated with decreased risk of metabolic 
syndrome; and no association was found between polyunsaturated fatty acids or 
cholesterol intake and metabolic syndrome risk. However, the above results are differ 
between studies, which may due to different study design methods (eg, different 
sample size, different metabolic syndrome definition/measures, age difference, and 
ethnicity differences).  
Studies on other a priori dietary patterns and metabolic syndrome were also reviewed. 
The highly protective effect of Mediterranean diet on metabolic syndrome has been 
supported, while the protective effect of Healthy Eating Index and Diet Quality Index 
on metabolic syndrome was not consistently found. 
In the next few sections, a posteriori dietary patterns and metabolic syndrome will be 
discussed.  
2.10 A posteriori dietary patterns and metabolic syndrome 
In the following section, a posteriori dietary patterns—healthy food pattern, prudent 
dietary pattern, and western food pattern—and metabolic syndrome risk will be 
discussed (see Table 11).  
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2.10.1 A posteriori dietary patterns and metabolic syndrome 
‘Healthy food patterns’ have been found to be protective against having metabolic 
syndrome. These favourable dietary patterns are mainly characterised by high 
consumption of low fat products, such as fish, vegetables, legumes, whole grains 
cereals, fruits, fruit juices, poultry, and tea. The healthy food pattern in the ATTICA 
study (3042 Greeks aged 18 to 89 years) was associated with a lower risk of metabolic 
syndrome after adjusting for smoking status, years of education, income, use of 
medication and BMI.249 A study of 486 Iranian women showed that healthy food 
pattern characterised by high consumption in fruits, tomatoes, poultry, legumes, 
cruciferous and green leafy vegetables, other vegetables, tea, fruit juices, and whole 
grains, was also associated with lower odds of having metabolic syndrome.250 
According to Taiwan National Health and Nutrition Examination Survey, a food pattern 
including lean meat, egg, soybean, vegetables, dark green vegetables, carrot, fruit, 
seaweed, and mushroom was associated with decreased metabolic syndrome risk 
among Taiwanese women.251 However, a study among Brazilian low-income adults 
showed no protective effect of healthy pattern characterised by whole dairy items, 
fresh juices, whole breads, fruits, non-starchy vegetables, homemade popcorn and 
fish on metabolic syndrome risk.252 Comparing study results from different regions, 
regardless of the differences of dietary habits due to cultures, a healthy pattern 
consisting of protein, vegetables, fruits and legumes can be seen as a protective food 
pattern against metabolic syndrome.    
Another dietary pattern called the ‘prudent pattern’ was identified by two studies—one 
cross-sectional study conducted among urban Mexican men and women aged 20-70, 
and the other, a cohort study conducted in US among 9514 people aged 45-64.230;253 
The prudent dietary pattern is similar to the healthy food pattern aforementioned. It is 
characterised by high consumptions of vegetables, fruits, legumes, fish, poultry and 
low consumptions in pastries, refined cereals, and cookies. However, neither of these 
studies found any association between prudent food pattern and risk of metabolic 
syndrome. 
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Table 11 Characteristics of reviewed studies examining associations between a posteriori dietary patterns and metabolic syndrome  
Authors, year  Study type Country n Age (yrs), Sex  Definition  Dietary 
assessment 
Dietary pattern 
identification 
methods 
Panagiotakos et 
al. 2007249 
Cross-sectional 
study 
Greece  3042 18-89 M/F NCEP ATP III FFQ PCA 
Leite and 
Nicolosi 2009254 
Cross-sectional 
study 
Italy  1052 42-74 
M/F 
NCEP ATP III 24h recall & 
FFQ 
Cluster analysis 
Denova-
Gutierrez et al. 
2010253 
Cross-sectional 
study   
Mexico  5240 20-70 
M/F 
NCEP ATP III FFQ Factor analysis 
DiBello et al. 
2009255   
Cross-sectional 
study 
Samoan island 1508 18+ 
 
NCEP ATP III 24h recall &FFQ PLS 
Sonnenberg et 
al. 2005256 
Cohort study  US 1615 18-76 
F 
NCEP ATP III FFQ Cluster analysis  
Fabiana Castillo 
Marsola et al. 
2011252   
Cross-sectional 
study 
Brazil  237 35+ 
M/F 
NCEP ATP III 24h recall &FFQ Varimax rotation 
Esmaillzadeh et 
al. 2007250 
Cross-sectional  Iran 486 40-60 
F 
NCEP ATP III FFQ PCA 
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Authors, year  Study type Country n Age (yrs), Sex  Definition  Dietary 
assessment 
Dietary pattern 
identification 
methods 
Lutsey et al. 
2008230 
Cohort study  US 9514 45-64 
M/F  
rNCEP FFQ PCA 
Yeh et al. 
2011251 
Cross-sectional Taiwan  5647 18+ 
M/F 
IDF FFQ RRR 
Song and 
Joung2011257 
Cross-sectional 
study 
Korea  4730 20+ 
M/F 
NCEP ATP III 
(IDF ethnicity-
specific values 
for waist 
circumference) 
24h recall Cluster analysis 
Duffey et al258 Cohort study US 4161 18-30 
M/F 
NCEP ATP III Dietary history Cluster analysis 
Min et al259 Cross-sectional 
study 
Korea 371 30-50 
M/F 
IDF 24h recall, 2-day 
diet record 
Factor analysis 
Sahay et al Cross-sectional 
study 
Croatia 1442 Not clear Not clear FFQ PCA 
Abbreviation: M- Male; F- Female; FFQ- Food Frequency Questionnaire; PCA- Principal Component Analysis; RRR- Reduced Rank 
Regression; PLS-Partial least squares regression.
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The ‘western food pattern’ is characterised by high intake of pastries, refined 
cereals/grains, red meat, processed meat, sweets, desserts, potatoes, and low 
consumptions in whole grain cereals, seafood, low-fat dairy products was found as 
an unfavourable dietary pattern in three studies. In the Mexican Health Workers 
Cohort Study, Denova-Gutierrez et al found that western food pattern was associated 
with increased risk of metabolic syndrome.253 A cohort study based on Atherosclerosis 
Risk in Communities project showed that western food pattern was positively 
associated with incidence of metabolic syndrome.230 Among Iranian women, a 
western food pattern increased the odds of having metabolic syndrome, and was 
consistent with the results from other studies.250  
Several food patterns, such as high glycaemic index and high-fat pattern (including 
red or white meat and meat products, and potatoes), animal products pattern 
(including meat, eggs, and dairy products), high-protein/fat pattern, or empty calorie 
pattern (higher intakes of total fat, calories, and sweetened beverages and lowest 
intakes of dietary fibre and vegetables) have been identified and all shared similarities 
with western food pattern. Moreover, these food patterns were associated with higher 
odds of having metabolic syndrome.249;253;254;256 However, according to Panagiotakos 
et al, dietary patterns characterised by dairy products and eggs are not associated 
with metabolic syndrome risk.249 A food pattern called ‘modern food pattern’ which is 
similar to western food pattern showed borderline negative effects on metabolic 
syndrome risk among both Samoans and American Samoans.255 
Apart from the patterns described above in this section, several more specific food 
patterns were investigated in various studies. A food pattern typified by alcohol 
beverages was generated in Greek ATTICA study.249 It showed that higher alcohol 
consumption was positively associated with the risk of having metabolic syndrome, 
while no such association was found in a Korean study.257 Leite and Nicolosi found 
that people with higher consumption of starch food pattern (rich in starch, vegetal 
proteins and Na) had 80% greater likelihood of having metabolic syndrome when 
compared to the common group (close to the overall mean expected intakes-
moderately low in fat, and moderately high in carbohydrate); meanwhile, a food 
pattern that consisted of vegetables, legumes, and fruits, showed no association with 
metabolic syndrome risk.254 
Several studies compared different food patterns to traditional food and their 
association with metabolic syndrome risk. These traditional food patterns include food 
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patterns in Samoan Island, Brazil, Iran, and Korea. But no significant protective effect 
was found for metabolic syndrome.250;252;255;257  
Only one study from Korean National Health and Nutrition Examination Survey 
compared the associations between dietary patterns and metabolic syndrome using 
different definitions of metabolic syndrome, but no difference was found.257 
In addition to studies focusing on association between metabolic syndrome and 
dietary patterns, there are many studies evaluating role of dietary patterns on the 
components of metabolic syndrome. The next section will review these. 
2.10.2 A posteriori dietary patterns and components of metabolic syndrome 
A posteriori dietary patterns and central obesity  
Studies have used waist circumference, waist:hip ratio and BMI, as measures of 
central obesity to investigate relationship between this component of metabolic 
syndrome and dietary pattern.  
Some studies showed that western dietary pattern was significantly associated with 
higher odds of having central obesity when using ATPIII criteria (waist circumference 
≥102cm in men and 88cm in women),250;253 while another study did not show any 
significant association between western dietary pattern and central obesity.252 In 
addition, dietary patterns with high glycaemic index and high-fat products and alcohol 
increased the risk of being obese (waist circumference ≥102/88 cm),249 while Delavar 
et al’s study did not find this.260 According to Denova-Gutierrez et al,253 high animal 
protein/fat pattern was also associated with higher risk of having central obesity. A 
healthy food pattern and prudent dietary pattern was generally protective for central 
obesity.250;252;253;260  
When using EGIR criteria for central obesity (waist circumference ≥94/80 cm), results 
showed that there was no significant association between low-fat and high fibre food 
pattern and obesity, but food pattern called fibre bread was inversely associated with 
the risk of having central obesity among men.261 
Williams et al found that a food pattern characterised with high intake of green 
vegetables, fruits, fish, and low intake of fried food, processed meat was negatively 
correlated with waist: hip ratio.262 When using BMI as a measure of central obesity, 
cereals intake pattern has been found to be negatively associated with obesity, while 
a pattern characterised by frequent intakes of confectionery and chocolate but low 
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intake of vegetables was positively correlated with the risk of having higher risk of 
central obesity.262;263  
A posteriori dietary patterns and hypertension  
Blood pressure is another component of metabolic syndrome. Two different 
thresholds for hypertension are used in definitions of metabolic syndrome, with 
≥130/85 mmHg, adopted by ATP III, rNCEP and IDF,63;264;265 and WHO and EGIR 
using ≥140/90 mmHg. In this review, only papers with the NCEP ATP III, rNCEP, and 
IDF definition of hypertension were found, and consequently reviewed.  
The association between dietary patterns and hypertension differs between countries. 
Esmaillzadeh and colleagues identified a healthy food pattern among Iranian women 
aged 40-60, and showed it was associated with lower odds of having elevated blood 
pressure, while western food pattern was associated with higher odds of having 
elevated blood pressure.250 However, another cross-sectional study conducted in 
Iran, found no association between healthy food pattern and hypertension.260 This 
difference may be due to different sample sizes and different statistical methods. A 
Mexican study also showed no significant association between prudent dietary pattern 
(similar to the healthy food pattern) and hypertension, while western pattern modestly 
increased the risk of hypertension.253 A Brazilian cross-sectional study showed that 
there was no association between either western or healthy dietary pattern and 
elevated blood pressure.252 However, this Brazilian study used a low income 
population. Dibello and other researchers identified a ‘modern’ dietary pattern similar 
to the western pattern, among American Samoans and Samoans, but this was not 
associated with hypertension.255 Panagiotakos et al found that a low-fat food pattern 
was associated with reduced risk of high systolic blood pressure (>130 mmHg), and 
higher alcohol consumption was associated with higher risk of having elevated 
systolic pressure.249 
A posteriori dietary patterns and dyslipidaemia 
Most studies investigating the association between dietary pattern and dyslipidaemia 
focused on the separate effects of triglycerides and HDL-C. Only a study by Wirfalt et 
al looked at the association with dyslipidaemia as a whole.261 Among women, a white 
bread food pattern was associated with higher risk of dyslipidaemia, however, this 
association was attenuated when adjusted for fatty acid ratio and intake of some 
micronutrients. Among men, a fibre bread pattern remained modestly associated with 
lower risk of dyslipidaemia.  
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Panagiotakos and colleagues found that low-fat food pattern was positively 
associated with HDL-C level.249 Williams et al found that a dietary pattern typified by 
high consumption of green vegetables, fruits, fish, and low consumption of fried food 
and processed meat, was positively correlated with HDL-C level.262  A study 
conducted by Delavar et al showed that healthy food pattern characterised by low-fat 
products was correlated with high HDL-C level.260 Moreover, Esmaillzadeh et al 
showed healthy food pattern was associated with high HDL-C.250 The Samoan study 
identified a ‘Neo-traditional’ pattern characterised by high intake of crab/lobster, 
coconut products, taro, and low intake of processed foods including potato chips and 
soda.255 Higher intake of this pattern was associated with lower risk of having low 
HDL-C among American Samoans. In addition, a food pattern characterised by high 
intake of dairy products and eggs was positively correlated with HDL-C level.260 
However, according to a Mexican study, a prudent pattern was not associated with 
low HDL-C levels.  
Dietary patterns characterised by high glycaemic index and high-fat and alcohol were 
negatively correlated with HDL-C level according in a Greek study.249 A western food 
pattern was found to have an adverse effect on the risk of lower HDL-C.253;266 
However, high glycaemic index and high-fat pattern were not  associated with HDL-C 
level.260  
A healthy food pattern was negatively correlated with triglycerides level,250;260 but 
another study found no association.252 Moreover, no association between prudent 
pattern and risk of high triglycerides level was found in a Mexican study.253   
The western food pattern was significantly associated with higher risk of having high 
triglycerides level,250;253;266 but some studies found no association.252 According to 
Panagiotakos et al (2007), dairy products, eggs and alcohol pattern were positively 
associated with triglycerides level, but Delavar et al found an inverse relationship 
between them.260 McNaughton et al267 also found that patterns characterised by high 
consumption of white bread, sweetened drinks, lower consumption of vegetables and 
red meat and cabbage were positively associated with triglycerides level. A negative 
association was found between triglycerides level and low-fat products pattern.249;262  
A posteriori dietary patterns and fasting plasma glucose  
A study conducted in Cyprus and the Greek Islands showed that a low-fat food pattern 
was associated with lower fasting blood glucose level, while a study of similar 
population showed inconsistent results.249;263 Delavar et al, Marsola and Esmaillzadeh 
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et al found that healthy food pattern was associated with lower fasting blood glucose 
level.250;252;260 Denova-Gutierrez et al253 showed that the western pattern food was 
associated with higher fasting blood glucose, while several other studies did not find 
significant results.250;252  
2.10.3 Summary of the role of a posteriori dietary pattern and their role on 
metabolic syndrome 
According to the reviewed articles, healthy food pattern/prudent food pattern was 
generally associated with a lower risk of metabolic syndrome, while western food 
pattern was associated with a higher risk of metabolic syndrome and its components. 
However, not all studies found this. 
2.11 Diet in Central and Eastern European countries 
There are only a few studies on nutrition status in the study countries. The diet in this 
region has been known to have high in energy and fat intake, but low in fruit and 
vegetable intake.268-270 This may be because the climate in some areas which is not 
suitable for planting fruits and vegetables, and it may also be due to the previous 
political focus on increasing protein intake (eg, meat and dairy products).271 
After the collapse of the Former Soviet Union, the food market and consumption in 
the Central and Eastern Europe faced a nutrition transition. After 1989, subsidies on 
meat and animal fats ended, which resulted in a decline of fat intake in these 
countries.272 Conversely, consumption of fruits and vegetables increased during this 
time. Moreover, due to the economic and marketing reform, prices for some food 
increased within short periods of time, and this could be the reason certain food (such 
as fresh fish) has not been widely consumed. 
The Household Budget Survey was conducted to examine the dietary changes in the 
region.273 The energy intake was found to increase in 1980s in the Czech Republic 
and Poland, then after 1990, it reduced until 1994-1995, and the consumption 
increased after this. Moreover, between 1989 and 1997, in the Czech Republic, beef 
consumption decreased by 7kg per capita, while the chicken consumption increased 
by 6kg per capita, but consumption of processed meat stayed high in the 1990s.273;274 
In addition, more households started using new cooking methods, such as deep fried 
food. The food pattern in Russia transformed from high consumption of bread and 
potato in 1950s to a high consumption of red meat, milk, and sugar in late 1980s.182 
In 1985, a study showed that compared with U.S. participants, Russian participants 
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had higher intake of saturated fatty acids, but lower intake of polyunsaturated fatty 
acids and protein.275 The results from the Russian Longitudinal Monitoring Survey 
showed that despite the slight decrease of total energy intake, the fat and protein 
intake both decreased among Russian adults, potentially due to increased prices of 
dietary sources of protein and fat.276 Moreover, among the main food groups 
(including fruits and vegetables, meat and fish, dairy, bread, fats, sugar, and eggs), 
consumption decreased except for potato consumption between early 1990s and 
early 2000s.277;278 
However, very limited research on recent diet quality has been done in the region. 
2.12 Literature review summary and gaps in research 
Metabolic syndrome was found to be highly prevalent and strongly associated with 
cardiovascular disease events and mortality. This is likely that diet could play a critical 
role in reducing prevalence of metabolic syndrome, as well as other diseases. 
However, existing evidence is limited and little is known about metabolic syndrome 
prevalence and diet quality in Eastern European countries. 
In the literature, evidence of a priori dietary patterns in relation to metabolic syndrome 
needs to be developed further, especially on HDI and metabolic syndrome research. 
HDI has been recognised as a useful predictor for dietary quality and it has been used 
in international comparison studies in relation to mortality. According to the few 
available studies on HDI and metabolic syndrome risk, high HDI score was not 
associated with metabolic syndrome, but was associated with smaller waist 
circumference and lower blood glucose. However, to the author’s knowledge, there 
are only three studies on HDI and metabolic syndrome risk. The sample sizes of these 
three studies were small (ranging from 110 to 1349), while one of the studies used a 
non-random sampling design, which makes it difficult to compare their results and 
interpret the findings. Although more studies have been done on dietary components 
of HDI and metabolic syndrome, the inconsistent results were possibly due to different 
study characteristics. Therefore, a large population study in different countries using 
a consistent design is needed to better understand the association between HDI and 
metabolic syndrome, especially in Eastern Europe.  
In the posteriori dietary patterns research, the names and composition of dietary 
patterns are numerous among studies but, in general, available literature suggest that 
healthy food pattern has a positive effect on risk of metabolic syndrome (and its 
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components), while western food pattern has an adverse effect; but some inconsistent 
results have been reported. 
To the author’s knowledge, no study of dietary patterns and metabolic syndrome has 
been done in Central and Eastern European Countries, and there are only few studies 
on metabolic syndrome related topics. Moreover, there is no cross-country study with 
a large enough sample size to compare the association between dietary patterns and 
metabolic syndrome in several countries. These gaps can be, at least partially, filled 
by the current study. In addition to filling some gaps in research of metabolic 
syndrome, this thesis also focuses on novel methodological aspects of nutritional 
research. HDI has been used in previous studies almost exclusively as dichotomous, 
and in this thesis, a continuous HDI score with a total score of 70 will be used in order 
to capture the valuable dietary information.  
As highlighted previously, a substantial proportion of the European population are 
estimated to be affected by metabolic syndrome and its components. This suggests 
that the present study would have important public health implications, since dietary 
habits as well as other unhealthy lifestyle behaviours identified could be potentially 
modified. Before designing dietary interventions to reduce metabolic syndrome across 
Europe, it is important to explore the relationships between different dietary patterns 
and metabolic syndrome in a more diverse number of populations. There is a lack of 
such evidence particularly in Central and Eastern European countries. In this thesis, 
dietary pattern and metabolic syndrome in Central and Eastern European countries, 
and its related potential risk factors will be discussed in detail, with the aim of providing 
valuable evidence for policy makers. 
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Chapter 3  Aims and objectives of this thesis 
3.1 Aims 
There are three main aims of this thesis. The first aim is to examine the prevalence of 
metabolic syndrome in the Czech Republic, Russia, and Poland. The second aim is 
to further examine how different dietary patterns among these countries relate to 
social and demographic factors (age, sex, SEP, smoking, physical activity). The third 
aim is to evaluate the association between HDI score and risk of metabolic syndrome 
and its components. 
3.2 Objectives 
By addressing the first aim of the thesis, the specific objectives are: 
1. To examine the prevalence of metabolic syndrome and its components in the 
Czech Republic, Russia, and Poland. 
2. To examine how metabolic syndrome prevalence relates to demographic 
factors (age, sex, SEP) and health behaviours (smoking and physical activity) 
in the Czech Republic, Russia, and Poland. 
 
By addressing the second aim of the thesis, the specific objective is:  
3. To examine and compare dietary patterns in the Czech Republic, Russia, and 
Poland using the HDI; and to further examine HDI in relation to age, sex, SEP, 
smoking, and physical activity in each country.  
 
By addressing the third aim of the thesis, the specific objectives are: 
4. To examine the associations between the HDI and risk of metabolic syndrome 
and its components in the Czech Republic, Russia, and Poland. 
5. To examine the associations between dietary components of the HDI and risk 
of metabolic syndrome and its components in the Czech Republic, Russia, 
and Poland. 
6. To examine the associations between HDI scores and metabolic syndrome 
and its components in the pooled dataset by combining three countries 
together. 
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7. To compare the sample characteristics, and associations between HDI score 
and metabolic syndrome risk using the complete case and imputed data 
sources. 
3.3 Hypotheses  
In response to the objectives, I hypothesised that: 
1. The prevalence of metabolic syndrome and its components is relatively high 
in the Czech Republic, Russia, and Poland compare with Western European 
countries. 
2. The prevalence of metabolic syndrome is higher in men than women in the 
Czech Republic and Poland, but it is higher in women than men in Russia; it 
increases with older age and lower SEP. Non-smokers have lower prevalence 
of metabolic syndrome compared with smokers and past-smokers; physically 
active participants have lower prevalence than physically less active ones. 
3. The study samples have on average a low HDI score, especially low scores 
for saturated fatty acids, dietary fibres, protein, cholesterol, and sugar. HDI 
score increases with older age, higher SEP, and increased physical activity. 
Women have a higher adherence to HDI compared with men, and non-
smokers have a higher adherence to HDI compared with ex- and current 
smokers. 
4. A higher HDI score is associated with lower risk of metabolic syndrome and 
its components, namely, central obesity, raised blood pressure, high 
triglycerides, low HDL-C, and high blood glucose level. 
5. A higher score in HDI individual dietary components is associated with lower 
risk of metabolic syndrome and its components. 
6. A higher HDI score is associated with lower metabolic syndrome risk in the 
pooled dataset, and the magnitude of associations is similar to the country 
specific sample analyses.  
7. The sample characteristics are similar between imputed and restricted sample 
for main analyses, and the positive association between higher HDI and lower 
metabolic syndrome risk is similar to the association found in restricted sample. 
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Chapter 4  Methods 
4.1 Introduction to the HAPIEE study 
This thesis used data from the baseline survey of the HAPIEE (Health, Alcohol and 
Psychosocial factors In Eastern Europe) cohort study. The baseline survey was first 
conducted in the Czech Republic, Russia, and Poland in 2002-2005. The study 
consists of three cohorts in six centres in the Czech Republic (Havirov/Karvina, 
Hradec Kralove, Jihlava, Krometiz, Liberec, and Ústí nad Labem), Russia 
(Novosibirsk), and Poland (Krakow). The planned sample size for each country was 
10,000 men and women aged 45-69 years at baseline. The study sample was 
randomly selected and stratified by gender and 5-year age-groups. Subjects were 
selected from population registers in the Czech Republic and Poland, while the 
Russian sample was selected from electoral lists. In total, 28,945 adults aged 45-69 
years were recruited, including 13,617 men and 15,328 women.18  
The baseline survey included structured questionnaires and a medical examination 
that took place in a clinic. The questionnaires covered health, lifestyle, food frequency 
(in the last 3 months prior to interview), socioeconomic circumstances, psychosocial 
factors, quality of life of retired persons, and psychosocial environment at work of 
those still employed. The medical examination included a fasting venous blood 
sample, measurement of height, weight, leg length, waist and hip circumference, 
blood pressure, lung function and cognitive function testing. In the Czech Republic 
and Poland, questionnaires were completed at home, and then participants were 
invited for a clinical examination in the clinics. In Russia, participants completed both 
questionnaire and the clinical examination in the clinics. Therefore, compared with 
Russia, in the Czech Republic and Poland a slightly smaller proportion of participants 
had both data on questionnaire and clinical examination (82% and 87% respectively). 
The response rates in the wave 1 of HAPIEE study were 55% in the Czech Republic 
and 61% in both Russia and Poland (See Table 12). 
 
90 
 
Table 12 Response rates in the HAPIEE study 
Country N (men ) N (women) 
Total 
participants 
Eligible 
participants 
Response 
rate 
Czech 
Republic 
4123 4734 8857 16100 55% 
Russia 4264 5096 9360 15340 61% 
Poland 5230 5498 10728 17590 61% 
Total 13617 15328 28945 49030  
 
In the following sections, the analytical sample for this PhD thesis will be described, 
along with the definition of metabolic syndrome and its components, the dietary data 
used, study power, analytical methods used, and ethical issues.  
4.2 Analytical sample 
A series of exclusion criteria were used to prepare the data for use in this thesis (see 
Figure 3, Figure 4, and Figure 5 showing the flow charts for each country). First, the 
minority of subjects younger than 45 years old or older than 70 years old at baseline 
were excluded (84 in the Czech Republic, 59 in Russia, and 19 in Poland). Second, 
since body weight is needed in order to calculate extreme nutrient intake (described 
in section 4.5), subjects with missing body weight were excluded (34 in the Czech 
Republic, 0 in Russia, and 21 in Poland). Third, subjects with more than 15 lines of 
the FFQ missing were excluded from the sample (436 in the Czech Republic, 14 in 
Russia, and 276 in Poland).37 Fourth, those who answered ‘No’ to the question ‘Are 
the foods and drinks listed in the previous table representative of the foods and drinks 
that you consumed in the last 3 months’, but did not give any details of other foods 
that are typically eaten more than once a week were excluded (232 in the Czech 
Republic, 29 in Russia, and 378 in Poland). Moreover, subjects with extreme nutrient 
values, based on predicted energy expenditure, were identified and excluded (150 in 
the Czech Republic, 56 in Russia, and 66 in Poland); this will be explained in more 
detail in section 4.7.1. After the exclusion of extreme energy values, subjects were 
excluded if they: reported eating more than 65 portions per day (mean: 32.2, SD: 9.5; 
“65” was more than 6 times of standard deviation of the mean); reporting eating ‘more 
than 6 portions/day’ on 5 or more occasions (mean: 0.5, SD: 0.9; “5” was around 5 
times of standard deviation of the mean); or if the majority of diet intake was tea, 
coffee, or sugar (102 in the Czech Republic, 48 in Russia, and 28 in Poland). In 
addition, subjects with at least one missing component of metabolic syndrome (1866 
in the Czech Republic, 246 in Russia, and 1395 in Poland) were excluded. Finally, 
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subjects with any missing data for covariates were excluded (893 in the Czech 
Republic, 120 in Russia, and 874 in Poland; covariates were education level, smoking 
status, leisure physical activity, sports time, working activity, family history of diabetes 
and stroke, medication for at least one of abnormalities (ie, high cholesterol, diabetes, 
high blood pressure)). The final sample with complete data consisted of 5060 subjects 
in the Czech Republic, 8788 in Russia, and 7671 subjects in Poland aged 45-69 years 
old. 
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Figure 3  Analytical sample selection in the Czech Republic 
 
 
 
8773 subjects 
8739 subjects 
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150 subjects: extreme EI/BMR 
7921 subjects 
102 subjects: extreme number of 
food items consumed per day 
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1866 subjects:outcome missing 
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893 subjects: covariates missing 
8857 subjects 
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Figure 4 Analytical sample selection in Russia 
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Figure 5  Analytical sample selection in Poland 
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4.3 Metabolic syndrome and its components in the HAPIEE study: 
definition and methods of measurement  
Metabolic syndrome and its components are the main outcome measures in this 
thesis. Metabolic syndrome was defined using the ATP III definition.63 Components of 
ATP III metabolic syndrome are central obesity, raised blood pressure, high 
triglycerides, low HDL-C, and raised blood glucose. In this thesis, the ATP III definition 
was slightly modified for raised blood pressure, this minor modification will be 
described below. Each outcome was coded as a dichotomous variable. In the 
following paragraphs, data collection methods and definitions of these parameters will 
be described. 
4.3.1 Central obesity 
Central obesity was defined using waist circumference, and was measured using a 
tape measure. The tape was pulled taut and applied at the half way point between the 
costal margin and iliac crest. Participants were asked to breathe out gently and let 
their arms hang loosely by their sides and look straight ahead. Measurements were 
taken to the nearest 0.1cm and recorded. Central obesity was defined as waist 
circumference ≥102 cm in men or ≥88 cm in women.63 
4.3.2 Raised blood pressure 
Blood pressure was measured using an Omron M5-I digital blood pressure monitor. 
Participants were first asked to sit quietly for 5 minutes before blood pressure taken. 
For each participant, blood pressure was measured three times with two-minute 
intervals.  
The average values of the last two measurements of systolic and diastolic blood 
pressure were used. Where one blood pressure reading was missing, blood pressure 
was calculated as the average of the two available measurements if the difference 
between these two measurements was less than 10mmHg, otherwise the value 
remained as missing; where only one blood pressure reading was available, the 
measurement was assumed to be missing, due to its expected imprecision. Raised 
blood pressure was defined as systolic blood pressure≥130mmHg or diastolic blood 
pressure≥85mmHg.63 In this thesis, subjects that had been told by the doctor as 
having hypertension were also classified as having raised blood pressure; this is a 
minor modification of the original ATP III definition.  
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4.3.3 High triglycerides and low HDL-C 
The venous blood sample was taken from participants’ arm using venepuncture. In 
the Czech Republic, lipid concentrations in serum were measured on a Roche 
COBAS MIRA auto-analyser, using a conventional enzymatic method with reagents 
from Boehringer Mannheim Diagnostics and Hoffman-La Roche. In Russia, lipid 
concentrations in serum were measured using an auto-analyser FP 901 (Finland) 
using an enzymatic method with reagents from Biocon Diagnostic (Germany). In 
Poland, serum lipid analysis was conducted using a Modular P and Hitachi 917 
analyser (Roche) using dedicated Roche reagents. All laboratories in the HAPIEE 
study were certified, and the assay methods were calibrated and with internal quality 
control. High level of triglycerides was defined as ≥1.7 mmol/L and low HDL-C was 
defined as <1.03 mmol/L in men or <1.29 mmol/L in women.63 
4.3.4 High plasma blood glucose 
In the Czech Republic, blood glucose was measured from capillary blood by Reflotron. 
In Russia, blood glucose was measured from serum. In Poland, blood glucose was 
measured in plasma. However, the glucose level described in ATP III metabolic 
syndrome criteria was based on plasma glucose.63 In order to harmonise the glucose 
measures among the three HAPIEE centres, the capillary blood glucose in the Czech 
sample and the serum blood glucose in Russian sample were recalculated to plasma 
glucose equivalent values using the formula suggested by European Society of 
Cardiology and European Association for the Study of Diabetes (see Table 13).279 
Subjects with extreme plasma glucose level were investigated with other related 
variables such as diabetes diagnosis and treatment of diabetes. In the Czech sample, 
two participants with glucose level greater than 20mmol/L had no diagnosis of 
diabetes and no treatment of diabetes records; therefore, their glucose level were 
recoded to missing. When blood glucose level drops to 2.22mmol/L, an apparent 
impairment would occur, but no emergency case was reported during clinical 
examinations.280 Therefore, values of plasma glucose level less than 2.22mmol/L 
were recoded to missing. Raised plasma blood glucose was defined as ≥6.1 mmol/L.63 
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Table 13 Conversion factors between plasma and other vehicles for glucose 
values ii  
Plasma glucose (mmol/L) = 0.558 + 1.119 X whole blood glucose (mmol/L) 
Plasma glucose (mmol/L) = 0.102 + 1.066 X capillary blood glucose (mmol/L) 
Plasma glucose (mmol/L) = - 0.137 + 1.047 X serum glucose (mmol/L) 
 
Standardised plasma glucose by using measurements from Clinical Trial 
Service Unit and Epidemiological Studies Unit (CTSU) laboratory 
Since the methods of collection and analysis of blood glucose were different in the 
three countries, standardising plasma glucose concentrations is needed to enable 
comparison between centres and reduce systematic error. A random sample of 3242 
blood glucose samples selected from all three cohorts were analysed in the CTSU 
laboratory, at Oxford University (987 from the Czech Republic, 1283 from Russia, and 
972 from Poland). A standardised plasma glucose measure was calculated using the 
plasma glucose levels from CTSU, the local plasma glucose levels based on local 
laboratories measurements, and conversion factors from Table 13. This strategy was 
only adopted in the Czech and Polish samples because a continuous value of plasma 
glucose was unavailable from Russian sample. Russian investigators only provided 
the binary variable defining whether glucose levels were <6.1 mmol/L or ≥6.1 mmol/L. 
However, the sensitivity and specificity between the CTSU and local measurements 
were also investigated (see Table 14). As the CTSU measurements were treated as 
the ‘gold standard’, samples have a glucose ≥6.1 mmol/L from the CTSU laboratory 
were treated as the true/confirmed cases. Table 14 shows that 216 samples were 
found have glucose level ≥6.1mmol/L among 388 samples which were identified ≥ 
6.1mmol/L by the local laboratory. In addition, 50 samples were found have glucose 
level ≥ 6.1mmol/L among samples were identified having glucose level <6.1mmol/L 
(851 in total), and these samples were assumed to be falsed categorised into 
‘<6.1mmol/L’. Therefore, the sensitivity of the local laboratory measurements was 
216/266 or 81.2%. This means that among samples have a true value of ≥6.1mmol/L, 
81.2% of these were found have glucose level ≥6.1mmol/L by the local laboratory. 
The specificity of the local laboratory measurements was 801/973 or 82.3%, indicating 
                                               
ii Adapted from Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: 
executive summary279 
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that 82.3% among the samples which have true glucose level < 6.1mmol/L were 
identified correctly. Given the available binary plasma glucose data, the calculation 
based on equation modelling could not be achieved in Russian sample. Therefore, in 
the following section, the detailed methods for calculating the standardised plasma 
glucose in the Czech and Polish samples are explained. 
 
Table 14 Sensitivity and specificity of high blood glucose in randomly 
selected Russian sample 
 CTSU measurements  
Local laboratory 
measurements 
Yes  No Total  
Yes  216 172 388 
No  50 801 851 
Total  266 973 1239 
 
Sensitivity = 216/266 = 81.2% 
Specificity = 801/973 = 82.3% 
 
 
For the purpose of this thesis, the glucose level analysed in CTSU is considered the 
‘gold standard’ because it was analysed in the same laboratory, and it has been used 
in a number of other studies. Thus, it is important to compare the local measurement 
to the ‘gold standard’ values. First, the correlation coefficient between local and CTSU 
glucose levels was calculated for both countries (see Figure 6 and Figure 7). A strong 
linear relationship between local and CTSU glucose level was found in both Czech 
and Polish samples. The correlation coefficients between local and CTSU glucose 
level were large: 0.84 and 0.94 in Czech and Polish sample, respectively; a value of 
1 would indicate perfect correlation  
. 
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Figure 6 Correlation between local and CTSU glucose level in Czech sample 
 
 
Figure 7  Correlation between local and CTSU glucose level in Polish sample 
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Although a strong linear relationship between two measurements was shown, it did 
not necessarily mean the two measures agree.281 Therefore, Bland-Altman plots were 
also created to check agreement between the two measurements in the Czech and 
Polish samples (See Figure 8 and Figure 9). Three horizontal lines in both figures 
show the mean difference between the two measurements, and the mean difference 
plus and minus 2 times the standard deviation (limits of agreement). In the Czech 
sample, 765 (out of 938) participants had lower results of blood glucose in CTSU than 
in local lab, and 569 participants (out of 971) in Polish sample. The mean differences 
between two measures were -0.62 and -0.06 in the Czech and Polish samples, 
respectively; in addition, in both samples, the 95% confidence intervals for limits of 
agreement were small, especially in the Polish sample. This could be due to the 
Reflotron test of blood glucose being imprecise compared with the plasma glucose 
measurements (see Table 15). Therefore, there is a bias between the CTSU (gold 
standard) and local lab glucose results, although no noticeable variation could be 
found in agreement among the range of glucose results.  
 
 
Figure 8  Bland-Altman plot: the agreement of blood glucose between local 
and CTSU measurements in Czech sample 
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Figure 9  Bland-Altman plot: the agreement of blood glucose between local 
and CTSU measurements in Polish sample 
 
Table 15 Agreement statistics between local glucose level and CTSU glucose 
level 
 N 
Mean 
difference 
Lower limit of 
agreement 
(95% CI) 
Upper limit of 
agreement 
(95% CI) 
Czech sample 938 -0.62 
-2.84 
(-2.65, -2.43) 
1.31 
(1.20, 1.41) 
Polish sample 971 -0.06 
-0.88 
(-0.93, -0.84) 
0.77 
(0.72, 0.81) 
 
 
Cook’s distance was also calculated for both samples to identify outliers, and a Cook’s 
distance value > 1 was used to classify an outlier.282 However, in both samples, no 
outliers were identified.  
Finally, robust regression was used to generate equations to estimate the 
standardised plasma glucose values for all participants. In linear regression models, 
CTSU glucose levels were used as the dependent variable and local glucose levels 
used as the independent variable; polynomials were also added into these models to 
achieve a better model fit. In the Polish sample, a simple linear model was selected 
due to a linear relationship between local and CTSU glucose level. In the Czech 
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sample, first, a model including a square polynomials was performed in order to 
achieve a better model fit; however, when adding another cubit polynomial in the 
model, the model fit was significantly better compared to the model only included a 
square polynomials (P<0.001 from a likelihood ratio test). Finally, by comparing the 
statistics of model fit (R-square, RMSE, and F-test) and likelihood ratio test statistics, 
a model including square and cubic polynomials was selected for the Czech sample:  
Czech Republic: Standardised glucose=-1.766local+ 0.251local2- 0.007local3 +8.375 
Poland: Standardised glucose=0.967local+ 0.232 
4.3.5 Metabolic syndrome 
Metabolic syndrome was constructed using the component measures described in 
sections 4.3.1-4.3.4. To be classified as having metabolic syndrome, participants 
must have at least three of the following:63 
1. Central obesity (waist circumference ≥102 cm in men or ≥88 cm in women); 
2. High blood pressure (systolic blood pressure ≥130 mmHg or diastolic blood 
pressure ≥85 mmHg or have been told by the doctor that has hypertension); 
3. High triglycerides (≥1.7 mmol/L);  
4. Low HDL-C (<1.03 mmol/L in men or <1.29 mmol/L in women); 
5. High plasma blood glucose (≥6.1 mmol/L).  
4.4 HDI score and its components 
The Healthy Diet Indicator (HDI) is the main dietary exposure in this thesis. HDI was 
calculated on the basis of the WHO recommendations.205 The dietary data was 
collected using food frequency questionnaire (FFQ).283 The FFQ was adapted from 
the FFQ used in Whitehall II study,284 and has been validated. There were slightly 
different numbers of food items in each country due to the inclusion of country-specific 
dishes. In total, there were 136 items in the Czech Republic, 147 in Russia, and 148 
in Poland. Portion size was specified for each item and country specifically. 
Participants were asked how often, on average, they had consumed such portion of 
the item during the last three months. There were 9 possible responses for each item 
ranging from ‘never or less than once per month’ to ‘six or more times per day’. The 
full English version of FFQ with the additional country specific items marked can be 
found in Appendix I. The strategy of dealing with missing data in FFQ will be explained 
in section 4.7.1. 
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Based on the FFQ, the frequency of food intake was converted into daily food 
consumption. Next, the nutrient content of specific food was multiplied with standard 
portion of the food in order to calculating nutrient intakes. In calculating the nutrient 
intake, the food composition data was mainly based on the McCance & Widdowson’s 
(2002) tables. Food composition was also obtained using country specific food 
composition tables, the United States Department of Agriculture Nutrient Data 
database, International table of glycaemic index and glycaemic load values, and 
manufacturer data.285-288 
In the WHO recommendations,205 there were 15 dietary components. In the HAPPIE 
study, 9 components were selected on the basis of the data collected in the FFQ: 
saturated fatty acids, n-3 polyunsaturated fatty acids, n-6 polyunsaturated fatty acids, 
trans fatty acids, protein, mono and disaccharides, dietary fibre, fruits and vegetables, 
and cholesterol.203  
In this thesis, a short version of HDI was created, which included 7 dietary factors: 
saturated fatty acids, polyunsaturated fatty acids, protein, mono and disaccharides, 
dietary fibre, fruits and vegetables, and cholesterol. Compared with the original 
development of HDI, n-3 polyunsaturated fatty acids and n-6 polyunsaturated fatty 
acids were combined as one component—polyunsaturated fatty acids; furthermore, 
trans fatty acids was omitted. The polyunsaturated fatty acids are commonly used as 
the different fatty acids measures (n-3/6 polyunsaturated fatty acids) do not typically 
provide additional information compared with the single combined measure. The short 
version was created to aid comparisons with findings from other cohorts, because the 
dietary factors included measures that most studies should have, so making 
comparison between different studies easier.  
In the original HDI, each component has a dichotomous score: 0 (not meeting the 
recommendation) and 1 (meeting the recommendation). Recently, it has been 
suggested that adherence to recommended level should be treated as continuous 
measure, with closer adherence given a higher score.289 This continuous scoring 
system was used in this thesis. In the short version of HDI, each component has a 
score ranging from 0-10 (0 represents the worst adherence, 10 represents the best 
adherence). The total score of the HDI has a range of 0-70, with0 representing worst 
adherence and 70 representing the best adherence (see Table 16).  
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Table 16 Short version of the healthy diet indicator 
Components  
Scores 
0 0-10 10 
Saturated fat(energy%) >15 10< x ≤15 ≤10 
PUFA(energy%) >16 0≤ x <6 or 10≤ x <16 6≤ x ≤10 
Protein(energy%)             >25 0≤ x <10 or 15< x ≤25 10≤ x ≤15 
Mono and 
disacharides(energy%) 
>30 10< x ≤30 ≤10 
Dietary fibre(NSP)(g/day) =0 0< x <20 ≥20 
Fruits and 
vegetables(g/day)   
=0 0< x <400 ≥400 
Cholesterol(mg/day) >400 300< x ≤400 ≤300 
4.5 Other variables in the study  
As well as the main exposure (HDI score and its components) and outcome 
(metabolic syndrome and its components) variables, other variables were included in 
analyses as potential confounders or effect modifiers. These were age, sex, education 
level, current economic activity, smoking status, number of hours in leisure time 
physically demanding activities, number of hours engaging in sports, weight, energy 
intake, and  alcohol intake. In the following sections, the definition of these variables 
will be described.  
Age was used both as a continuous and categorical variable. When used as a 
categorical variable, it was categorised to age groups (1) 45-49, (2) 50-54, (3) 55-59, 
(4) 60-64, and (5) 65-69 years. Sex was used as a binary variable with two categories 
of (1) men and (2) women.  
Education was categorised into 4 groups according to the highest completed level: 
(1) no formal education, incomplete primary or complete primary education, (2) 
vocational education, (3) secondary education, and (4) university education.  
Working activity was grouped into 4 categories: (1) non-pensioner working, (2) non-
pensioner not working, (3) pensioner working, and (4) pensioner not working.  
Smoking status was grouped into 3 categories: (1) smokers, (2) past smokers, and 
(3) never smokers.  
Physical activity was classified on the basis of number of hours per day spent on 
physically demanding activities in leisure time, and it was grouped into 4 categories: 
(1) <1h/d, (2) ≥1 and <2h/d, (3) ≥2 and <3h/d, and (4) ≥3h/d. In the Czech Republic, 
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there is only one measure on number of hours per day spent on physically demanding 
activities in leisure time, while in Russia and Poland, most individuals have 2 
measures: a winter and a summer estimate. Therefore, in these two study samples, 
where winter and summer values were given, the average value of two was used; and 
where only one of the values of two was available, the available one was used as the 
final value. Another physical activity measure was classified on the basis of number 
of hours per day engaging in sports, and it was grouped into 3 categories: (1) 0, (2) 
>0 and ≤1h/d, (3)>1h/d. Where more than 8 hours per day was reported as hours per 
day spent on physically demanding activities in leisure time or engaging in sports, 
these values were recoded to missing values (89 and 20 observations respectively). 
Body weight was used in the calculation of basal metabolic rate (BMR) to identify 
extreme energy intake, therefore, data cleaning on weight variable was necessary. 
There are two weight measures in the HAPIEE study, self-reported weight and 
clinically examined weight. Cleaning of weight measure was thus done in two steps. 
First, some implausible values were removed. Second, the clinical weight measure 
was used as ‘gold standard’; however, some participants (in the Czech and Polish 
sample) had clinical measure missing because they did not visit the clinics. Therefore, 
self-reported weight was used together with clinical weight measure in order to 
calculate an objective weight measure using regression equation. These two steps 
will now be explained below. In the self-reported weight, extreme values were coded 
to missing (self-reported weight>200kg). In addition, one participant had weight and 
height data incorrectly transcribed as each other, and this was corrected. There were 
also some other further potentially ‘extreme’ values in both self-reported height and 
weight. However, after data checking based on the comparison of clinical measures, 
energy intake, age, health status (diabetes, high cholesterol, or hypertension 
presented or not), it showed that these potentially ‘extreme’ values were plausible 
because of their reasonable energy intake, height, and health status. For example, 
one person with self-reported weight less than 40kg, but she also had 1.48m height, 
and diagnosed diabetes; thus the low body weight was assumed to be plausible. 
Because of potential reporting bias in self-reported weight, linear regression models 
including objective weight, self-reported weight, sex, age, and education level were 
used to predict the objective weight. After the calculation, the correlation coefficient 
between the predicted objective weight and self-reported weight was 0.98. This 
predicted objective weight was then used to replace the missing data in clinical 
examined weight, and used in further analyses as a measure of personal weight. 
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Thus, participants without the calculated body weight was excluded from the 
analytical sample from the very early stage of sample selection (see Section 4.2).  
Family history of stroke and diabetes were used as the binary variables: (1) having 
parents/sibling suffering from stroke/diabetes, and (2) having no parents/siblings 
suffering from stroke/diabetes.  
Medication for at least one of the abnormalities (ie, high cholesterol, diabetes, high 
blood pressure) was used as a binary variable: (1) yes: have medication for at least 
one of the abnormalities, and (2) have no medication for any of the abnormalities. 
Energy intake was calculated based on FFQ and local food composition data, and 
was used as a continuous variable with unit of kcal/day.37 Alcohol intake also 
calculated from FFQ and was used as a continuous variable with unit of gram/day.  
4.6 Study power  
The HAPIEE study is the largest population study in the Central and Eastern Europe, 
and its large sample size is expected to provide enough study power to examine the 
association between HDI score and metabolic syndrome risk. Because the diagnosis 
of metabolic syndrome depends on the clinical measures, participants who were 
absent in clinical examination were excluded. In the main analyses, a complete cases 
sample was used. The number of subjects excluded from the final sample could likely 
reduce the study power. Therefore, the study power was calculated for the complete 
cases sample. 
Assuming the confidence interval is at 95%, and the odds ratios (OR) in comparing 
metabolic syndrome risk in the bottom quintile of HDI score (the exposed group) to 
the risk in the top quintile of HDI score (the unexposed group) are 1.25, 1.50, and 
2.00, the study powers were calculated accordingly. As shown in Table 17, study 
power for most of the study samples are above 85% apart from the Czech sample 
with OR of 1.25.250 However, in the main analyses of the thesis, the HDI score was 
used as a continuous variable, thus, the study power in each study sample would be 
even higher. Therefore, assuming a moderate effect size, all three current study 
samples have sufficient study power to examine the association between HDI score 
and metabolic syndrome risk.  
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Table 17  Study power calculations in the Czech, Russian, and Polish samples 
OR Study power (95% CI) 
 Czech Republic  Russia Poland 
1.25 71% 91% 87% 
1.50 99% >99.9% >99.9% 
2.00 >99.9% >99.9% >99.9% 
4.7 Analytical methods used in the thesis 
In the following sections, analytical methods including strategies on dealing with 
missing data, and detailed statistical methods used in this thesis will be described 
step by step.  
4.7.1 Missing data and outliers 
Missing data in FFQ 
After excluding subjects with more than 15 missing lines in FFQ, in the remaining 
dietary data, if there were missing data, the items left blank in FFQ were intermittent, 
which means the items were most probably not consumed.183;290-292 The decision was 
taken to change these remaining missing items to zero intakes. As well as cleaning 
the data, this also reduced the number of missing variables and increased the number 
of subjects included in the further statistical analyses. The zero intake settings within 
the missing items could cause misclassification of the food intake, and the alternative 
way of avoiding the misclassification is imputation. However, since the left-blank items 
were not random (it could be due to items not consumed or participant not 
remembering the intake).  
Identification of outliers in FFQ 
The outliers in FFQ nutrients intake was identified on the basis of predicted energy 
expenditure. The predicted energy expenditure was based on the ratio of energy 
intake (EI) to basal metabolic rate (BMR) (ie, EI/BMR). BMR was calculated based on 
the equations by Schofield in 1985 which was summarised in Human Energy 
Requirements by Food and Agriculture Organisation (See Table 18).293 The equations 
are based on subjects’ age, sex, and body weight. The Schofield equation has been 
criticised for its overestimation of BMR populations, especially tropical and Asian 
populations, due to its inclusion of disproportioned Italian subjects in the study sample 
(Italians have a higher BMR than other populations).294 However, compared with the 
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newly developed equations, it has the best performance295 and has been used in 
multiple European population studies.296;297 Subjects with clinical weight variable 
missing were excluded from the study sample before BMR calculation. After the 
calculation of EI/BMR ratio, subjects within the top and bottom 0.5% of the ratio were 
assumed to have extreme nutrient intake, and have been excluded from the study 
sample.298;299 This method of identifying implausible nutrient intake has been used in 
European Prospective Investigation into Cancer and Nutrition (EPIC) study, and 
previously in papers using data from the HAPIEE study, ie, the same sample as this 
thesis.37;298 Although a higher cut-point than 0.5 was suggested in population studies 
with similar sample sizes, it may not suitable for studies with FFQs.300 Moreover, 
exclusion of top and bottom 0.5% of the ratio could also retain greater number of 
valuable data. 
Table 18  Equations for estimating BMR from body weight adapted from 
Human Energy Requirements293 
Age (years ) BMR: kcal/day 
Males  
30-60 11.472kg+873.1 
>=60 11.711kg+587.7 
Females  
30-60 8.126kg+845.6 
>=60 9.082kg+658.5 
 
Missing data on outcome and covariates 
In the thesis, metabolic syndrome and its components are the main outcomes. The 
clinical measures including blood pressure, waist circumference, HDL-C, 
triglycerides, and blood glucose were collected during the clinic visit, participants who 
did not attend the clinic had missing values on these measures. After the previous 
exclusion on age, FFQ, and extreme food intake, as shown in Table 19, a large 
proportion of participants did not have the metabolic syndrome measures, between 
16-20% in the Czech Republic, and around 13% in Poland. In Russia, because both 
the questionnaire and the examination were completed in the clinic, there were fewer 
missing values (<3%). Among people with missing data on metabolic syndrome 
measures, 1316 Czechs, 3 Russians, and 1333 Poles had missing data due to their 
non-attendance of the clinic examination on sites.  
The missing patterns for other variables used in the thesis (see section 4.5) are 
needed to be understood. As shown in Table 20, less than 8% of participants had 
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missing values on covariates in the Czech Republic, while the proportion was less 
than 1% in Russia, and less than 5% in Poland.  
One way of dealing with missing data is omitting the observations with missing data, 
ie complete case analyses. In a complete case scenario, the final sample size in this 
thesis would be 5,060 in the Czech Republic, 8,788 in Russia and 7,671 in Poland 
after a loss of 34.5%, 0.04%, and 22.8% of participants in the Czech Republic, Russia, 
and Poland, respectively. However, by omitting subjects with any missing data, the 
study power would be reduced, and the precision (the confidence intervals) of the 
estimates could be worse (wider). An alternative approach—multiple imputation—for 
dealing with missing data is popular because it can increase study sample size and 
may produce unbiased results. In the following section, the assumptions required for 
multiple imputation will be explained. 
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Table 19 Percentages of missing data on outcomes in the Czech Republic, 
Russia, and Poland 
Country  Variable Missing % 
Czech 
Republic  
(n=7819) 
Waist circumference 1,317 16.84 
Plasma glucose 1,549 19.81 
SBPiii 1st reading 1,318 16.86 
SBP 2nd reading 1,324 16.93 
SBP 3rd reading 1,331 17.02 
DBPiv 1st reading 1,317 16.84 
DBP 2nd reading 1,325 16.95 
DBP 3rd reading 1,331 17.02 
HDL-C 1,620 20.72 
Triglycerides 1,603 20.5 
Russia  
(n=9154) 
Waist circumference 3 0.03 
Plasma glucose 228 2.49 
SBP 1st reading 3 0.03 
SBP 2nd reading 5 0.05 
SBP 3rd reading 6 0.07 
DBP 1st reading 4 0.04 
DBP 2nd reading 5 0.05 
DBP 3rd reading 10 0.11 
HDL-C 30 0.33 
Triglycerides 32 0.35 
Poland 
(n=9940) 
Waist circumference 1,333 13.41 
Plasma glucose 1,338 13.46 
SBP 1st reading 1,333 13.41 
SBP 2nd reading 1,348 13.56 
SBP 3rd reading 1,359 13.67 
DBP 1st reading 1,333 13.41 
DBP 2nd reading 1,349 13.57 
DBP 3rd reading 1,360 13.68 
HDL-C 1,338 13.46 
Triglycerides 1,341 13.49 
                                               
iii SBP: systolic blood pressure 
iv DBP: diastolic blood pressure 
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Table 20 Percentage of missing data on covariates in the Czech Republic, 
Russia, and Poland 
Country  Variable Missing % 
Czech 
Republic 
(n=7819) 
Education  22 0.28 
Smoking 71 0.91 
Working activity 63 0.81 
Leisure activity 238 3.04 
Hours in engaging sports 214 2.74 
Medication for high blood pressure 39 0.5 
Medication for abnormal cholesterol 66 0.84 
Medication for diabetes 26 0.33 
Family history of stroke 590 7.55 
Family history of diabetes 575 7.35 
Russia 
(n=9154) 
Education  0 0 
Smoking 0 0 
Working activity 0 0 
Leisure activity 69 0.75 
Hours in engaging sports 12 0.13 
Medication for high blood pressure 0 0 
Medication for abnormal cholesterol 0 0 
Medication for diabetes 0 0 
Family history of stroke 49 0.54 
Family history of diabetes 49 0.54 
Poland 
(n=9940) 
Education  6 0.06 
Smoking 28 0.28 
Working activity 17 0.17 
Leisure activity 91 0.92 
Hours in engaging sports 496 4.99 
Medication for high blood pressure 64 0.64 
Medication for abnormal cholesterol 42 0.42 
Medication for diabetes 23 0.23 
Family history of stroke 262 2.64 
Family history of diabetes 292 2.94 
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There are three possible distributions for missing data: ‘missing completely at 
random’, ‘missing at random’, and ‘missing not at random’.301 ‘Missing completely at 
random’ means the missing data is a random subset of the existing observed data. 
That is, the probability of an observation missing is not related to the unobserved 
value itself or to the values of any observed variables or values, so that the distribution 
of the missing data is similar to the observed data. For example, the laboratory 
samples were lost in transit from the local clinic to the certified laboratory, the lost 
samples has no systematic differences compared to the non-lost samples. ‘Missing 
at random’ means that there might be some systematic differences between the 
missing data and the observed data, and the differences could be explained by other 
observed variables. For example, the participants dropped out of the study because 
of their medical conditions and the medical condition was recorded in the 
questionnaire, so that the participants stayed in the study are healthier compared to 
the dropouts. ‘Missing not at random’ means that the missing data cannot be fully 
explained by the observed data, that is even after taking into account of the observed 
data, the systematic differences remain between the missing data and observed data. 
For example, in the self-reported questionnaire collection, some people did not 
respond to the household income question, this is because people did not want to 
reveal their income no matter low or high; even after taking into account of the 
education variable, the income variable was still difficult to predict because of the lack 
of information on other variables, such as house ownership or postcode. The 
assumption for using multiple imputation is that missing data are ‘missing completely 
at random’ or ‘missing at random’. 
Unfortunately, there is no formal statistical test using the available data to examine 
whether data is ‘missing at random’ or ‘missing not at random’.301 Therefore, the 
reason for missing data can only be based on the background knowledge of the study.  
In the HAPIEE study, the majority of missing data is for outcome measures. Usually, 
people who do not come to the clinics are less healthy compared to participants who 
come to the clinic.302 This means that the missing data might be dependent 
on/explained by the observed variables in the dataset; for example, age and diagnosis 
of chronic diseases. In order to check the differences between participants with 
missing data and those with complete data, a sensitivity analysis was performed in 
comparing the characteristics of these two groups (see Table 21, Table 22, and Table 
23).  
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In the Czech Republic, participants excluded from the final sample were older, less 
educated, less physically active, but with higher total energy intake and alcohol intake; 
they tended to have family history of stroke and diabetes, and medication for at least 
one of abnormalities (ie, high cholesterol, diabetes, and high blood pressure). On the 
other hand, there was no difference in terms of gender and smoking status (see Table 
21).  
In Russia, participants excluded from sample were also older and less educated; 
included more pensioners not working, and were more likely to be ex- or current 
smokers. Furthermore, they had higher energy and alcohol intake. However, there 
was no difference in terms of physical activity, family history of stroke or diabetes, or 
medication (see Table 22).  
In Poland, as in the other two countries, excluded participants from the final sample 
were older; they also had lower level of physical activity and were more likely to be 
ex- or current smokers. But among two groups, there was no difference in gender, 
education, working activity, energy/alcohol intake, family history of stroke/diabetes, 
and medications (see Table 23). 
In summary, the final study sample included people who were younger, with higher 
SEP, and with healthier lifestyle. Therefore, the systematic difference between the 
observed data and unobserved data may be explained by the observed variables. In 
addition, previous HAPIEE research suggested that the non-respondents were also 
due to the incorrect home address contacts or living at their official home address, 
which would assume the missing data were ‘missing completely at random’.18 Thus, 
the exclusion strategy for the complete-cases analysis may introduce some selection 
bias in the final study sample. However, in the multiple imputation, the assumption of 
‘missing at random’ or ‘missing completely at random’ is still questionable. Both the 
complete case analysis and multiple imputation have limitations. Therefore, the main 
analyses were conducted on complete case dataset, and only sensitivity analysis 
comparing results from two methods have been done on multiply imputed dataset.  
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Table 21 Characteristics of participants according to their inclusion in 
complete case analyses in the Czech Republic  
Variable (mean and SD, or % as indicated) 
Excluded 
(N=2703) 
In sample      
(N=5060) 
P* 
Mean (SD) Mean (SD)  
Age   58.6 (7.4) 57.9 (7.0) <0.001 
Energy intake (Kcal/d)  2062.2 (847.4) 2010.3 (625.1) 0.002 
Alcohol intake (g/d)  7.2 (13.0) 8.4 (13.5) <0.001 
  % %  
Sex  Men  46.8 46.3 0.236 
 Women 53.2 53.7  
Education  Primary or lower  13.9 11.6 0.001 
 Vocational  38.1 36.6  
 Secondary  35.0 37.4  
 University   13.1 14.4  
Working activity  Working:non-pensioner 45.2 48.4 0.007 
 
Not working:non-
pensioner 
0.9 0.6  
 Working:pensioner 8.5 7.5  
 Not working:pensioner 45.5 43.5  
Sports time   0 hour 34.6 28.5 <0.001 
 0-1 hour 43.7 45.5  
 >1 hour 21.7 26.0  
Leisure activity  <1 hour 39.4 33.3 <0.001 
 1-2 hours 23.9 25.8  
 2-3 hours 18.4 21.4  
 >3 hours 18.3 19.6  
Smoking  Current smoker 26.6 26.4 0.432 
 Past smoker 28.8 30.1  
 Never smoker 44.6 43.6  
Family history of 
stroke 
Yes  32.0 29.5 0.017 
No  68.0 70.5  
Family history of 
diabetes 
Yes  38.1 33.8 <0.001 
No  61.9 66.3  
Medication  Yes 53.3 49.1 <0.001 
 No  46.7 50.9  
*For continuous variables, t-test was applied, while for categorical variables, chi-square test was applied.  
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Table 22 Characteristics of participants according to their inclusion in 
complete case analyses in Russia 
Variable (mean and SD, or % as indicated) 
Excluded 
(N=366) 
In sample      
(N=8788) 
P* 
Mean (SD) Mean (SD)  
Age   59.7 (8.3) 58.0 (7.0) <0.001 
Energy intake (Kcal/d)  
3099.4 
(1255.5) 
2527.8 (760.6) <0.001 
Alcohol intake (g/d)  7.9 (17.5) 5.4 (12.5) <0.001 
  % %  
Sex  Men  52.1 45.0 <0.001 
 Women 47.9 55.0  
Education  Primary or lower  14.3 10.1 0.005 
 Vocational  24.7 26.7  
 Secondary  32.3 34.4  
 University   28.7 28.9  
Working activity  Working:non-pensioner 32.42 39.3 <0.001 
 
Not working:non-
pensioner 
0.96 1.1  
 Working:pensioner 16.48 18.6  
 Not working:pensioner 50.14 40.9  
Sports time   0 hour 70.5 72.0 0.644 
 0-1 hour 12.6 12.4  
 >1 hour 16.9 15.7  
Leisure activity  <1 hour 19.1 15.8 0.072 
 1-2 hours 22.4 25.6  
 2-3 hours 25.8 24.7  
 >3 hours 32.7 33.9  
Smoking  Current smoker 30.49 28 0.015 
 Past smoker 16.21 13.44  
 Never smoker 53.3 58.56  
Family history of 
stroke 
Yes  24.8 23.6 0.504 
No  75.2 76.4  
Family history of 
diabetes 
Yes  13.9 12.0 0.150 
No  86.1 88.0  
Medication  Yes 37.0 36.4 0.752 
 No  63.1 63.6  
*For continuous variables, t-test was applied, while for categorical variables, chi-square test was applied.  
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Table 23 Characteristics of participants according to their inclusion in 
complete case analyses in Poland  
Variable (mean and SD, or % as indicated) 
Excluded 
(N=2269) 
In sample      
(N=7671) 
P* 
Mean (SD) Mean (SD)  
Age   57.9 (7.3) 57.6 (6.9) 0.029 
Energy intake (Kcal/d)  2161.7 (770.0) 2176.5 (639.0) 0.358 
Alcohol intake (g/d)  2.7 (9.1) 2.8 (7.2) 0.840 
  % %  
Sex  Men  
48.0 49.1 
0.311 
 Women 
52.0 50.9 
 
Education  Primary or lower  
11.7 11.5 
0.659 
 Vocational  
21.3 21.1 
 
 Secondary  
39.3 38.5 
 
 University   
27.7 28.9 
 
Working activity  Working:non-pensioner 
41.4 42.1 
0.849 
 
Not working:non-
pensioner 1.7 1.6 
 
 Working:pensioner 
6.6 6.6 
 
 Not working:pensioner 
50.3 49.8 
 
Sports time   0 hour 
32.2 29.0 
0.003 
 0-1 hour 
36.0 36.1 
 
 >1 hour 
31.9 34.9 
 
Leisure activity  <1 hour 
33.6 27.8 
<0.001 
 1-2 hours 
28.7 30.7 
 
 2-3 hours 
19.4 21.9 
 
 >3 hours 
18.3 19.6 
 
Smoking  Current smoker 
36.3 30.4 
<0.001 
 Past smoker 
27.1 28.8 
 
 Never smoker 
36.6 40.9 
 
Family history of 
stroke 
Yes  
17.8 17.5 
0.686 
No  
82.2 82.6 
 
Family history of 
diabetes 
Yes  
22.1 21.1 
0.253 
No  
77.9 78.9 
 
Medication  Yes 
53.2 53.0 
0.923 
 No  
46.9 47.0 
 
*For continuous variables, t-test was applied, while for categorical variables, chi-square test was applied.  
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In the multiple imputation, it is advisable to include all the variables that are included 
in the final model in the imputation model, including the interaction terms.301 In the 
study sample, effect modifiers were only found in the Czech sample, but not in 
Russian and Polish samples; therefore, the interaction term was included in the 
imputation model. For the outcome measures (metabolic syndrome and its 
components), the following measures were included: three readings of both systolic 
and diastolic blood pressure, triglyceride and HDL-C level, the standardised plasma 
glucose (see Section 4.3.4), and waist circumference. For the covariates, the 
variables below were included: smoking (current smoker, past smoker, never smoker), 
hours/day spent on leisure activity (<1 hour, 1-2 hours, 2-3 hours, >3 hours), 
hours/day engaging physical activity (0 hour, 0-1 hour, >1 hour), working activity 
(working:non-pensioner, not working:non-pensioner, Working:pensioner, not 
working:pensioner), education (primary school or no formal education, vocational, 
secondary, university), medication for blood pressure/cholesterol/diabetes (yes, no), 
family history on stroke and diabetes (yes, no).  
Chained equation multiple imputation was performed.303 There is no gold-standard for 
the number of imputed datasets which need to be created. However, creating at least 
20 datasets is preferable in order to decrease the sampling variability from the 
imputation process.301 Therefore, twenty imputations were performed in this thesis. 
The sensitivity analyses comparing individuals with complete and incomplete data, 
and regression results in the imputed dataset will be presented in Section 5.6.1.  
4.7.2 Confounders, effect modifiers, and mediators  
A confounder is associated with both the exposure and outcome, but it is not on the 
causal pathway between the exposure and outcome. Confounders can over- and 
under-estimate the unadjusted association between the exposure and outcome.304 
Moderating variable (also called an effect modifier), is a variable that affects the 
magnitude of an exposure association across strata of another variable.304 A mediator 
is a variable that associated with the exposure and outcome, and is on the causal 
pathway between them.305 
Not accounting for such covariates could introduce bias into the findings of this thesis, 
and they were thus included in the main statistical analysis in Chapter 5. 
The potential confounders and effect modifiers were chosen initially on a-priori basis 
from the literature background. The potential confounders were then related to 
metabolic syndrome and then HDI. The potential confounders were finally selected 
118 
 
as those both associated with the outcome (metabolic syndrome) and exposure (HDI). 
Potential effect modifiers were also tested using Likelihood Ratio Tests by comparing 
model including and excluding the potential effect modifiers. If the model including 
effect modifier yielded a significantly better model fit, the effect modifier was chosen 
for the final analyses. The details of potential confounders and effect modifiers 
(related to objectives 2 and 3) in this thesis will be described in section 5.5. 
4.7.3 Statistical methods used in examining the association between HDI and 
metabolic syndrome  
As discussed in section 4.6 and 4.7.1, in the main analyses of this thesis complete 
case analyses were used (ie, observations with missing values on exposure, 
outcomes, and other covariates were excluded from the analyses). In the following 
section, the statistical methods used to examine the relationship between HDI and 
metabolic syndrome will be explained by following the order of seven objectives stated 
in section 3.2.  
To achieve objective 1 (examining the prevalence of metabolic syndrome and its 
components in the Czech Republic, Russia, and Poland): the prevalence of metabolic 
syndrome and its components were calculated by country and sex. The descriptive 
statistics including means and standard deviations of metabolic syndrome 
components—waist circumference, blood pressure (systolic and diastolic blood 
pressure), triglycerides, HDL-C, and plasma glucose (only in the Czech and Polish 
samples)—were calculated by country and sex. The means of each metabolic 
syndrome component (in continuous form) were compared by t-tests within countries 
to explore any sex difference. (See Section 5.2) 
To achieve objective 2 (examining how metabolic syndrome prevalence relates to 
demographic factors and health behaviours in the Czech Republic, Russia, and 
Poland): the association between prevalence of metabolic syndrome and its 
components and the following categorical variables including education level, 
smoking status, hours of engaging leisure activity per day, hours of engaging in sports 
per day, working activity, family history of diabetes and stroke, and medication of at 
least one of the abnormalities (ie, high cholesterol, diabetes, high blood pressure) 
were calculated by country, and prevalence was compared using chi-square test. 
(See Section 5.3) 
To achieve objective 3 (examining and comparing dietary patterns in the Czech 
Republic, Russia, and Poland using the HDI): The summary statistics including mean, 
119 
 
median, and standard deviation of HDI and its dietary components were calculated 
stratified by country and sex. The sex differences in each country were examined 
using t-test for HDI total score, and Wilcoxon rank-sum test for components of HDI 
score. 
The means of the HDI total score was compared using one way ANOVA according to 
demographic (age group and sex) and sample characteristics (education level, 
smoking status, hours of engaging leisure activity per day, hours of engaging in sports 
per day, working activity, family history of diabetes and stroke, and medication of at 
least one of the abnormalities (ie, high cholesterol, diabetes, high blood pressure)) 
and stratified by country. The HDI total score was also related to alcohol and daily 
energy intake using linear regression (see Section 5.4). 
To achieve objective 4 (examining the associations between the HDI and risk of 
metabolic syndrome and its components in the Czech Republic, Russia, and Poland): 
The potential confounders and interaction terms in the relationship of HDI and 
metabolic syndrome including age, sex, education level, smoking status, hours of 
engaging leisure activity per day, hours of engaging in sports per day, working activity, 
family history of diabetes and stroke, and medication of at least one of the 
abnormalities (ie, high cholesterol, diabetes, high blood pressure) were first tested 
using logistic regression modelling and Likelihood ratio test. (See Section 5.5) 
Logistic regression was used to assess the relationship between HDI and metabolic 
syndrome and its components. Model 1 only included HDI and metabolic syndrome 
to calculate the crude effect size. Model 2 was adjusted for age and sex. In model 3, 
other potential confounders were also included (education level, smoking status, 
hours of engaging leisure activity per day, hours of engaging in sports per day, 
working activity, family history of diabetes and stroke, and medication of at least one 
of the abnormalities (ie, high cholesterol, diabetes, high blood pressure) (see Section 
5.6.1).  
To achieve objective 5 (examining the associations between dietary components of 
the HDI and risk of metabolic syndrome and its components in the Czech Republic, 
Russia, and Poland): logistic regression was used to examine the association 
between the 7 individual dietary components of HDI (saturated fatty acids, 
polyunsaturated fatty acids, protein, mono and disaccharides, fruits and vegetables, 
dietary fibre, and cholesterol) and metabolic syndrome, by country. As stated in the 
previous paragraph, three regression models were performed in each case (from 
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unadjusted to fully adjusted for all potential confounders and inclusion of all effect 
modifiers) (see Section 5.6.2). 
To achieve objective 6 (examining the associations between HDI scores and 
metabolic syndrome and its components in the pooled dataset by combining three 
countries together) logistic regression was used to examine the association between 
HDI scores and metabolic syndrome and its components in the pooled dataset by 
combining three countries together. The variable ‘country’ was added as a potential 
confounder in the final analysis (see Section 5.6.3).  
To achieve objective 7 (compare the sample characteristics, and associations 
between HDI score and metabolic syndrome risk using the complete case and 
imputed data sources): multiple imputation was performed using chained equations. 
The sample characteristics were compared between the complete and imputed 
datasets. Logistic regression was used to assess the association between HDI and 
metabolic syndrome risk in the imputed dataset (see Section 5.7.1). 
4.8 Ethical issues 
The HAPIEE study was approved by University College London Hospital Research 
Ethics Committee Alpha in the United Kingdom and by the local ethics committees in 
all participating centres.18 All participants gave written informed consent before 
contributing to the data collection (health questionnaire and medical examination). 
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Chapter 5  Results – metabolic syndrome and HDI in the 
HAPIEE study 
This chapter presents the main results of this thesis, including descriptions of the 
sample characteristics, prevalence of metabolic syndrome, prevalence of metabolic 
syndrome components, and HDI score distributions. It then presents analyses 
examining the relationship between HDI and with covariates, confounders and effect 
modifiers, and the association between HDI scores and metabolic syndrome (and its 
components). Main results will be conducted using both complete case and multiply 
imputed datasets, and these results will be compared. 
5.1 Sample characteristics 
Table 24 shows the sample characteristics in relation to covariates (stratified by sex) 
for the Czech Republic, Russia, and Poland. The mean age in three study samples 
was similar, and ranged from 57.3 years in Polish women to 58.4 years in Czech men. 
The proportion of participants in each age group was similar in three countries, with 
slightly more participants in the older age groups. More participants from Russia and 
Poland had a university degree than those from the Czech Republic (31.7% in men 
and 26.5% in women in Russia, 30.4% in men and 27.3% in women in Poland, 
compared with 18.5% in men and 11.1% in women in the Czech Republic). The 
prevalence of smoking was high in three study samples (over 25% in each of the three 
combined sex samples, results not shown), and smoking was more frequent in men 
compared with women, especially in Russia (49.7% in men and 10.2% in women). 
Women were more physically active compared with men during leisure time in all 
countries; 24.9% of Czech women participated in more than 3 hours/day of leisure 
activity compared with 13.5% of Czech men—the trend was similar in the other two 
countries. In Poland, around 35% of men and women spent more than 1 hour per day 
participating in sports, compared with 25% of Czechs and 15% of Russians. Most of 
the non-pensioners had a job at the time of interview in all three countries; among 
pensioners, more men had a job compared to women, and more Russian pensioners 
had a continued job after retirement compared with the other two study samples 
(Russia: 39.5% in men and 25.2% in women, results are not shown in the table). In 
the Czech Republic and Poland, around half of the men and women took at least one 
medication for high blood glucose, diabetes, or high cholesterol, while less Russian 
men than women took medication (25.6% in men, and 45.4% in women). Czech men 
and women had the most cases of family history of diabetes (32.1% in men, 35.5% in 
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women), followed by Poles (19.6% in men and 22.2% in women) and Russians (9.6% 
in men, and 14.0% in women). Around 30% of Czech men and women had a family 
history of stroke, compared with less than 20% in Russia and Poland, although 28.1% 
of Russian women reported a family history. More women had a family history of 
diabetes or stroke in all countries compared with men. The daily alcohol intake was 
much higher in men than women in all three study samples (Czech Republic: 14.1/3.4 
g/day (men/women mean alcohol intake); Russia: 10.4/1.3 g/day; Poland: 4.5/1.1 
g/day). Russian men and women had the highest daily energy intake compared with 
the other two countries, and men had higher energy intake than women in all three 
countries (Czech Republic: 2076.1/1944.2 kcal/day (men/women mean daily energy 
intake); Russia: 2765.7/2354.4 kcal/day; Poland: 2287.2/2076.6 kcal/day).  
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Table 24  Sample characteristics in the Czech Republic, Russia, and Poland 
 Czech Republic Russia Poland 
 Men   
(N=2355) 
Women 
(N=2705) 
Men   
(N=3972) 
Women 
(N=4816) 
Men   
(N=3773) 
Women 
(N=3898) 
 Mean  SD Mean  SD Mean  SD Mean  SD Mean  SD Mean  SD 
Age (years) 58.4  0.1 57.4  0.1 58.2 0.1 58.0 0.1 58.1  0.1 57.3  0.1 
Alcohol intake (g/day) 14.1 16.8 3.4 6.3 10.4 17.0 1.3 3.5 4.5 9.2 1.1 4.0 
Energy intake (Kcal/day) 2076.
1 629.8 
1944.
2 640.2 
2765.
7 819.5 
2354.
4 713.2 
2287.
2 673.3 
2076.
6 621.4 
             
 N % N % N % N % N % N % 
Age group (%)             
      45-49 379 16.1 510 18.9 636 16.0 863 17.9 630 16.7 770 19.8 
      50-54 433 18.4 570 21.1 782 19.7 931 19.3 743 19.7 847 21.7 
      55-59 456 19.4 507 18.7 862 21.7 1039 21.6 820 21.7 811 20.8 
      60-64 521 22.1 653 24.1 764 19.2 898 18.6 771 20.4 756 19.4 
      65-70 566 24.0 465 17.2 928 23.4 1085 22.5 809 21.4 714 18.3 
Education (%)             
     Primary or lower 115 4.9 473 17.5 450 11.3 451 9.4 341 9.0 547 14.0 
      Vocational 1034 43.9 807 29.8 868 21.9 1474 30.6 1028 27.2 579 14.9 
      Secondary 771 32.7 1125 41.6 1394 35.1 1,614 33.5 1257 33.3 1706 43.8 
      University  435 18.5 300 11.1 1260 31.7 1277 26.5 1147 30.4 1066 27.3 
Smoking (%)             
      Current smoker 699 29.7 635 23.5 1976 49.7 492 10.2 1289 34.2 1034 26.5 
      Past smoker 908 38.6 615 22.7 975 24.5 210 4.4 1398 37.1 823 21.1 
      Never smoker 748 31.8 1455 53.8 1021 25.7 4114 85.4 1086 28.8 2041 52.4 
Leisure time activity (%)             
      <1 hour/d 953 40.5 735 27.2 888 22.4 507 10.5 1359 36.0 777 19.9 
      1-2 hours/d 639 27.1 666 24.6 1152 29.0 1098 22.8 1163 30.8 1180 30.3 
      2-3 hours/d 445 18.9 630 23.3 937 23.6 1232 25.6 716 19.0 957 24.6 
      >3 hours/d 318 13.5 674 24.9 995 25.1 1979 41.1 535 14.2 984 25.2 
Sports (%)             
      0 hour/d 685 29.1 756 28.0 2809 70.7 3524 73.2 1074 28.5 1152 29.6 
      0-1 hour/d 1070 45.4 1237 45.7 508 12.8 577 12.0 1369 36.3 1,399 35.9 
      >1 hour/d 600 25.5 712 26.3 655 16.5 715 14.8 1330 35.3 1347 34.6 
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 Czech Republic Russia Poland 
 Men   
(N=2355) 
Women 
(N=2705) 
Men   
(N=3972) 
Women 
(N=4816) 
Men   
(N=3773) 
Women 
(N=3898) 
 
 N % N % N % N % N % N % 
Working activity             
Working:non-pensioner 1241 52.7 1211 44.8 1827 46.0 1611 33.5 1722 45.6 1493 38.3 
Not working:non-
pensioner 4 0.2 25 0.9 4 0.1 95 2.0 7 0.2 113 2.9 
Working:pensioner 200 8.5 182 6.7 846 21.3 784 16.3 282 7.5 222 5.7 
Not working:pensioner 910 38.6 1287 47.6 1295 32.6 2326 48.3 1762 46.7 2070 53.1 
Medication              
Yes 1152 48.9 1336 49.4 1015 25.6 2184 45.4 1910 50.6 2152 55.2 
No  1203 51.1 1369 50.6 2957 74.5 2632 54.7 1863 49.4 1746 44.8 
Family history of 
diabetes  
            
Yes 755 32.1 959 35.5 383 9.6 674 14.0 738 19.6 866 22.2 
No  1600 67.9 1746 64.6 3589 90.4 4142 86.0 3035 80.4 3032 77.8 
Family history of stroke             
Yes 627 26.6 864 31.9 728 18.3 1352 28.1 566 15.0 772 19.8 
No  1728 73.4 1841 68.1 3244 81.7 3464 71.9 3207 85.0 3126 80.2 
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5.2  Prevalence of metabolic syndrome and its components in the 
HAPIEE study 
In this section, the results for prevalence of metabolic syndrome in respond to 
Objective 1 (see Section 3.2) are shown. Table 25 shows the descriptive results of 
individual components of metabolic syndrome by country and sex. Men had larger 
waist circumference compared with women in the three countries (P<0.001). In men, 
Czechs had the largest waist circumference (98.0cm), followed by Poles (97.7cm), 
and Russians (94.1cm); in women, Russian had the largest waist circumference 
(91.8cm) followed by Czechs (88.7cm), and Russians (87.7cm). Czech and Polish 
men had higher systolic and diastolic blood pressure compared with Czech and Polish 
women (P<0.001), while Russian men and women had very similar blood pressure 
readings (Czech Republic: 144.2/90.8mmHg in men and 134.3/87.0mmHg in women; 
Russia: 142.7/90.3mmHg in men and 142.9/89.9mmHg in women; Poland: 
142.4/88.1mmHg in men and 134.3/84.5mmHg in women). Men had higher 
triglycerides in the Czech and Polish samples (P<0.001), while Russian women had 
slightly higher level of triglycerides compared with men (P<0.001) (Czech Republic: 
2.1mmol/L in men and 1.7mmol/L in women; Russia: 1.5mmol/L in men and 
1.6mmol/L in women; Poland: 1.8mmol/L in men and 1.5mmol/L in women). For HDL-
C (the ‘healthy’ cholesterol), women had higher levels compared with men in all 
countries (P<0.001). For plasma glucose, men had higher level than women in the 
Czech and Polish samples (P<0.001). Because glucose level in Russia was a binary 
variable (≥6.1mmol/L or not), its relationship to sex is described below in the 
prevalence section.  
Table 26 shows the prevalence of metabolic syndrome by country and sex. In the 
Czech Republic and Poland, men and women had a similar prevalence of metabolic 
syndrome (Czech sample: 37.1% in men and 35.7% in women, P=0.316; Polish 
sample: 27.9% in men and 28.6% in women, P=0.532); while in Russia, women had 
higher prevalence of metabolic syndrome compared with men (20.8% in men and 
36.3% in women, P<0.001). In all three countries, the prevalence of having raised 
blood pressure was high—over 50% in all subsamples (Czech Republic: 73.7% in 
men and 58.2% in women; Russia: 62.4% in men and 65.5% in women; Poland: 
66.1% in men and 54.5% in women). The prevalence of central obesity was high, 
especially in women, the statistics were 50.4%, 60.9%, and 47.0% among Czech, 
Russian, and Polish women, respectively; while among men, they were 33.9%, 
25.1%, and 32.3%, respectively. The prevalence of high triglycerides was high, and 
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the prevalence was higher among men compared with women in the Czech Republic 
and Poland (Czech Republic: 50.3% in men and 38.2% in women; Poland: 41.4% in 
men and 31.3% in women), while in Russia, the prevalence was lower among men 
(26.3% in men and 31.4% in women). In all countries, the prevalence of having low 
HDL-C was higher among women than men, and especially in Russia, where the 
prevalence among women was around 3 times higher than men (20.3% in women 
and 5.4% in men). The prevalence of having a high blood glucose was higher among 
men than women in all countries (P<0.001). 
Table 27 shows the prevalence of each component of metabolic syndrome among 
participants with metabolic syndrome by country and sex. In all countries, the most 
frequent abnormality was blood pressure (Czech Republic: 94.3% in men, and 88.0% 
in women; Russia: 92.6% in men, and 91.0% in women; Poland: 91.8% in men and 
86.8% in women). Central obesity was another commonly occurring component 
among participants with metabolic syndrome, especially among women in all three 
countries (Czech Republic: 67.4% in men, and 87.5% in women; Russia: 72.3% in 
men, and 93.0% in women; Poland: 74.7% in men, and 90.6% in women). Around 
85% of Czech men and 79.1% of Czech women with metabolic syndrome had high 
triglycerides level, followed by 82.3% in Polish men and 75.3% in Polish women, and 
78.2% in Russian men and 70.9% in Russian women. In Russia, almost 80% of men 
with metabolic syndrome had high glucose, although the proportion in women was 
lower (62.8%), while the percentages in the Czech and Polish sample were lower than 
in Russian sample (Czech Republic: 49.7% in men and 38.4% in women; Poland: 
53.0% in men and 40.5% in women). Low HDL-C was more common in the Czech 
and Polish samples (Czech Republic: 57.4% in men, and 68.0% in women; Poland: 
45.9% in men, and 60.5% in women). In Russia, the proportion of women with 
metabolic syndrome having low HDL-C was more than double that of men (18.3% in 
men, and 44.8% in women).  
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Table 25 Mean value of each component of metabolic syndrome by country and sex in the HAPIEE study 
*P-value from t-test ** SBP:systolic blood pressure ***DBP: diastolic blood pressure 
 
 
Czech Republic  Russia  Poland 
 
 Men 
 (N=2355) 
Women 
(N=2705) 
 Men  
(N=3972) 
Women 
(N=4816) 
 Men  
(N=3773) 
Women  
(N=3898) 
  
 Mean  SD Mean  SD P* Mean  SD Mean  SD P* Mean  SD Mean  SD P* 
Waist circumference 
(cm) 
98.0 10.3 88.7 12.9 <0.001 94.1 12.1 91.8 13.2 <0.001 97.7 10.6 87.7 12.1 <0.001 
SBP** 
(mmHg) 
144.2 18.7 134.3 19.6 <0.001 142.7 23.1 142.9 25.9 0.743 142.4 20.3 134.3 21.3 <0.001 
DBP*** 
(mmHg) 
90.8 10.7 87.0 10.9 <0.001 90.3 13.3 89.9 13.4 0.122 88.1 11.8 84.5 11.5 <0.001 
Triglycerides 
(mmol/L) 
2.1 1.4 1.7 0.9 <0.001 1.5 0.8 1.6 0.8 <0.001 1.8 1.1 1.5 0.8 <0.001 
HDL-C 
(mmol/L) 
1.3 0.3 1.5 0.4 <0.001 1.5 0.5 1.6 0.5 <0.001 1.3 0.3 1.6 0.4 <0.001 
Plasma blood 
glucose 
(mmol/L) 
5.9 1.5 5.7 1.3 <0.001 n/a n/a n/a n/a n/a 5.6 1.5 5.3 1.3 <0.001 
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Table 26 Prevalence of metabolic syndrome and its components in the HAPIEE sample 
*P-value from chi-square test. 
 
 
 
 Czech Republic  Russia  Poland  
 
Men   
(N=2355) 
Women 
(N=2705) 
 
Men   
(N=3972) 
Women  
(N=4816) 
 
Men  
(N=3773) 
Women  
(N=3898) 
 
 N % N % P* N % N % P* N % N % P* 
Metabolic 
syndrome 
873 37.1 966 35.7 0.316 827 20.8 1748 36.3 <0.001 1054 27.9 1114 28.6 0.532 
Raised blood 
pressure 
1735 73.7 1575 58.2 <0.001 2480 62.4 3154 65.5 0.003 2494 66.1 2126 54.5 <0.001 
Central obesity 799 33.9 1363 50.4 <0.001 997 25.1 2935 60.9 <0.001 1220 32.3 1831 47.0 <0.001 
High triglycerides 1184 50.3 1034 38.2 <0.001 1044 26.3 1510 31.4 <0.001 1561 41.4 1220 31.3 <0.001 
Low HDI-C 646 27.4 875 32.4 <0.001 216 5.4 976 20.3 <0.001 708 18.8 1018 26.1 <0.001 
Raised blood 
glucose 
610 25.9 473 17.5 <0.001 1210 30.5 1368 28.4 0.035 831 22.0 584 15.0 <0.001 
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Table 27 The proportion of components of metabolic syndrome among participants with metabolic syndrome 
 
 Czech Republic Russia Poland 
 Men (%) Women (%) Men (%) Women (%) Men (%) Women (%) 
Raised blood pressure 94.3 88.0 92.6 91.0 91.8 86.8 
Central obesity 67.4 87.5 72.3 93.0 74.7 90.6 
High triglycerides 85.0 79.1 78.2 70.9 82.3 75.3 
Low HDL-C 57.4 68.0 18.3 44.8 45.9 60.5 
High glucose 49.7 38.4 79.8 62.8 53.0 40.5 
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5.3 The association between sample characteristics and metabolic 
syndrome  
In this section, in response to Objective 2, the prevalence of metabolic syndrome will 
be presented in relation to sample characteristics.  
Table 28 shows the prevalence of metabolic syndrome in relation to the covariates 
used in the thesis. Lower alcohol intake was associated with metabolic syndrome only 
in Russian sample (P<0.001), not in the other two. This may due to the sex difference 
in alcohol consumption in Russian men and women (see Table 24), and it will be 
discussed in Chapter 6  Contrary to expectation, lower energy intake was associated 
with metabolic syndrome in three countries (P<0.002). In all countries, the prevalence 
of metabolic syndrome was higher  with older age (P<0.001), with a peak of over 25% 
in the 65-69 years age group in all three study samples. There were no significant sex 
difference in prevalence of metabolic syndrome in the Czech and Polish sample 
(P=0.316 and P=0.532, respectively), but in the Russian sample, more women had 
metabolic syndrome than men (P<0.001). Prevalence of metabolic syndrome was 
also associated with education level (P<0.001): metabolic syndrome was more 
prevalent among participants with lower education in the Czech sample, especially 
those with vocational (41.2%) and secondary (32.7%) education; however, in Russian 
and Polish samples, although prevalence among those with secondary education was 
also higher (36.3% in Russian sample, 38.4% in Polish sample), the prevalence 
among participants with vocational and university education was similar (Russia: 
26.5% with vocational education, 25.7% with university education; Poland: 22.1% with 
vocational education, 23.2% with university education), and those with primary or 
lower education had the lowest prevalence in these two samples (11.5% in Russia 
and 16.4% in Poland). In all three countries, prevalence of metabolic syndrome was 
significantly associated with smoking status: interestingly among people with 
metabolic syndrome, there were more never smokers than both past smokers and 
current smokers having metabolic syndrome (non-smokers: 41.3% in the Czech 
sample, 68.6% in the Russian sample, and 41.6% in the Polish sample). Leisure time 
activity was not significantly associated with metabolic syndrome in the Russian and 
Polish sample, but was associated in the Czech sample (P=0.001); among subjects 
with metabolic syndrome, 35.2% of them undertook <1 hour/day leisure activity, 
followed by 24.5% of those with 1-2 hours/day, 21.3% with >3 hours/day, and 19.0% 
with 2-3 hours/day. Hours spent  participating in sports was significantly associated 
with metabolic syndrome in three countries (P<0.001): in the Czech sample, around 
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42.9% people with metabolic syndrome had 0-1 hour/day spent on sports, 33.4% did 
not spend any time on sports, and the rest had >1 hour/day spent on sports; while in 
Russia, most people with metabolic syndrome had no hour spending on sports 
(75.6%), 10.9% with 0-1hour/day, and 13.5% with >1 hour/day; in Poland, the more 
hours spent on sports was associated with lower risk of metabolic syndrome (>1 
hour/day: 34.7%; 0-1 hour/day: 33.4%; 0 hour/day: 32.0%). Working activity was also 
associated with metabolic syndrome. In three countries, over half of the participants 
with metabolic syndrome were pensioners who were not working at the moment 
(55.3% in the Czech sample, 51.8% in the Russian sample, 61.6% in the Polish 
sample), and around one third were non-pensioners who were working (36.7% in the 
Czech sample, 29.3% in the Russian sample, and 29.8% in the Polish sample). 
However, unlike the other two samples, among participants with metabolic syndrome, 
in the Russian sample, there were more working pensioners compared with the other 
two samples (7.0% in the Czech sample, 17.8% in the Russian sample, and 7.4% in 
the Polish sample). In all three study samples, more participants with metabolic 
syndrome used at least one medication for high blood pressure, diabetes, or high 
cholesterol (P<0.001). Family history of diabetes and stroke was also associated with 
metabolic syndrome in all three countries (P<0.05). 
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Table 28 Sample characteristics in relation to metabolic syndrome by country 
  Czech Republic Russia    Poland   
  No 
(N=3221) 
Yes   
(N=1839) 
P* No  
(N=6213) 
Yes  
(N=2575) 
P* No 
(N=5503) 
Yes   
(N=2168) 
P* 
  Mean(SD) Mean (SD)  Mean (SD) Mean (SD)  Mean (SD) Mean (SD)  
Alcohol intake (g/day)  8.6 (13.2) 7.9 (13.9) 0.067 6.0 (13.3) 4.0 (10.6) <0.001 2.8 (6.9) 2.7 (8.2) 0.597 
Energy intake  (kcal/day)  2026.6 
(635.9)  
1968.8 
(642.1)  
0.002 2589.7 
(799.8)  
2421.0 
(752.7)  
<0.001 2199.0 
(654.6) 
2132.5 
(656.9) 
<0.001 
           
  % %  % %  % %  
Age group            
      45-49  77.2 22.8 <0.001 80.7 19.3 <0.001 83.0 17.0 <0.001 
      50-54  72.2 27.8  73.7 26.3  76.5 23.5  
      55-59  61.2 38.8  67.7 32.4  68.4 31.6  
      60-64  56.6 43.4  67.6 32.4  68.2 31.8  
      65-69  54.0 46.0  66.2 33.8  63.6 36.4  
Sex           
Male   62.9 37.1 0.316 79.2 20.8 <0.001 72.1 27.9 0.532 
Female   64.3 35.7  63.7 36.3  71.4 28.6  
Education            
     Primary or lower  51.7 48.3 <0.001 67.0 33.0 <0.001 60.0 40.0 <0.001 
      Vocational  58.8 41.2  70.9 29.1  70.3 29.7  
      Secondary  68.3 31.8  68.9 31.1  71.9 28.1  
      University   73.5 26.5  73.9 26.1  77.3 22.7  
Smoking            
      Current smoker  65.1 34.9 0.001 82.2 17.8 <0.001 75.9 24.1 <0.001 
      Past smoker  59.8 40.3  68.9 31.1  68.2 31.8  
      Never smoker  65.5 34.5  65.6 34.4  71.2 28.9  
Leisure time activity            
      <1 hour/d  61.6 38.4 0.001 71.4 28.6 0.102 71.2 28.8 0.706 
      1-2 hours/d  65.5 34.5  72.5 27.5  71.9 28.1  
      2-3 hours/d  67.5 32.5  69.6 30.4  72.7 27.3  
      >3 hours/d  60.5 39.5  69.8 30.2  71.2 28.8  
Sports            
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  Czech Republic Russia    Poland   
  No 
(N=3221) 
Yes   
(N=1839) 
P* No  
(N=6213) 
Yes  
(N=2575) 
P* No 
(N=5503) 
Yes   
(N=2168) 
P* 
      0 hour/d  57.3 42.7 <0.001 69.3 30.7 <0.001 68.9 31.1 <0.001 
      0-1 hour/d  65.8 34.2  74.1 25.9  73.9 26.1  
      >1 hour/d  66.8 33.2  74.7 25.3  71.9 28.1  
Working activity           
Working:non-pensioner  72.5 27.5 <0.001 78.0 22.0 <0.001 79.9 20.1 <0.001 
Not working:non-
pensioner 
 
34.5 65.5  73.7 26.3 
 
79.2 20.8 
 
Working:pensioner  66.2 33.8  71.8 28.2  68.1 31.9  
Not working:pensioner  53.8 46.2  63.1 36.9  65.2 34.8  
Medication **           
Yes  48.4 51.7 <0.001 50.8 49.2 <0.001 59.8 40.2 <0.001 
No   78.5 21.5  82.1 17.9  85.2 14.9  
Family history of 
diabetes  
          
Yes  57.9 42.1 <0.001 63.3 36.7 <0.001 64.4 35.6 <0.001 
No   66.6 33.4  71.7 28.3  73.7 26.3  
Family history of stroke           
Yes  59.8 40.2 <0.001 66.4 33.6 <0.001 68.7 31.3 0.006 
No   65.3 34.7  72.0 28.0  72.4 27.6  
*P-value: chi-square tests**Medication was defined as having at least one of the medication for high blood pressure, high glucose, or high cholesterol. 
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5.4 HDI in the HAPIEE study 
In this section, in response to the Objective 3, the distribution of HDI and its 
components will be described, along with relationships between HDI and covariates. 
The total HDI score was approximately normally distributed in each country, while the 
components of HDI were slightly skewed.  
Table 29 shows the mean, standard deviation, and median of HDI total score and its 
components by country and sex. There were sex differences in the components of 
HDI in each country, but overall women had higher HDI (a healthier diet) in all three 
countries. In the Czech sample, women had an 0.2 units higher total HDI score 
compared with men (P<0.001); women also had a higher (healthier) score in saturated 
fats, protein, fruits and vegetables, fibre, and cholesterol, while men had higher score 
in sugar; there was no difference on polyunsaturated fats score between men and 
women. In Russia, women also had an 0.2 units higher HDI total score compared with 
men (P<0.001); Russian women also had higher score in saturated fats, protein, fruits 
and vegetables, and cholesterol compared to men, while men had higher score in 
polyunsaturated fats, sugar, and fibre intake. In Poland, women had 0.2 units higher 
HDI total score compared to men (P<0.001); Polish women had higher score in 
saturated fats, protein, fruit and vegetables, and cholesterol, while men had higher 
score in polyunsaturated fats and sugar; there was no difference of fibre intake 
between men and women.  
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Table 29 Average HDI by country and sex  
 Czech Republic Russia Poland 
 Men (N=2355) Women (N=2705)  Men (N=3972) Women (N=4816)  Men (N=3773) Women (N=3898)  
 Mean SD Median Mean SD Median P* Mean SD Median Mean SD Median P* Mean SD Median Mean SD Median P* 
HDI 4.6 0.7 4.6 4.8 0.7 4.9 <0.001 4.3 0.6 4.3 4.5 0.7 4.4 <0.001 4.2 0.7 4.1 4.4 0.7 4.3 <0.001 
SFA 3.2 3.2 2.5 4.0 3.4 3.5 <0.001 2.4 3.0 0.7 2.9 3.3 1.7 <0.001 2.1 3.0 0.1 2.8 3.3 1.3 <0.001 
PUFA 9.5 1.0 10.0 9.4 1.1 10.0 0.162 9.3 1.8 10.0 8.8 2.3 10.0 <0.001 8.3 1.4 8.4 8.0 1.5 8.1 <0.001 
Protein 6.4 2.6 6.7 7.1 2.5 7.5 <0.001 7.0 2.4 7.3 7.2 2.5 7.7 <0.001 6.4 2.4 6.6 6.7 2.3 6.9 <0.001 
Sugar 4.6 2.8 4.6 3.0 2.7 2.6 <0.001 6.1 2.2 6.2 4.9 2.5 5.1 <0.001 4.5 2.6 4.5 3.2 2.6 2.9 <0.001 
Fruit & vegetables 8.2 2.5 10.0 9.1 1.9 10.0 <0.001 7.8 2.3 8.3 8.3 2.2 9.4 <0.001 8.5 2.2 10.0 8.9 1.9 10.0 <0.001 
Fibre 7.6 2.1 7.7 8.2 2.0 8.8 <0.001 8.3 1.7 8.6 8.1 1.8 8.4 <0.001 8.4 1.8 10.0 8.4 1.8 10.0 0.717 
Cholesterol 6.8 4.1 10.0 7.8 3.7 10.0 <0.001 2.3 3.8 0 4.5 4.5 3.0 <0.001 3.8 4.3 1.6 5.7 4.3 7.0 <0.001 
*T-test was performed for HDI (total score), Wilcoxon rank-sum test was performed for the components of HDI scores because of the assumption of normality was not met 
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Table 30,Table 31, and Table 32 show the correlations between the HDI components 
by country. Saturated fatty acids score and other components of HDI were 
significantly but weakly correlated (P<0.003), except for fruit and vegetable score 
(P=0.129). For example, in all countries, saturated fatty acids and polyunsaturated 
fatty acids scores were weakly negatively but significantly correlated (β=-0.167 in the 
Czech sample, β=-0.133 in the Russian sample, and β=-0.176 in the Polish sample); 
saturated fatty acid scores were positively correlated with protein in both Czech 
(β=0.069) and Russian (β=0.031) samples, but in the Polish sample, the correlation 
was in the opposite direction (β =-0.126). Moreover, saturated fatty acid and 
cholesterol scores were moderately positively correlated in the Russian sample 
(β=0.474), but the correlation was slightly weaker in the Czech (β=0.348) and Polish 
(β=0.380) samples, but remained significant (P<0.001). Polyunsaturated fatty acids 
and other components of HDI were all weakly but significantly correlated (P<0.05): for 
example, it was weakly negatively correlated with protein (β=-0.133 in the Czech 
sample, β=-0.185 in the Russian sample, β=-0.073 in the Polish sample). The protein 
score was weakly and significantly correlated with other scores of components of HDI 
except with fruit and vegetable in the Russian sample and cholesterol in the Polish 
sample. Moreover, the correlation with sugar was consistently stronger in all three 
study samples (β=-0.387 in the Czech sample, β=-0.230 in the Russian sample, β=--
0.278 in the Polish sample). Sugar score was negatively and significantly correlated 
with fibre and cholesterol scores, and moderately correlated with fruits and vegetables 
in the Czech and Polish samples (β=-0.423 in the Czech sample and β=-0.426 in the 
Polish sample; P<0.001 for both). Fruits and vegetables score was strongly positively 
correlated with fibre score in all three samples (β=0.725 in the Czech sample, β=0.697 
in the Russian sample, and β=0.705 in the Polish sample; P<0.001), and it was weakly 
negatively correlated with cholesterol score in all three countries (P<0.001). Fibre and 
cholesterol scores were weakly negatively correlated in all countries (β=-0.255 in the 
Czech sample, β=-0.354 in the Russian sample, β=-0.281 in the Polish sample; 
P<0.001 for all samples). In summary, the consistent relationship found in the three 
study samples were the positive correlations between saturated fatty acids and 
cholesterol score, and between fruit and vegetable score and fibre scores.
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Table 30 Correlation coefficients between components of HDI in the Czech 
sample (N=5060) 
 SFA PUFA Protein Sugar F & V Fibres Cholesterol 
SFA* 1.000       
PUFA* -0.167 1.000      
P value <0.001       
Protein 0.069 -0.133 1.000     
P value <0.001 <0.001      
Sugar -0.341 0.116 -0.387 1.000    
P value <0.001 <0.001 <0.001     
F & V* 0.200 0.051 0.082 -0.423 1.000   
P value <0.001 <0.001 <0.001 <0.001    
Fibre 0.253 0.032 0.154 -0.313 0.725 1.000  
P value <0.001 0.022 <0.001 <0.001 <0.001   
Cholesterol 0.348 -0.131 0.169 -0.179 -0.110 -0.255 1.000 
P value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001  
*Abbreviations: SFA- saturated fats; PUFA- Polyunsaturated fats; F&V: Fruit and 
vegetables 
 
 
 
Table 31 Correlation coefficients between components of HDI in the Russian 
sample (N=8788) 
 SFA PUFA Protein Sugar F & V Fibres Cholesterol 
SFA* 1.000       
PUFA* -0.133 1.000      
P value <0.001       
Protein 0.031 -0.185 1.000     
P value 0.003 <0.001      
Sugar -0.198 -0.125 -0.230 1.000    
P value <0.001 <0.001 <0.001     
F & V* -0.016 -0.039 -0.003 -0.245 1.000   
P value 0.129 <0.001 0.783 <0.001    
Fibre -0.045 0.025 0.105 -0.083 0.697 1.000  
P value <0.001 0.021 <0.001 <0.001 <0.001   
Cholesterol 0.474 -0.142 0.143 -0.170 -0.165 -0.354 1.000 
P value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001  
*Abbreviations: SFA- saturated fats; PUFA- Polyunsaturated fats; F&V: Fruit and 
vegetables 
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Table 32 Correlation coefficients between components of HDI in the Polish 
sample (N=7671) 
 SFA PUFA Protein Sugar F & V Fibres Cholesterol 
SFA* 1.000       
PUFA* -0.176 1.000      
P value <0.001       
Protein -0.126 -0.073 1.000     
P value <0.001 <0.001      
Sugar -0.274 0.280 -0.278 1.000    
P value <0.001 <0.001 <0.001     
F & V* 0.133 0.105 0.038 -0.426 1.000   
P value <0.001 <0.001 0.001 <0.001    
Fibre 0.147 0.078 0.154 -0.354 0.705 1.000  
P value <0.001 <0.001 <0.001 <0.001 <0.001   
Cholesterol 0.380 -0.215 0.010 -0.119 -0.126 -0.281 1.000 
P value <0.001 <0.001 0.376 <0.001 <0.001 <0.001  
*Abbreviations: SFA- saturated fats; PUFA- Polyunsaturated fats; F&V: Fruit and 
vegetables 
 
 
 
Table 33 shows the associations between total HDI score and a range of covariates. 
In all countries, HDI score was higher in older adults (P<0.001); women had higher 
HDI score than men (P<0.001); and never smokers and past smokers had a higher 
HDI score compared with current smokers (P<0.001). In both Czech and Polish 
samples, HDI score increased with longer time spent on leisure activity and 
engagement in sports (P<0.001), but such associations were not found in Russia 
(P=0.398), where HDI score was lower with more time spent on sports engagement 
(P<0.001). In the Czech and Russian samples, the HDI score decreased with higher 
education level (P=0.043 in the Czech sample, P=0.009 in the Russian sample), but 
in Poland education was not associated with HDI score (P=0.445). Subjects taking at 
least one medication for high blood pressure, cholesterol, or diabetes had a lower HDI 
score than those who did not in the Czech sample (P<0.001). However, in the Russian 
and Polish samples, HDI scores were lower among subjects not taking medication 
(P<0.001). Those with a family history of diabetes had higher HDI score compared 
with those without (P<0.001), but this was not significant among Czechs (P=0.153). 
In the Czech and Polish samples, subjects with family history of stroke had higher 
HDI score compared with those without (P=0.007 in the Czech sample, P=0.032 in 
the Polish sample), but this association was not found among Russians (P=0.297). 
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Finally, HDI score was associated with working activity (P<0.001), and a high HDI 
score was correlated with lower alcohol consumption per day, and total energy intake 
per day in all countries (P<0.001).   
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Table 33 Sample characteristics in relation to HDI total score in the HAPIEE study  
Covariates  Czech Republic (N=5060) Russia (N=8788) Poland (N=7671) 
  HDI mean (SD) P* HDI mean (SD) P * HDI mean (SD) P * 
Age group 45-49 46.3(7.1) <0.001 42.9(6.3) <0.001 42.0(6.4) <0.001 
 50-54 46.9(6.8)  43.3(6.4)  42.2(6.5)  
 55-59 47.4(6.9)  44.0(6.9)  43.0(6.6)  
 60-64 48.2(7.0)  44.4(6.9)  43.4(6.5)  
 65-69 48.2(6.9)  45.1(7.2)  43.7(6.8)  
Sex Men 46.3(7.2) <0.001 43.1(6.5) <0.001 42.0(6.5) <0.001 
 Women 48.5(6.5)  44.7(7.0)  43.7(6.6)  
Smoking Current smoker 46.2(7.1) <0.001 42.5(6.4) <0.001 41.7(6.5) <0.001 
 Past smoker 47.7(6.9)  43.7(6.6)  43.2(6.5)  
 Never smoker 48.1(6.7)  44.8(6.9)  43.5(6.6)  
Leisure activity <1 hour/d 47.1(7.1) <0.001 44.1(6.9) 0.398 42.3(6.8) 0.015 
 1-2 hours/d 47.4(6.8)  44.1(6.8)  43.3(6.5)  
 2-3 hours/d 47.6(6.9)  43.9(6.8)  43.1(6.6)  
 >3 hours/d 48.0(6.8)  43.9(6.8)  42.9(6.4)  
Sports time 0 hour/d 46.7(7.1) <0.001 44.2(6.9) <0.001 42.0(6.4) <0.001 
 0-1 hour/d 47.6(6.9)  43.8(6.4)  43.2(6.8)  
 >1 hour/d 48.2(6.7)  43.3(6.9)  43.3(6.5)  
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Covariates  Czech Republic (N=5060) Russia (N=8788) Poland (N=7671) 
  HDI mean (SD) P* HDI mean (SD) P * HDI mean (SD) P * 
Working activity Working:non-pensioner 46.6(6.9) <0.001 43.0(6.3) <0.001 42.2(6.4) <0.001 
 Not working:non-pensioner 49.5(6.4)  43.5(6.8)  42.8(7.0)  
 Working: pensioner 47.7(6.9)  43.9(6.6)  42.9(6.6)  
 Not working: pensioner 48.4(6.8)  44.9(7.2)  43.5(6.7)  
Education Primary or lower 48.0(7.1) 0.043 44.6(7.3) 0.009 43.0(6.6) 0.445 
 Vocational 47.4(7.0)  44.2(6.8)  42.5(6.4)  
 Secondary 47.6(6.7)  43.7(6.8)  43.1(6.7)  
 University 46.9(7.1)  43.9(6.7)  42.9(6.6)  
Medication** Yes  48.3(6.8) <0.001 43.5(6.6) <0.001 41.9(6.4) <0.001 
 No 46.7(6.9)  44.8(7.0)  43.7(6.7)  
Family history of 
diabetes 
Yes 47.7(7.0) 0.153 44.4(6.8) 0.043 43.2(6.8) 0.014 
No 47.4(6.9)  43.9(6.8)  42.8(6.6)  
Family history of 
stroke 
Yes 47.9(6.8) 0.007 44.1(6.9) 0.297 43.2(6.6) 0.032 
No 47.3(7.0)  43.9(6.8)  42.8(6.6)  
  r  r  r  
Alcohol intake (g/day)  -0.147 <0.001 -0.078 <0.001 -0.080 <0.001 
Energy intake 
(kcal/day) 
 
-0.130 <0.001 -0.236 <0.001 -0.223 <0.001 
*P-value for trend using linear regression for age group, leisure activity, sports time, education; P-value for correlation coefficient (r) for alcohol intake and energy intake; P-value 
from t-test  for sex, medication, family history of diabetes, family history of stroke; P-value from one-way ANOVA for smoking, working activity. 
**At least have one medication for blood pressure, diabetes, or cholesterol 
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5.5 Potential confounders, mediators, and effect modifiers 
According to the previous analyses conducted in sections 5.2 and 5.4, which 
examined metabolic syndrome and HDI in relations to covariates. The following 
variables were therefore chosen as potential confounders in each study sample (ie, 
variables associated with both the exposure and outcome but not on the causal 
pathway).  
 Czech Republic: 
 Age group 
 Sex  
 Smoking status 
 Leisure activity 
 Sports time 
 Working activity 
 Education 
 Medication for blood pressure, diabetes, or cholesterol 
 Family history of stroke 
 Energy intake 
 Russia:  
 Age group 
 Sex 
 Smoking status 
 Sports time 
 Working activity 
 Education 
 Medication for blood pressure, diabetes, or cholesterol 
 Family history of diabetes 
 Alcohol intake  
 Energy intake 
 Poland: 
 Age group 
 Sex  
 Smoking status 
 Sports time 
 Working activity  
 Medication for blood pressure, diabetes, or cholesterol 
143 
 
 Family history of diabetes 
 Family history of stroke 
 Energy intake  
Mediators are also the important elements in the epidemiological studies. However, 
mediators were not considered in this thesis due to the cross-sectional study design, 
which are not recommended to test for mediation.306  
Potential effect modifiers were also tested using interaction tests. These analyses 
suggested that sex was not effect modifier in the association between HDI and 
metabolic syndrome in any of three countries (Czech Republic: P=0.37; Russia: 
P=0.21; Poland: P=0.63). Therefore, analyses between HDI and metabolic syndrome 
were carried out without sex stratification. Moreover, country was not a significant 
effect modifier in the association between HDI and metabolic syndrome either 
(P=0.115), but country specific analyses were carried out due to some country specific 
methodological designs, and combined analyses conducted in addition (see Section 
5.6.3). Education and energy intake were found to be effect modifiers in the 
association between HDI and metabolic syndrome in the Czech sample; however, 
this was not found in Russia or Poland.  
In order to facilitate the comparison among countries, the regression model in the 
main analyses included all the confounders and interaction terms which had been 
found in any country. Therefore, in multivariable regression models, adjustment was 
made for the following: age group, sex, smoking status, leisure activity hours per day, 
hours in engaging sports per day, working activity, education, medication for blood 
pressure, diabetes, or cholesterol, family history of diabetes, family history of stroke, 
alcohol intake, and energy intake were included. Interaction terms were also included 
between education and HDI, and between energy intake and HDI. In the pooled 
analyses, a categorical variable indicating country was also added in the final model 
as a potential confounder.  
5.6 Association between HDI and metabolic syndrome (and its 
components) in the HAPIEE study  
In the following sections, the results in response to Objective 4 are presented. To 
investigate the associations between HDI (and its components) and metabolic 
syndrome (and its components), three models were performed: first, a crude 
(unadjusted) model; second, a model adjusted for age group and sex; and finally a 
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model additionally adjusted for a range of other potential confounders (smoking 
status, leisure activity hours per day, hours in engaging sports per day, working 
activity, education, medication for blood pressure, diabetes, or cholesterol, family 
history of diabetes, family history of stroke, alcohol intake, and energy intake) and 
effect modifiers (education and energy intake). 
5.6.1 HDI total score and metabolic syndrome—country specific results 
Table 34 shows the association between total HDI score and metabolic syndrome and 
its components by country. In the Czech sample, HDI total score was not associated 
with metabolic syndrome, high blood pressure, low HDL-C, or high glucose. A higher 
score of total HDI (healthier diet) was associated with higher risk of central obesity 
and lower risk of high triglycerides in the unadjusted model (OR:1.15, 
95%CI(1.06,1.24), P<0.001; 0.91(0.84,0.99),P=0.029), but both associations were 
fully attenuated after adjustment for potential confounders. In the Russian sample, a 
higher HDI score was associated with higher risk of having metabolic syndrome (1.11 
(1.04,1.19),P=0.003), high blood pressure (1.12 (1.05,1.20), P<0.001), central obesity 
(1.09 (1.02,1.16), P=0.007), high triglycerides (1.07 (1.00,1.15), P=0.045),  and low 
HDL-C (1.11 (1.02,1.21), P=0.020)  in the unadjusted models, but these associations 
were fully attenuated in the adjusted models. In Polish sample, a higher HDI total 
score was associated with higher risk of metabolic syndrome (1.18 (1.09,1.27), 
P<0.001), high blood pressure (1.17 (1.07,1.28), P<0.001), central obesity (1.15 
(1.07,1.23), P<0.001), low HDL-C (1.14 (1.07,1.23), P<0.001), and high glucose (1.14 
(1.05,1.24), P=0.001). After adjusting for age group and sex, the associations 
between HDI and metabolic syndrome (1.12 (1.04,1.21), P=0.003), high blood 
pressure (1.14 (1.06,1.22), P=0.001), low HDL-C (1.09 (1.01,1.19), P=0.033), and 
high glucose (1.16 (1.06,1.27), P=0.001) remained significant although attenuated. 
However, after full adjustment, these associations were fully attenuated.  
In the next section, the association between individual components of HDI and 
metabolic syndrome and its components will be presented.  
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Table 34  The association between HDI scorea and metabolic syndrome in the 
HAPIEE study by country 
aHDI total score with 10-unit increment  
bmodel 1: unadjusted model 
cmodel 2: adjusted for age group and sex 
dmodel 3: adjusted for age group, sex, smoking status, leisure activity hours per day, hours in engaging 
sports per day, working activity, education, medication for blood pressure, diabetes, or cholesterol, family 
history of diabetes, family history of stroke, alcohol intake, and energy intake; added interaction terms 
between education and HDI, and energy intake and HDI  
 Model 1b  Model 2c  Model 3d  
 OR (95% CI) P OR (95% CI) P OR (95% CI) P 
Czech Republic       
Metabolic syndrome 1.05 (0.97,1.14) 0.260 0.99 (0.91,1.08) 0.843 1.00 (0.78,1.28) 0.974 
High blood pressure 1.04 (0.96,1.13) 0.332 1.05 (0.96,1.15) 0.282 0.97 (0.74,1.28) 0.838 
Central obesity 1.15 (1.06,1.24) 0.001 1.00 (0.91,1.08) 0.926 1.11 (0.86,1.42) 0.425 
High TG 0.91 (0.84,0.99) 0.029 0.94 (0.87,1.02) 0.151 0.92 (0.72,1.16) 0.472 
Low HDL-C 0.98 (0.90,1.06) 0.587 0.93 (0.85,1.02) 0.103 0.88 (0.69,1.13) 0.312 
High glucose 1.04 (0.94,1.14) 0.454 1.04 (0.94,1.15) 0.467 0.95 (0.72,1.24) 0.708 
       
Russia       
Metabolic syndrome 1.11 (1.04,1.19) 0.003 1.00 (0.93,1.07) 0.937 1.03 (0.83,1.28) 0.804 
High blood pressure 1.12 (1.05,1.20) <0.001 1.05 (0.98,1.12) 0.185 0.83 (0.62,1.12) 0.225 
Central obesity 1.09 (1.02,1.16) 0.007 0.92 (0.86,0.98) 0.015 1.00 (0.80,1.25) 0.978 
High TG 1.07 (1.00,1.15) 0.045 1.02 (0.96,1.10) 0.490 1.01 (0.82,1.25) 0.913 
Low HDL-C 1.11 (1.02,1.21) 0.020 1.00 (0.91,1.10) 0.956 1.01 (0.77,1.32) 0.959 
High glucose 1.05 (0.98,1.12) 0.178 1.02 (0.95,1.09) 0.663 0.96 (0.78,1.18) 0.678 
       
Poland       
Metabolic syndrome 1.18 (1.09,1.27) <0.001 1.12 (1.04,1.21) 0.003 0.91 (0.73,1.14) 0.404 
High blood pressure 1.15 (1.07,1.23) <0.001 1.14 (1.06,1.22) 0.001 0.81 (0.62,1.04) 0.097 
Central obesity 1.14 (1.07,1.23) <0.001 1.03 (0.96,1.10) 0.456 0.85 (0.68,1.06) 0.140 
High TG 1.02 (0.95,1.10) 0.568 1.05 (0.98,1.13) 0.153 1.05 (0.85,1.30) 0.650 
Low HDL-C 1.14 (1.05,1.24) 0.001 1.09 (1.01,1.19) 0.033 1.04 (0.83,1.31) 0.710 
High glucose 1.17 (1.07,1.28) <0.001 1.16 (1.06,1.27) 0.001 0.92 (0.72,1.18) 0.526 
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5.6.2 HDI components, metabolic syndrome, and its components – country 
specific results 
This section presents associations between each of the seven components of HDI 
score (saturated fatty acids, polyunsaturated fatty acids, protein, sugar, fruit and 
vegetable, fibre, and cholesterol) and metabolic syndrome and its components (in 
response to Objective 5).  
Table 35 shows the association between a one unit increase in saturated fatty acids 
score and risk of metabolic syndrome and the components of metabolic syndrome in 
three study samples. In the Czech sample, saturated fatty acids score was not 
associated with risk of metabolic syndrome nor its components, except high blood 
glucose. After adjusting for potential confounders and including interaction terms, a 
one unit increase in saturated fatty acids score was associated with 8% increased risk 
of having high blood glucose (1.08 (1.01,1.16), P=0.036) in the Czech sample. In the 
Russian sample, higher saturated fatty acids score was associated with a slightly 
increased risk of some components of metabolic syndrome in unadjusted models: for 
example, a one unit increase in saturated fatty acids score was associated with 4% 
increased risk of having a low HDL-C level. However, these associations were fully 
attenuated after adjustment for potential confounders. In the Polish sample, the 
association between saturated fatty acids score and metabolic syndrome and its 
components was similar to the Russian sample in the unadjusted model. However, 
unlike the Russian sample, the fully adjusted model in the Polish sample showed 
some significant associations: a one unit increase in saturated fatty acid score was 
associated with higher risk of having high triglycerides (1.06 (1.00,1.12), P=0.048) 
and high blood glucose (1.07 (1.00,1.15), P=0.043), but associated with lower risk of 
having central obesity (0.93 (0.88,0.99), P=0.017) after adjusting for all confounders 
and including the effect modifiers.  
The association between polyunsaturated fatty acids score and risk of metabolic 
syndrome and its components is shown in Table 36. In the Czech sample, a higher 
score in polyunsaturated fatty acids was associated with higher risk of high blood 
pressure in the unadjusted and age and sex adjusted models. However, in the fully 
adjusted model, the association was fully attenuated. No other association was found 
in the Czech sample. In the Russian sample, a higher polyunsaturated fatty acid score 
was weakly associated with lower risk of metabolic syndrome and its components: for 
example, a higher score of polyunsaturated fatty acids were associated with lower 
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risk of metabolic syndrome in the age and sex adjusted model (0.97 (0.95,0.99), 
P=0.012). However, these associations were attenuated fully after adjusting for 
confounders. In the Polish sample, higher score in polyunsaturated fatty acids was 
associated with lower risk of having low HDL-C, but the association with HDL-C was 
not significant in the fully adjusted model, while the association with lower risk of 
having high triglycerides was only significant after adjusting for more confounders 
(0.91 (0.83,1.00), P=0.043).  
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Table 35 The association between saturated fatty acids scorea and metabolic 
syndrome in the HAPIEE study by country 
aSaturated fats score with one unit increment  
bmodel 1: unadjusted model 
cmodel 2: adjusted for age group and sex 
dmodel 3: adjusted for age group, sex, smoking status, leisure activity hours per day, hours in engaging 
sports per day, working activity, education, medication for blood pressure, diabetes, or cholesterol, family 
history of diabetes, family history of stroke, alcohol intake, and energy intake; added interaction terms 
between education and HDI, and energy intake and HDI  
 Model 1b  Model 2c  Model 3d  
 OR (95% CI) P OR (95% CI) P OR (95% CI) P 
Czech Republic       
Metabolic syndrome  1.01 (0.99,1.02) 0.544 1.01 (0.99,1.02) 0.524 1.04 (0.98,1.11) 0.218 
High blood pressure 0.99 (0.98,1.01) 0.518 1.01 (0.99,1.02) 0.535 1.02 (0.95,1.09) 0.616 
Central obesity 1.01 (0.99,1.02) 0.476 0.99 (0.98,1.01) 0.433 1.03 (0.96,1.10) 0.391 
High TG 0.99 (0.98,1.01) 0.379 1.00 (0.98,1.02) 0.940 1.03 (0.97,1.09) 0.358 
Low HDL-C 1.01 (1.00,1.03) 0.120 1.01 (0.99,1.03) 0.288 0.96 (0.90,1.02) 0.212 
High glucose 1.00 (0.98,1.02) 0.630 1.00 (0.98,1.02) 0.793 1.08 (1.01,1.16) 0.036 
       
Russia       
Metabolic syndrome  1.03 (1.02,1.05) <0.001 1.01 (1.00,1.03) 0.086 0.99 (0.93,1.05) 0.764 
High blood pressure 1.05 (1.03,1.06) <0.001 1.03 (1.02,1.05) <0.001 0.94 (0.88,1.00) 0.069 
Central obesity 1.03 (1.01,1.04) <0.001 1.00 (0.99,1.01) 0.983 0.98 (0.92,1.04) 0.447 
High TG 1.02 (1.01,1.03) 0.007 1.01 (1.00,1.03) 0.128 0.96 (0.90,1.01) 0.120 
Low HDL-C 1.04 (1.02,1.06) <0.001 1.03 (1.01,1.05) 0.008 1.01 (0.94,1.09) 0.825 
High glucose 1.01 (1.00,1.03) 0.097 1.01 (0.99,1.02) 0.478 0.96 (0.91,1.02) 0.190 
       
Poland       
Metabolic syndrome  1.05 (1.03,1.06) <0.001 1.03 (1.02,1.05) <0.001 1.02 (0.96,1.08) 0.557 
High blood pressure 1.04 (1.03,1.06) <0.001 1.03 (1.02,1.05) <0.001 1.02 (0.95,1.09) 0.645 
Central obesity 1.03 (1.01,1.04) <0.001 1.01 (0.99,1.02) 0.498 0.93 (0.88,0.99) 0.017 
High TG 1.02 (1.01,1.04) 0.003 1.03 (1.01,1.04) <0.001 1.06 (1.00,1.12) 0.048 
Low HDL-C 1.04 (1.03,1.06) <0.001 1.04 (1.02,1.05) <0.001 1.00 (0.94,1.06) 0.955 
High glucose 1.03 (1.01,1.05) 0.002 1.02 (1.00,1.04) 0.027 1.07 (1.00,1.15) 0.043 
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Table 36 The association between polyunsaturated fatty acids scorea and 
metabolic syndrome in the HAPIEE study by country 
aPolyunsaturated fats score with one unit increment  
bmodel 1: unadjusted model 
cmodel 2: adjusted for age group and sex 
dmodel 3: adjusted for age group, sex, smoking status, leisure activity hours per day, hours in engaging 
sports per day, working activity, education, medication for blood pressure, diabetes, or cholesterol, family 
history of diabetes, family history of stroke, alcohol intake, and energy intake; added interaction terms 
between education and HDI, and energy intake and HDI  
 Model 1b  Model 2c  Model 3d  
 OR (95% CI) P OR (95% CI) P OR (95% CI) P 
Czech Republic       
Metabolic syndrome  1.03 (0.97,1.08) 0.347 1.03 (0.97,1.09) 0.306 1.04 (0.91,1.19) 0.570 
High blood pressure 1.07 (1.02,1.13) 0.009 1.07 (1.01,1.13) 0.015 1.00 (0.87,1.16) 0.966 
Central obesity 1.01 (0.96,1.06) 0.746 1.02 (0.97,1.08) 0.414 0.97 (0.85,1.12) 0.694 
High TG 1.02 (0.97,1.07) 0.458 1.01 (0.96,1.07) 0.622 1.00 (0.88,1.13) 0.946 
Low HDL-C 0.97 (0.92,1.03) 0.329 0.98 (0.93,1.03) 0.419 0.99 (0.87,1.13) 0.880 
High glucose 1.01 (0.94,1.07) 0.875 1.00 (0.94,1.07) 0.966 1.05 (0.90,1.22) 0.564 
       
Russia       
Metabolic syndrome  0.96 (0.94,0.98) <0.001 0.97 (0.95,0.99) 0.012 0.98 (0.91,1.05) 0.516 
High blood pressure 0.97 (0.95,0.99) 0.013 0.97 (0.95,0.99) 0.004 0.98 (0.90,1.06) 0.585 
Central obesity 0.94 (0.92,0.96) <0.001 0.97 (0.95,0.99) 0.010 0.97 (0.90,1.05) 0.459 
High TG 1.00 (0.98,1.02) 0.866 1.00 (0.98,1.02) 0.867 0.99 (0.92,1.06) 0.769 
Low HDL-C 0.93 (0.91,0.96) <0.001 0.96 (0.94,0.99) 0.003 0.94 (0.86,1.02) 0.149 
High glucose 0.98 (0.96,1.00) 0.057 0.97 (0.95,0.99) 0.010 0.96 (0.89,1.03) 0.208 
       
Poland       
Metabolic syndrome  0.98 (0.95,1.01) 0.210 1.00 (0.97,1.04) 0.833 0.97 (0.88,1.07) 0.515 
High blood pressure 1.00 (0.97,1.03) 0.942 1.02 (0.99,1.05) 0.258 1.02 (0.91,1.14) 0.760 
Central obesity 1.01 (0.97,1.04) 0.722 1.05 (1.02,1.09) 0.002 1.01 (0.92,1.12) 0.771 
High TG 0.99 (0.96,1.02) 0.446 0.98 (0.95,1.01) 0.216 0.91 (0.83,1.00) 0.043 
Low HDL-C 0.94 (0.90,0.97) <0.001 0.95 (0.91,0.98) 0.005 0.95 (0.86,1.05) 0.353 
High glucose 1.06 (1.02,1.10) 0.006 1.08 (1.03,1.12) <0.001 1.06 (0.94,1.18) 0.344 
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Table 37 shows the association between protein score and risk of metabolic syndrome 
and its components. In the Czech sample, a higher protein score was associated with 
lower risk of metabolic syndrome and its components. However, the effects were 
weakened after adjusting for confounders and the inclusion of the effect modifiers, 
except for the association with lower risk of having high blood glucose (0.87 
(0.80,0.94), P<0.001). Similar results were also found in Russia: a one unit increase 
in protein score was associated with 7% lower risk of having high blood glucose (0.93 
(0.88,0.99), P=0.022). In the Polish sample, in the fully adjusted model, higher score 
in protein was significantly associated with not just lower risk of having high blood 
glucose (0.82 (0.75,0.89), P<0.001), but also metabolic syndrome (0.92 (0.86,0.98), 
P=0.015), and central obesity (0.90 (0.84,0.96), P=0.002). 
The association between sugar score and risk of metabolic syndrome and its 
components is shown in Table 38. In the Czech sample, a higher score in sugar intake 
was associated with higher risk of metabolic syndrome and most components in the 
unadjusted model. For example, after adjusting for confounders and including effect 
modifiers, a higher score in sugar intake was only associated with a higher risk of 
having high blood glucose (1.11 (1.03,1.19), P=0.008). Higher sugar score was also 
significantly associated with lower risk of having low HDL-C in the fully adjusted model 
(0.93 (0.87,1.00), P=0.048). In the Russian sample, the higher sugar score was 
significantly associated with higher risk of having high blood pressure (1.10 
(1.02,1.18), P=0.011) as well as high glucose (1.12 (1.05,1.19), P=0.001) in the fully 
adjusted model. Higher sugar score was also associated with lower risk of having low 
level of HDL-C (0.93 (0.91,0.95), P<0.001), but was only significant in the unadjusted 
model. In the Polish sample, a one unit increase in the sugar score was associated 
with 23% increased risk of having high blood glucose in the fully adjusted model (1.23 
(1.15,1.32), P<0.001)—double the increased risk seen in the Czech and Russian 
samples.  
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Table 37 The association between protein scorea and metabolic syndrome in 
the HAPIEE study by country 
a Protein score with one unit increment  
bmodel 1: unadjusted model 
cmodel 2: adjusted for age group and sex 
dmodel 3: adjusted for age group, sex, smoking status, leisure activity hours per day, hours in engaging 
sports per day, working activity, education, medication for blood pressure, diabetes, or cholesterol, family 
history of diabetes, family history of stroke, alcohol intake, and energy intake; added interaction terms 
between education and HDI, and energy intake and HDI  
 Model 1b  Model 2c  Model 3d  
 OR (95% CI) P OR (95% CI) P OR (95% CI) P 
Czech Republic       
Metabolic syndrome  0.95 (0.92,0.97) <0.001 0.93 (0.91,0.95) <0.001 0.94 (0.87,1.01) 0.093 
High blood pressure 0.94 (0.92,0.97) <0.001 0.94 (0.92,0.96) <0.001 0.98 (0.90,1.06) 0.556 
Central obesity 0.98 (0.96,1.00) 0.044 0.94 (0.92,0.97) <0.001 0.98 (0.91,1.06) 0.634 
High TG 0.97 (0.95,0.99) 0.002 0.97 (0.95,1.00) 0.023 1.00 (0.93,1.07) 0.985 
Low HDL-C 0.98 (0.96,1.00) 0.086 0.97 (0.95,0.99) 0.011 0.95 (0.88,1.02) 0.149 
High glucose 0.89 (0.87,0.91) <0.001 0.89 (0.86,0.91) <0.001 0.87 (0.80,0.94) <0.001 
       
Russia       
Metabolic syndrome  0.93 (0.92,0.95) <0.001 0.92 (0.90,0.94) <0.001 0.97 (0.91,1.03) 0.292 
High blood pressure 0.95 (0.93,0.96) <0.001 0.94 (0.92,0.96) <0.001 0.98 (0.91,1.05) 0.547 
Central obesity 0.94 (0.93,0.96) <0.001 0.92 (0.90,0.93) <0.001 0.94 (0.88,1.00) 0.055 
High TG 0.96 (0.94,0.98) <0.001 0.96 (0.94,0.98) <0.001 0.97 (0.92,1.04) 0.409 
Low HDL-C 0.98 (0.96,1.01) 0.162 0.97 (0.95,0.99) 0.017 1.01 (0.93,1.10) 0.769 
High glucose 0.92 (0.90,0.93) <0.001 0.91 (0.90,0.93) <0.001 0.93 (0.88,0.99) 0.022 
       
Poland       
Metabolic syndrome  0.91 (0.89,0.93) <0.001 0.91 (0.89,0.93) <0.001 0.92 (0.86,0.98) 0.015 
High blood pressure 0.92 (0.90,0.94) <0.001 0.93 (0.91,0.95) <0.001 1.05 (0.98,1.14) 0.176 
Central obesity 0.94 (0.92,0.95) <0.001 0.93 (0.91,0.95) <0.001 0.90 (0.84,0.96) 0.002 
High TG 0.95 (0.93,0.97) <0.001 0.96 (0.94,0.98) <0.001 0.95 (0.89,1.01) 0.116 
Low HDL-C 0.99 (0.97,1.01) 0.455 0.99 (0.96,1.01) 0.236 0.94 (0.88,1.01) 0.073 
High glucose 0.83 (0.81,0.85) <0.001 0.84 (0.82,0.86) <0.001 0.82 (0.75,0.89) <0.001 
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Table 38 The association between sugar scorea and metabolic syndrome in 
the HAPIEE study by country 
aSugar score with one unit increment  
bmodel 1: unadjusted model 
cmodel 2: adjusted for age group and sex 
dmodel 3: adjusted for age group, sex, smoking status, leisure activity hours per day, hours in engaging 
sports per day, working activity, education, medication for blood pressure, diabetes, or cholesterol, family 
history of diabetes, family history of stroke, alcohol intake, and energy intake; added interaction terms 
between education and HDI, and energy intake and HDI  
 Model 1b  Model 2c  Model 3d  
 OR (95% CI) P OR (95% CI) P OR (95% CI) P 
Czech Republic       
Metabolic syndrome  1.06 (1.03,1.08) <0.001 1.06 (1.04,1.08) <0.001 1.04 (0.97,1.12) 0.249 
High blood pressure 1.08 (1.05,1.10) <0.001 1.04 (1.02,1.07) <0.001 1.04 (0.96,1.12) 0.375 
Central obesity 1.03 (1.01,1.05) 0.005 1.08 (1.05,1.10) <0.001 1.06 (0.99,1.14) 0.081 
High TG 1.04 (1.02,1.06) <0.001 1.02 (1.00,1.04) 0.116 1.00 (0.93,1.07) 0.975 
Low HDL-C 0.98 (0.96,1.00) 0.064 0.99 (0.97,1.01) 0.405 0.93 (0.87,1.00) 0.048 
High glucose 1.13 (1.10,1.15) <0.001 1.11 (1.08,1.14) <0.001 1.11 (1.03,1.19) 0.008 
       
Russia       
Metabolic syndrome  1.01 (0.99,1.03) 0.497 1.05 (1.03,1.07) <0.001 1.04 (0.97,1.11) 0.231 
High blood pressure 1.04 (1.02,1.06) <0.001 1.06 (1.04,1.08) <0.001 1.10 (1.02,1.18) 0.011 
Central obesity 0.98 (0.96,1.00) 0.014 1.07 (1.05,1.09) <0.001 1.00 (0.94,1.07) 0.948 
High TG 0.99 (0.97,1.01) 0.380 1.01 (0.99,1.03) 0.500 1.00 (0.94,1.07) 0.973 
Low HDL-C 0.93 (0.91,0.95) <0.001 0.99 (0.96,1.01) 0.346 0.94 (0.86,1.02) 0.161 
High glucose 1.06 (1.04,1.08) <0.001 1.06 (1.04,1.08) <0.001 1.12 (1.05,1.19) 0.001 
       
Poland       
Metabolic syndrome  1.04 (1.02,1.06) <0.001 1.05 (1.03,1.07) <0.001 1.04 (0.98,1.10) 0.235 
High blood pressure 1.05 (1.03,1.06) <0.001 1.03 (1.01,1.05) 0.002 1.02 (0.95,1.09) 0.537 
Central obesity 1.01 (0.99,1.02) 0.413 1.04 (1.02,1.06) <0.001 1.02 (0.96,1.09) 0.477 
High TG 1.03 (1.02,1.05) <0.001 1.02 (1.00,1.03) 0.074 1.01 (0.95,1.07) 0.821 
Low HDL-C 0.97 (0.95,0.99) 0.002 0.99 (0.97,1.01) 0.222 1.00 (0.94,1.07) 0.909 
High glucose 1.17 (1.14,1.19) <0.001 1.16 (1.14,1.19) <0.001 1.23 (1.15,1.32) <0.001 
153 
 
Table 39 shows the association between dietary score for fruits and vegetables and 
risk of metabolic syndrome and its components. In the Czech sample, higher score 
for fruit and vegetable intake was significantly associated with 5% higher risk of having 
central obesity (1.05 (1.03,1.08), P<0.001), and a 4% higher risk of having low HDL-
C (1.04 (1.01,1.07), P=0.004) in the unadjusted model. However, the associations 
were fully attenuated after including all potential confounders and effect modifiers. In 
the Russian sample, higher fruit and vegetable score was associated with higher risk 
of having metabolic syndrome (1.04 (1.02,1.06), P<0.001), central obesity (1.04 
(1.02,1.06), P<0.001), higher triglycerides (1.04 (1.02,1.06), P<0.001), low HDL-C 
(1.04 (1.02,1.07), P=0.002), and high glucose level (1.03 (1.01,1.05), P<0.002) in the 
unadjusted models. However, after adjustment all potential confounders and effect 
modifiers, the only association still significant was a higher risk of having high glucose 
level (1.07 (1.00,1.14), P=0.044). In the Polish sample, score in fruits and vegetable 
intake was found associated only with higher risk of having metabolic syndrome (1.03 
(1.00,1.05), P=0.040), central obesity (1.04 (1.02,1.07), P<0.001), and low HDL-C 
(1.03 (1.00,1.06), P=0.030) in the unadjusted model, the association with metabolic 
syndrome (1.03 (1.00,1.05), P=0.036) and central obesity (1.03 (1.00,1.05), P=0.023) 
remained significant in the age-sex adjusted models, and was no longer significant in 
the fully adjusted model. Interestingly, in both the Czech and Polish samples, higher 
fruit and vegetable score was associated with 3% and 4% higher risk of having high 
glucose level, respectively, in the age and sex adjusted model. However, unlike in 
Russia, these associations were no longer significant in the fully adjusted model. 
Table 40 shows the association between fibre score and risk of metabolic syndrome 
and its components. In the Czech sample, higher fibre score was only significantly 
associated with higher risk of having low HDL-C in the unadjusted model (1.03 
(1.00,1.06), P=0.027), while in the age-sex adjusted model, the higher fibre score was 
associated with lower risk of having central obesity (0.97 (0.94,1.00), P=0.034). 
However, these associations were fully attenuated after adjusting for all potential 
confounders and effect modifiers. In the Russian sample, higher fibre score was 
associated with lower risk of having central obesity (0.96 (0.94,0.98), P=0.001) in the 
unadjusted model, and increased higher risk of having high triglycerides (1.03 
(1.01,1.06), P=0.013) and high glucose level (1.03 (1.00,1.06), P=0.049) in the age-
sex adjusted model. However, after including all the confounders and effect modifiers, 
these associations were attenuated. In the Polish sample, higher fibre score was 
significantly associated with higher risk of having central obesity (1.03 (1.00,1.06), 
P=0.022) and low HDL-C (1.04 (1.01,1.07), P=0.017), and the results remained 
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significant after adjusted for age and sex. However, this association was attenuated 
in the fully adjusted model. Thus, there were no significant association between fire 
score and metabolic syndrome or its components in the fully adjusted model in any of 
the samples. 
Table 41 shows the association between cholesterol score and risk of metabolic 
syndrome and its components. In the Czech sample, in the unadjusted model,  higher 
cholesterol score was associated with higher risk of having central obesity (1.01 
(1.00,1.03), P=0.045), but lower risk of having high triglycerides (0.98 (0.97,1.00), 
P=0.019) and low HDL-C (0.98 (0.97,1.00), P=0.020), but after adjusting for age and 
sex, only the protective association with low HDL-C remained significant (0.98 
(0.96,0.99), P=0.002); after adjusting for all potential confounders and including effect 
modifiers, this association was no longer significant (0.97 (0.92,1.02), P=0.201). In 
the Russian sample, higher cholesterol score was associated with greater risk of 
metabolic syndrome (1.03 (1.02,1.04), P<0.001), high blood pressure (1.02 
(1.01,1.03), P<0.001), central obesity (1.04 (1.03,1.05), P<0.001), and low HDL-C 
(1.04 (1.03,1.06), P<0.001), but these associations were all attenuated after adjusting 
for age and sex. In the fully adjusted model, higher cholesterol score was only 
significantly associated with higher risk of having metabolic syndrome 
(1.06(1.01,1.11), P=0.030), a finding not duplicated in the Czech or Polish samples. 
In the Polish sample, in the unadjusted model, higher cholesterol intake was 
associated with higher risk of having metabolic syndrome (1.02 (1.01,1.03), P=0.001), 
high blood pressure (1.02 (1.01,1.03), P=0.001), and central obesity (1.02 (1.01,1.03), 
P=0.001) as in the Russian sample. In addition, higher score for cholesterol intake 
was also associated with low HDL-C (1.02 (1.00,1.03), P=0.011). After adjusting for 
age and sex, only the association with high blood pressure (1.02 (1.01,1.03), P=0.002) 
remained significant. In the fully adjusted models, the with high blood pressure was 
no longer significant and higher cholesterol score was only associated with higher risk 
of having high glucose level (1.09 (1.03,1.15), P=0.002) although this association was 
not discovered in the Czech nor Russian samples.  
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Table 39 The association between fruit and vegetable scorea and metabolic 
syndrome in the HAPIEE study by country 
a Fruit and vegetable score with one unit increment  
bmodel 1: unadjusted model 
cmodel 2: adjusted for age group and sex 
dmodel 3: adjusted for age group, sex, smoking status, leisure activity hours per day, hours in engaging 
sports per day, working activity, education, medication for blood pressure, diabetes, or cholesterol, family 
history of diabetes, family history of stroke, alcohol intake, and energy intake; added interaction terms 
between education and HDI, and energy intake and HDI  
 Model 1b  Model 2c  Model 3d  
 OR (95% CI) P OR (95% CI) P OR (95% CI) P 
Czech Republic       
Metabolic syndrome  1.03 (1.00,1.05) 0.055 1.02 (0.99,1.05) 0.184 1.01 (0.93,1.10) 0.793 
High blood pressure 1.00 (0.97,1.02) 0.734 1.02 (0.99,1.05) 0.244 1.07 (0.98,1.17) 0.147 
Central obesity 1.05 (1.03,1.08) <0.001 1.01 (0.98,1.04) 0.458 1.02 (0.94,1.11) 0.627 
High TG 0.98 (0.95,1.00) 0.085 1.00 (0.97,1.02) 0.794 0.97 (0.89,1.05) 0.393 
Low HDL-C 1.04 (1.01,1.07) 0.004 1.03 (1.00,1.06) 0.059 1.01 (0.93,1.09) 0.871 
High glucose 1.02 (0.99,1.05) 0.266 1.03 (1.00,1.07) 0.045 1.04 (0.95,1.13) 0.439 
       
Russia       
Metabolic syndrome  1.04 (1.02,1.06) <0.001 1.03 (1.01,1.05) 0.007 1.05 (0.98,1.13) 0.150 
High blood pressure 0.99 (0.98,1.01) 0.608 1.00 (0.98,1.02) 0.854 0.98 (0.91,1.05) 0.547 
Central obesity 1.04 (1.02,1.06) <0.001 1.01 (0.99,1.03) 0.416 0.99 (0.92,1.06) 0.726 
High TG 1.04 (1.02,1.06) <0.001 1.04 (1.02,1.06) <0.001 1.06 (0.99,1.13) 0.084 
Low HDL-C 1.04 (1.02,1.07) 0.002 1.01 (0.98,1.04) 0.362 1.01 (0.92,1.11) 0.802 
High glucose 1.03 (1.01,1.05) 0.002 1.04 (1.02,1.07) <0.001 1.07 (1.00,1.14) 0.044 
       
Poland       
Metabolic syndrome  1.03 (1.00,1.05) 0.040 1.03 (1.00,1.05) 0.036 1.02 (0.95,1.09) 0.614 
High blood pressure 1.00 (0.98,1.02) 0.790 1.01 (0.99,1.04) 0.330 1.02 (0.94,1.09) 0.678 
Central obesity 1.04 (1.02,1.07) <0.001 1.03 (1.00,1.05) 0.023 1.03 (0.96,1.10) 0.432 
High TG 0.98 (0.96,1.01) 0.143 1.00 (0.97,1.02) 0.671 1.01 (0.95,1.08) 0.774 
Low HDL-C 1.03 (1.00,1.06) 0.030 1.02 (0.99,1.05) 0.164 0.99 (0.92,1.06) 0.704 
High glucose 1.03 (1.00,1.06) 0.082 1.04 (1.01,1.07) 0.009 1.07 (0.99,1.16) 0.075 
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Table 40 The association between fibre scorea and metabolic syndrome in the 
HAPIEE study by country 
aFibre score with one unit increment  
bmodel 1: unadjusted model 
cmodel 2: adjusted for age group and sex 
dmodel 3: adjusted for age group, sex, smoking status, leisure activity hours per day, hours in engaging 
sports per day, working activity, education, medication for blood pressure, diabetes, or cholesterol, family 
history of diabetes, family history of stroke, alcohol intake, and energy intake; added interaction terms 
between education and HDI, and energy intake and HDI  
 Model 1b  Model 2c  Model 3d  
 OR (95% CI) P OR (95% CI) P OR (95% CI) P 
Czech Republic       
Metabolic syndrome  1.00 (0.97,1.03) 0.986 0.99 (0.96,1.02) 0.464 1.01 (0.92,1.11) 0.777 
High blood pressure 0.99 (0.97,1.02) 0.664 1.00 (0.97,1.03) 0.938 1.08 (0.97,1.20) 0.142 
Central obesity 1.00 (0.98,1.03) 0.759 0.97 (0.94,1.00) 0.034 0.99 (0.90,1.09) 0.850 
High TG 0.98 (0.95,1.01) 0.141 0.99 (0.96,1.02) 0.458 0.95 (0.87,1.04) 0.311 
Low HDL-C 1.03 (1.00,1.06) 0.027 1.02 (0.99,1.05) 0.127 1.00 (0.91,1.09) 0.927 
High glucose 1.00 (0.97,1.04) 0.882 1.01 (0.97,1.04) 0.658 1.10 (0.99,1.22) 0.089 
       
Russia       
Metabolic syndrome  1.00 (0.97,1.02) 0.832 1.02 (0.99,1.04) 0.228 1.04 (0.95,1.14) 0.366 
High blood pressure 0.98 (0.96,1.01) 0.141 0.99 (0.97,1.02) 0.486 0.97 (0.88,1.07) 0.570 
Central obesity 0.96 (0.94,0.98) 0.001 0.99 (0.96,1.02) 0.465 0.95 (0.87,1.04) 0.290 
High TG 1.03 (1.00,1.05) 0.055 1.03 (1.01,1.06) 0.013 1.07 (0.98,1.17) 0.115 
Low HDL-C 0.98 (0.95,1.01) 0.237 1.01 (0.97,1.04) 0.761 0.97 (0.86,1.09) 0.604 
High glucose 1.02 (1.00,1.05) 0.094 1.03 (1.00,1.06) 0.049 1.09 (1.00,1.19) 0.059 
       
Poland       
Metabolic syndrome  1.02 (0.99,1.05) 0.198 1.02 (0.99,1.05) 0.198 1.00 (0.91,1.09) 0.951 
High blood pressure 1.00 (0.98,1.03) 0.790 1.00 (0.98,1.03) 0.858 1.05 (0.96,1.16) 0.307 
Central obesity 1.03 (1.00,1.06) 0.022 1.03 (1.01,1.06) 0.018 1.01 (0.93,1.10) 0.764 
High TG 1.00 (0.97,1.02) 0.904 1.00 (0.97,1.02) 0.895 1.01 (0.93,1.10) 0.788 
Low HDL-C 1.04 (1.01,1.07) 0.017 1.04 (1.01,1.07) 0.015 0.99 (0.90,1.08) 0.800 
High glucose 1.03 (0.99,1.06) 0.119 1.02 (0.99,1.06) 0.145 1.06 (0.96,1.17) 0.277 
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Table 41 The association between cholesterol scorea and metabolic syndrome 
in the HAPIEE study by country 
acholesterol score with one unit increment  
bmodel 1: unadjusted model 
cmodel 2: adjusted for age group and sex 
dmodel 3: adjusted for age group, sex, smoking status, leisure activity hours per day, hours in engaging 
sports per day, working activity, education, medication for blood pressure, diabetes, or cholesterol, family 
history of diabetes, family history of stroke, alcohol intake, and energy intake; added interaction terms 
between education and HDI, and energy intake and HDI  
 Model 1b  Model 2c  Model 3d  
 OR (95% CI) P OR (95% CI) P OR (95% CI) P 
Czech Republic       
Metabolic syndrome  1.00 (0.98,1.01) 0.747 0.99 (0.98,1.01) 0.218 1.03 (0.98,1.09) 0.213 
High blood pressure 1.00 (0.99,1.02) 0.769 1.00 (0.99,1.02) 0.561 1.00 (0.94,1.06) 0.911 
Central obesity 1.01 (1.00,1.03) 0.045 1.00 (0.98,1.01) 0.667 1.04 (0.99,1.10) 0.119 
High TG 0.98 (0.97,1.00) 0.019 0.99 (0.97,1.00) 0.076 1.03 (0.98,1.08) 0.319 
Low HDL-C 0.98 (0.97,1.00) 0.020 0.98 (0.96,0.99) 0.002 0.97 (0.92,1.02) 0.201 
High glucose 1.00 (0.98,1.02) 0.931 1.00 (0.98,1.02) 0.928 1.05 (0.99,1.11) 0.129 
       
Russia       
Metabolic syndrome  1.03 (1.02,1.04) <0.001 1.00 (0.99,1.01) 0.959 1.06 (1.01,1.11) 0.030 
High blood pressure 1.02 (1.01,1.03) <0.001 1.01 (1.00,1.02) 0.197 1.02 (0.97,1.08) 0.395 
Central obesity 1.04 (1.03,1.05) <0.001 0.99 (0.98,1.00) 0.271 1.03 (0.98,1.08) 0.303 
High TG 1.01 (1.00,1.02) 0.185 0.99 (0.98,1.01) 0.376 1.00 (0.95,1.05) 0.972 
Low HDL-C 1.04 (1.03,1.06) <0.001 1.01 (0.99,1.02) 0.342 1.02 (0.96,1.08) 0.494 
High glucose 1.01 (1.00,1.02) 0.110 1.00 (0.99,1.01) 0.512 1.03 (0.98,1.08) 0.261 
       
Poland       
Metabolic syndrome  1.02 (1.01,1.03) 0.001 1.01 (1.00,1.02) 0.181 1.02 (0.98,1.07) 0.295 
High blood pressure 1.02 (1.01,1.03) 0.001 1.02 (1.01,1.03) 0.002 1.01 (0.96,1.06) 0.797 
Central obesity 1.02 (1.01,1.03) 0.001 0.99 (0.98,1.00) 0.200 1.00 (0.96,1.04) 0.920 
High TG 1.00 (0.99,1.01) 0.950 1.01 (1.00,1.02) 0.157 1.02 (0.98,1.06) 0.394 
Low HDL-C 1.02 (1.00,1.03) 0.011 1.01 (0.99,1.02) 0.421 0.96 (0.92,1.01) 0.094 
High glucose 1.00 (0.99,1.02) 0.704 1.00 (0.99,1.02) 0.835 1.09 (1.03,1.15) 0.002 
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5.6.3 HDI scores and metabolic syndrome – the pooled results 
The associations found between HDI score and risk of metabolic syndrome and its 
components in the pooled dataset (combining all three countries together) are shown 
in Table 42 (in respond to Objective 6). With the exception of the risk of high blood 
pressure, higher HDI total score was associated with higher risk of having metabolic 
syndrome and its other components, but these associations were fully attenuated 
after adjusting for confounders and effect modifiers. A higher HDI total score was still 
associated with lower risk of having high blood pressure after adjusting for 
confounders and adding effect modifiers (0.82 (0.72,0.94),P=0.005). Higher score in 
polyunsaturated fatty acid was associated with lower risk of having central obesity, 
low HDL-C, but higher risk of high glucose, but after full adjustment, only the 
association with lower risk of having low HDL-C (0.93 (0.88,0.98), P=0.012). A higher 
score for protein was associated with lower risk of metabolic syndrome and 
components in the unadjusted model, but in the fully adjusted model the protective 
association was only significant for metabolic syndrome (0.94 (0.90,0.98), P=0.002), 
central obesity (0.94 (0.90,0.97),P=0.001), and high glucose (0.87 (0.83,0.90), 
P<0.001). However, a higher score in sugar was found associated with higher risk of 
having metabolic syndrome (1.04 (1.00,1.08), P=0.039), high blood pressure (1.07 
(1.02,1.11), P=0.002), and high glucose (0.87 (0.83,0.90), P<0.001) in the fully 
adjusted model. Higher score in fibre was associated in the fully adjusted model with 
higher risk of having metabolic syndrome (1.04 (1.00,1.09), P=0.047) and high 
glucose (1.08 (1.03,1.13), P=0.001). A higher score in fruits and vegetables was only 
associated with higher risk of having high blood glucose (1.07 (1.01,1.13), P=0.018) 
in the fully adjusted model. Finally, a higher score in cholesterol was associated with 
higher risk of having metabolic syndrome (1.04 (1.01,1.07), P=0.003) and high blood 
glucose (1.07 (1.04,1.10), P<0.001).  
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Table 42 The association between HDI score and its dietary components score 
and metabolic syndrome in the HAPIEE study (pooled dataset) 
 Model 1a  Model 2b  Model 3c  
 OR (95% CI) P OR (95% CI) P OR (95% CI) P 
HDI total score  (per-10 unit)      
Metabolic syndrome  1.17 (1.12,1.22) <0.001 1.09 (1.04,1.13) <0.001 0.96 (0.85,1.09) 0.558 
High blood pressure 1.13 (1.09,1.18) <0.001 1.09 (1.05,1.14) <0.001 0.82 (0.72,0.94) 0.005 
Central obesity 1.12 (1.08,1.17) <0.001 0.98 (0.94,1.02) 0.323 0.96 (0.85,1.09) 0.554 
High TG 1.07 (1.03,1.12) 0.001 1.07 (1.03,1.12) 0.001 0.98 (0.87,1.10) 0.760 
Low HDL-C 1.17 (1.11,1.22) <0.001 1.10 (1.05,1.16) <0.001 0.94 (0.82,1.07) 0.349 
High glucose 1.08 (1.03,1.13) 0.001 1.05 (1.01,1.10) 0.029 0.99 (0.87,1.13) 0.890 
SFAd (per-one unit)      
Metabolic syndrome  1.04 (1.03,1.04) <0.001 1.02 (1.01,1.03) <0.001 1.01 (0.98,1.05) 0.475 
High blood pressure 1.03 (1.02,1.04) <0.001 1.03 (1.02,1.04) <0.001 0.98 (0.95,1.02) 0.408 
Central obesity 1.02 (1.01,1.03) <0.001 1.00 (0.99,1.01) 0.810 0.97 (0.94,1.01) 0.136 
High TG 1.02 (1.01,1.03) <0.001 1.02 (1.01,1.03) <0.001 1.01 (0.98,1.05) 0.387 
Low HDL-C 1.04 (1.03,1.05) <0.001 1.03 (1.02,1.04) <0.001 0.98 (0.95,1.02) 0.369 
High glucose 1.01 (1.00,1.02) 0.020 1.01 (1.00,1.02) 0.153 1.03 (0.99,1.07) 0.135 
PUFAe (per-one unit)      
Metabolic syndrome  0.99 (0.98,1.01) 0.431 1.00 (0.98,1.02) 0.889 0.97 (0.92,1.02) 0.242 
High blood pressure 1.01 (0.99,1.02) 0.445 1.00 (0.99,1.02) 0.834 0.99 (0.94,1.05) 0.739 
Central obesity 0.98 (0.96,0.99) 0.003 1.00 (0.98,1.02) 0.937 0.99 (0.94,1.04) 0.613 
High TG 1.01 (0.99,1.02) 0.396 1.00 (0.99,1.02) 0.750 0.97 (0.92,1.02) 0.240 
Low HDL-C 0.96 (0.94,0.98) <0.001 0.97 (0.95,0.99) 0.001 0.93 (0.88,0.98) 0.012 
High glucose 1.02 (1.00,1.04) 0.025 1.02 (1.00,1.04) 0.079 0.99 (0.94,1.05) 0.767 
Protein (per-one unit)      
Metabolic syndrome  0.93 (0.92,0.94) <0.001 0.92 (0.91,0.93) <0.001 0.94 (0.90,0.98) 0.002 
High blood pressure 0.94 (0.93,0.95) <0.001 0.94 (0.93,0.95) <0.001 1.01 (0.96,1.05) 0.809 
Central obesity 0.95 (0.94,0.96) <0.001 0.93 (0.92,0.94) <0.001 0.94 (0.90,0.97) 0.001 
High TG 0.95 (0.94,0.96) <0.001 0.96 (0.95,0.97) <0.001 0.98 (0.94,1.02) 0.266 
Low HDL-C 0.97 (0.96,0.99) <0.001 0.96 (0.95,0.98) <0.001 0.97 (0.93,1.01) 0.123 
High glucose 0.90 (0.89,0.91) <0.001 0.90 (0.89,0.91) <0.001 0.87 (0.83,0.90) <0.001 
Sugar (per-one unit)      
160 
 
 Model 1a  Model 2b  Model 3c  
 OR (95% CI) P OR (95% CI) P OR (95% CI) P 
Metabolic syndrome  1.02 (1.01,1.04) <0.001 1.04 (1.03,1.05) <0.001 1.04 (1.00,1.08) 0.039 
High blood pressure 1.05 (1.04,1.06) <0.001 1.04 (1.03,1.06) <0.001 1.07 (1.02,1.11) 0.002 
Central obesity 1.01 (1.00,1.02) 0.033 1.06 (1.05,1.07) <0.001 1.02 (0.99,1.06) 0.164 
High TG 1.00 (0.99,1.01) 0.353 0.99 (0.98,1.00) 0.015 1.01 (0.98,1.04) 0.570 
Low HDL-C 0.93 (0.92,0.94) <0.001 0.95 (0.94,0.96) <0.001 0.98 (0.95,1.02) 0.433 
High glucose 1.13 (1.12,1.15) <0.001 1.13 (1.12,1.15) <0.001 1.13 (1.09,1.17) <0.001 
Fibre (per-one unit)      
Metabolic syndrome  1.03 (1.02,1.05) <0.001 1.03 (1.02,1.04) <0.001 1.04 (1.00,1.09) 0.047 
High blood pressure 0.99 (0.98,1.01) 0.274 1.00 (0.99,1.02) 0.477 1.00 (0.96,1.05) 0.843 
Central obesity 1.04 (1.02,1.05) <0.001 1.01 (1.00,1.02) 0.091 1.02 (0.98,1.06) 0.267 
High TG 1.02 (1.01,1.03) 0.003 1.03 (1.01,1.04) <0.001 1.02 (0.98,1.06) 0.341 
Low HDL-C 1.06 (1.05,1.08) <0.001 1.05 (1.03,1.06) <0.001 1.01 (0.96,1.05) 0.745 
High glucose 1.01 (0.99,1.02) 0.261 1.02 (1.00,1.03) 0.010 1.08 (1.03,1.13) <0.001 
Fruit and vegetables (per-one unit)      
Metabolic syndrome  1.00 (0.98,1.01) 0.723 1.00 (0.98,1.01) 0.692 1.02 (0.97,1.07) 0.444 
High blood pressure 0.99 (0.97,1.00) 0.121 0.99 (0.97,1.00) 0.113 1.03 (0.97,1.09) 0.344 
Central obesity 0.99 (0.98,1.01) 0.365 0.99 (0.98,1.01) 0.333 0.98 (0.93,1.03) 0.435 
High TG 1.00 (0.98,1.01) 0.531 1.00 (0.98,1.01) 0.516 1.01 (0.96,1.06) 0.759 
Low HDL-C 1.01 (0.99,1.03) 0.217 1.01 (0.99,1.03) 0.226 1.00 (0.95,1.06) 0.978 
High glucose 1.01 (1.00,1.03) 0.123 1.01 (1.00,1.03) 0.111 1.07 (1.01,1.13) 0.018 
Cholesterol  (per-one unit)      
Metabolic syndrome  1.03 (1.02,1.03) <0.001 1.01 (1.01,1.02) <0.001 1.04 (1.01,1.07) 0.003 
High blood pressure 1.02 (1.01,1.02) <0.001 1.01 (1.01,1.02) <0.001 1.00 (0.97,1.03) 0.973 
Central obesity 1.02 (1.02,1.03) <0.001 0.99 (0.99,1.00) 0.061 1.03 (1.00,1.05) 0.053 
High TG 1.02 (1.01,1.02) <0.001 1.02 (1.01,1.03) <0.001 1.02 (0.99,1.05) 0.121 
Low HDL-C 1.04 (1.03,1.05) <0.001 1.03 (1.02,1.04) <0.001 0.98 (0.95,1.01) 0.107 
High glucose 0.99 (0.99,1.00) 0.039 0.99 (0.98,1.00) 0.004 1.07 (1.04,1.10) <0.001 
a model 1: unadjusted model 
b model 2: adjusted for age group and sex 
c model 3: adjusted for age group, sex, country, smoking status, leisure activity hours per day, hours in 
engaging sports per day, working activity, education, medication for blood pressure, diabetes, or 
cholesterol, family history of diabetes, family history of stroke, alcohol intake, and energy intake; added 
interaction terms between education and HDI, and energy intake and HDI  
d SFA: saturated fatty acids 
e PUFA: polyunsaturated fatty acids 
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5.7 Sensitivity analyses   
5.7.1 Multiple imputation 
In this section, in response to Objective 7, the results from restricted and imputed 
samples are presented and descriptively compared. The means of metabolic 
syndrome component measures including three readings of systolic and diastolic 
blood pressure, waist circumference, triglycerides, HDL-C, and glucose were very 
similar in both the complete case and imputed data (see Table 43 & Table 44). 
Similarly, the proportions of Russians with a glucose level higher than 6.1mmol/L were 
similar in both sources of data (see Table 43).The distributions of covariates among 
complete case data and imputed data were also similar (see Table 44).  
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Table 43 Descriptive statistics of complete data and imputed data  
 Czech Republic Russia Poland 
 
Complete data 
N=5060 
Imputed data 
N=7819 
Complete data 
N=8788 
Imputed data 
N=9154 
Complete data 
N=7671 
Imputed data 
N=9940 
 Mean (95% CI) Mean  (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) 
Systolic blood pressure 1 144.3 (143.7,144.8) 144.6 (144.1,145.2) 148.0 (147.5,148.6) 148.0 (147.5,148.6) 144.2 (143.6,144.7) 144.3 (143.8,144.8) 
Systolic blood pressure 2 139.7 (139.2,140.3) 140.0 (139.5,140.5) 143.9 (143.4,144.4) 143.9 (143.4,144.4) 139.2 (138.7,139.6) 139.3 (138.8,139.7) 
Systolic blood pressure 3 138.1 (137.6,138.7) 138.3 (137.8,138.8) 141.7 (141.2,142.3) 141.7 (141.2,142.2) 137.5 (137.0,137.9) 137.6 (137.1,138.0) 
Diastolic blood pressure 1 90.2 (89.9,90.5) 90.2 (89.9,90.5) 91.9 (91.6,92.3) 91.9 (91.6,92.2) 87.8 (87.5,88.1) 87.9 (87.7,88.2) 
Diastolic blood pressure 2 89.0 (88.7,89.3) 89.1 (88.8,89.4) 90.6 (90.3,90.9) 90.6 (90.3,90.9) 86.5 (86.2,86.7) 86.5 (86.3,86.8) 
Diastolic blood pressure 3 88.5 (88.2,88.8) 88.5 (88.2,88.8) 89.5 (89.2,89.8) 89.5 (89.2,89.7) 86.1 (85.8,86.3) 86.2 (85.9,86.4) 
Waist circumference 93.0 (92.7,93.3) 93.3 (93.0,93.7) 92.8 (92.6,93.1) 92.8 (92.6,93.1) 92.6 (92.3,92.9) 92.6 (92.4,92.9) 
Triglycerides 1.9 (1.8,1.9) 1.9 (1.9,2.0) 1.5 (1.5,1.5) 1.5 (1.5,1.5) 1.7 (1.6,1.7) 1.7 (1.6,1.7) 
HDL-C 1.4 (1.4,1.4) 1.4 (1.4,1.4) 1.5 (1.5,1.5) 1.5 (1.5,1.5) 1.4 (1.4,1.4) 1.4 (1.4,1.4) 
Standardised blood glucose* 5.8 (5.7,5.8) 5.8 (5.7,5.8) 70.7 (70.0,71.6) (no) 71.8 (70.9,72.7) (no) 5.4 (5.4,5.5) 5.4 (5.4,5.5) 
   29.3 (28.3,30.3) (yes) 28.2 (27.3,29.1) (yes)   
*standardised blood glucose: the Russian sample was not standardised using CTSU measurements, and statistics in Russian sample were described by proportion of having 
high blood glucose or not due to the binary nature of the blood glucose data from Russia.  
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Table 44 Descriptive results on covariates in complete data and imputed data  
  Czech Republic Russia Poland 
Covariates        
Complete data 
% (95%CI) 
Imputed data 
% (95%CI) 
Complete data 
% (95%CI) 
Imputed data 
% (95%CI) 
Complete data 
% (95%CI) 
Imputed data 
% (95%CI) 
Smoking              Current smoker 26.3 (25.1,27.5) 26.4 25.2,27.6) 28.1 (27.2,29.0) 28.2 (27.3,29.1) 30.3 (29.3,31.3) 30.3 (29.3,31.3) 
Past smoker 30.1 (28.8,31.4) 30.1 (28.8,31.4) 13.5 (12.8,14.2) 13.6 (12.9,14.3) 29.0 (27.9,30.0) 29.0 (27.9,30.0) 
Never smoker 43.6 (42.3,45.0) 43.5 (42.2,44.9) 58.4 (57.4,59.5) 58.2 (57.2,59.2) 40.8 (39.7,41.9) 40.8 (39.7,41.9) 
        
Leisure activity <1 hour 33.3 (32.0,34.6) 33.4 (32.1,34.7) 15.9 (15.1,16.7) 15.9 (15.2,16.7) 27.8 (26.9,28.9) 27.8 (26.9,28.9) 
1-2 hours 25.8 (24.6,27.0) 25.8 (24.6,27.0) 25.6 (24.7,26.5) 25.5 (24.6,26.4) 30.5 (29.5,31.6) 30.5 (29.5,31.6) 
2-3 hours 21.2 (20.1,22.3) 21.2 (20.1,22.4) 24.7 (23.8,25.6) 24.7 (23.8,25.6) 21.8 (20.9,22.7) 21.8 (20.9,22.7) 
>3 hours 19.7 (18.6,20.8) 19.6 (18.5,20.7) 33.8 (32.9,34.8) 33.9 (32.9,34.9) 19.8 (18.9,20.7) 19.8 (18.9,20.7) 
        
Sports time 0 hour 28.5 (27.3,29.8) 28.5 (27.3,29.7) 72.1 (71.1,73.0) 72.0 (71.1,72.9) 29.0 (28.0,30.0) 29.0 (28.0,30.0) 
0-1 hour 45.6 (44.3,47.0) 45.6 (44.2,47.0) 12.3 (11.7,13.1) 12.4 (11.7,13.0) 36.1 (35.0,37.2) 36.1 (35.0,37.2) 
>1 hour 25.9 (24.7,27.1) 25.9 (24.7,27.2) 15.6 (14.8,16.4) 15.6 (14.9,16.4) 34.9 (33.8,36.0) 34.9 (33.8,36.0) 
        
Working activity Working:non-pensioner 48.5 (47.1,49.9) 48.5 (47.1,49.8) 39.1 (38.1,40.1) 38.9 (37.9,39.9) 41.9 (40.8,43.0) 41.9 (40.8,43.0) 
Not working:non-pensioner 0.6 (0.4,0.8) 0.6 (0.4,0.8) 1.1 (0.9,1.4) 1.1 (0.9,1.3) 1.6 (1.3,1.9) 1.6 (1.3,1.9) 
Working:pensioner 7.6 (6.9,8.4) 7.5 (6.9,8.3) 18.5 (17.7,19.4) 18.6 (17.8,19.4) 6.6 (6.0,7.1) 6.6 (6.0,7.1) 
Not working:pensioner 43.3 (42.0,44.7) 43.4 (42.1,44.8) 41.2 (40.2,42.2) 41.4 (40.4,42.4) 50.0 (48.8,51.1) 50.0 (48.8,51.1) 
        
Education level Primary or lower  11.5 (10.7,12.4) 11.6 (10.8,12.5) 10.3 (9.6,10.9) 10.3 (9.7,11.0) 11.6 (10.9,12.3) 11.6 (10.9,12.3) 
Vocational(apprenticeship) 36.3 (35.0,37.6) 36.4 (35.1,37.7) 26.6 (25.7,27.6) 26.6 (25.7,27.5) 20.9 (20.1,21.9) 20.9 (20.1,21.9) 
Secondary 37.6 (36.2,38.9) 37.5 (36.1,38.8) 34.2 (33.2,35.2) 34.2 (33.2,35.1) 38.6 (37.5,39.7) 38.6 (37.5,39.7) 
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  Czech Republic Russia Poland 
Covariates        
Complete data 
% (95%CI) 
Imputed data 
% (95%CI) 
Complete data 
% (95%CI) 
Imputed data 
% (95%CI) 
Complete data 
% (95%CI) 
Imputed data 
% (95%CI) 
University(degree) 14.6 (13.7,15.6) 14.5 (13.6,15.5) 28.9 (27.9,29.8) 28.9 (28.0,29.8) 28.8 (27.8,29.9) 28.8 (27.8,29.9) 
        
Medication for blood 
pressure 
Yes 34.6 (33.3,35.9) 34.6 (33.3,35.9) 32.1 (31.1,33.0) 32.0 (31.0,32.9) 37.9 (36.8,39.0) 37.9 (36.8,39.0) 
No 65.4 (64.1,66.7) 65.4 (64.1,66.7) 67.9 (67.0,68.9) 68.0 (67.1,69.0) 62.1 (61.0,63.2) 62.1 (61.0,63.2) 
        
Medication for 
cholesterol 
Yes 25.2 (24.0,26.4) 25.2 (24.0,26.4) 8.5 (8.0,9.1) 8.5 (7.9,9.1) 30.1 (29.1,31.1) 30.1 (29.1,31.1) 
No  74.8 (73.6,76.0) 74.8 (73.6,76.0) 91.5 (90.9,92.0) 91.5 (90.9,92.1) 69.9 (68.9,70.9) 69.9 (68.9,70.9) 
        
Medication for diabetes Yes 9.6 (8.9,10.5) 9.6 (8.8,10.4) 4.6 (4.2,5.1) 4.6 (4.1,5.0) 9.7 (9.0,10.3) 9.7 (9.0,10.3) 
No  90.4 (89.5,91.1) 90.4 (89.6,91.2) 95.4 (94.9,95.8) 95.4 (95.0,95.9) 90.3 (89.7,91.0) 90.3 (89.7,91.0) 
        
Family history on stroke Yes 29.4 (28.2,30.7) 29.5 (28.2,30.7) 23.7 (22.8,24.6) 23.8 (22.9,24.7) 17.4 (16.6,18.3) 17.4 (16.6,18.3) 
No  70.6 (69.3,71.8) 70.5 (69.3,71.8) 76.3 (75.4,77.2) 76.2 (75.3,77.1) 82.6 (81.7,83.4) 82.6 (81.7,83.4) 
        
Family history on 
diabetes 
Yes 33.8 (32.5,35.1) 33.9 (32.6,35.2) 12.0 (11.4,12.7) 12.2 (11.5,12.9) 20.9 (20.0,21.8) 20.9 (20.0,21.8) 
No  66.2 (64.9,67.5) 66.1 (64.8,67.4) 88.0 (87.3,88.6) 87.8 (87.1,88.5) 79.1 (78.2,80.0) 79.1 (78.2,80.0) 
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After the imputation, the prevalence of metabolic syndrome and its components was 
examined in both complete case and imputed data (see Table 45). These were found 
to be similar: in the Czech Republic, the prevalence of metabolic syndrome and its 
components were slightly higher in the imputed data than the complete data; in Poland, 
the similar pattern was found except the cholesterol measures; in Russia, the 
prevalence was slightly lower in the imputed data. 
 
Table 45 Prevalence of metabolic syndrome and its components in complete 
case data and imputed data 
 Czech Republic Russia Poland 
 
Complete 
case data 
% 
Imputed 
data 
% 
Complete 
case data 
% 
Imputed 
data 
% 
Complete 
case data 
% 
Imputed 
data 
% 
Metabolic syndrome 36.5 37.3 29.3 28.8 28.3 28.8 
High blood pressure 65.3 66.2 64.1 64.0 60.2 60.4 
Raised waist 
circumference 
42.7 43.9 44.7 44.6 39.8 40.3 
High triglycerides 43.9 45.2 29.1 29.0 36.3 36.3 
Low HDL-C 30.0 30.4 13.6 13.4 22.5 22.4 
High blood glucose 22.0 21.8 29.3 28.2 18.5 18.9 
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Table 46 presents the association between total HDI score and risk of metabolic 
syndrome in the imputed datasets. In general, the direction of the association between 
HDI and metabolic syndrome was consistent between the complete and imputed 
datasets. In the Czech sample, a ten-unit increase in HDI score was associated with 
12% lower risk of having low HDL-C (0.88 (0.80,0.97), P=0.010). Similar to the 
complete case results, higher HDI score was associated with higher risk of having 
central obesity but lower risk of having high triglycerides in the unadjusted models; 
however, the associations were fully attenuated after adjustment for potential 
confounders. In the Russian sample, a higher HDI score was associated with lower 
risk of having central obesity (0.91 (0.84,0.98), P=0.012). In the Polish sample, similar 
to the complete case results, a higher score of HDI was associated with higher risk of 
having metabolic syndrome (1.18 (1.08,1.28), P<0.001) and high glucose (1.22 
(1.11,1.34), P<0.001); the difference is that the effect attenuated to a greater extent 
after more adjustment in the adjusted models.  
To conclude, in the complete data analyses, HDI total score was not associated with 
metabolic syndrome and or components. The components of HDI score associated 
with metabolic syndrome in different directions. However, a higher protein score was 
associated with lower risk of metabolic syndrome and some of its components in all 
three countries. In the imputed dataset, a higher total HDI score was associated with 
lower risk of several metabolic syndrome components in the Czech Republic and 
Russia, but was associated with higher risk of metabolic syndrome and high glucose 
level in Poland.  
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Table 46 The association between HDI total score and metabolic syndrome in 
the HAPIEE study by country (in imputed datasets) 
a model 1: unadjusted model 
b model 2: adjusted for age group and sex 
c  model 3: adjusted for age group, sex, smoking status, leisure activity hours per day, hours in engaging 
sports per day, working activity, education, medication for blood pressure, diabetes, or cholesterol, family 
history of diabetes, family history of stroke, alcohol intake, and energy intake; added interaction terms 
between education and HDI, and energy intake and HDI  
 
 Model 1a  Model 2b  Model 3c  
 OR (95% CI) P OR (95% CI) P OR (95% CI) P 
Czech Republic       
Metabolic syndrome  1.03 (0.96,1.11) 0.437 0.97 (0.90,1.05) 0.519 0.98 (0.89,1.08) 0.633 
High blood pressure 1.04 (0.96,1.12) 0.318 1.04 (0.96,1.13) 0.300 1.00 (0.91,1.10) 0.991 
Central obesity 1.10 (1.03,1.18) 0.006 0.95 (0.88,1.02) 0.172 1.04 (0.95,1.14) 0.412 
High TG 0.91 (0.85,0.97) 0.008 0.95 (0.88,1.02) 0.170 0.97 (0.89,1.07) 0.548 
Low HDL-C 0.98 (0.90,1.06) 0.547 0.93 (0.86,1.01) 0.088 0.88 (0.80,0.97) 0.010 
High glucose 1.05 (0.97,1.15) 0.226 1.05 (0.96,1.14) 0.293 1.09 (0.98,1.21) 0.131 
       
Russia       
Metabolic syndrome  1.11 (1.04,1.19) 0.002 1.00 (0.94,1.07) 0.973 0.97 (0.89,1.05) 0.425 
High blood pressure 1.14 (1.07,1.21) <0.001 1.06 (0.99,1.13) 0.087 1.04 (0.95,1.13) 0.391 
Central obesity 1.10 (1.03,1.17) 0.002 0.93 (0.87,0.99) 0.020 0.91 (0.84,0.98) 0.012 
High TG 1.08 (1.01,1.15) 0.032 1.03 (0.96,1.10) 0.418 0.98 (0.91,1.06) 0.690 
Low HDL-C 1.12 (1.03,1.23) 0.009 1.01 (0.92,1.11) 0.826 0.99 (0.89,1.09) 0.805 
High glucose 1.03 (0.96,1.10) 0.395 1.00 (0.94,1.08) 0.898 0.99 (0.91,1.07) 0.739 
       
Poland       
Metabolic syndrome  1.21 (1.13,1.29) <0.001 1.15 (1.08,1.24) <0.001 1.18 (1.08,1.28) <0.001 
High blood pressure 1.17 (1.09,1.24) <0.001 1.15 (1.08,1.23) <0.001 1.09 (1.00,1.19) 0.058 
Central obesity 1.15 (1.08,1.22) <0.001 1.04 (0.97,1.10) 0.295 1.07 (0.99,1.15) 0.088 
High TG 1.04 (0.98,1.11) 0.195 1.08 (1.01,1.15) 0.028 1.09 (1.00,1.17) 0.040 
Low HDL-C 1.15 (1.07,1.24) <0.001 1.11 (1.03,1.19) 0.009 1.14 (1.04,1.24) 0.003 
High glucose 1.19 (1.10,1.28) <0.001 1.18 (1.09,1.27) <0.001 1.22 (1.11,1.34) <0.001 
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5.7.2 Nutrition knowledge, HDI, and metabolic syndrome 
In the HAPIEE study, there were two questions examining participants’ nutrition 
knowledge. In one question participants were asked “how do you think eating meat 
influences human health?”, while another asked participants “how do you think eating 
fruit and vegetables influence human health?”. Answers were given as improve 
strongly, improve slightly, no effect, make it worse slightly, or make it worse strongly. 
For analyses in this thesis, answers were re-categorised into three groups, improve 
(health), no effect, and worsen (health).  
Table 47 shows the response to nutrition knowledge for meat intake. A small number 
of subjects had missing data (68, 5, and 60, in the Czech, Russian, and Polish sample, 
respectively). In the Czech sample, 32.2% participants thought eating meat improved 
human health, while 49.6% thought it had no effect and 18.1% thought having it 
worsened health. However, the answer pattern was different in Russian and Polish 
sample: more than three fifths of the samples thought eating meat could improve 
health (68.6% in the Russian and 64.7% in Polish sample), and more than one fifth of 
the samples thought it had no effect on health (22.0% in the Russian and 26.2% in 
the Polish samples), while the rest thought meat could worsen health (9.5% in the 
Russian sample and 9.1% in the Polish sample).  
Table 48 shows the responses to nutrition knowledge for fruit and vegetable intake. 
There were some subjects with answer missing data (48, 1, and 44, in the Czech, 
Russian, and Polish sample, respectively). The pattern of the answers were very 
similar among three study samples: most participants thought eating fruits and 
vegetables were good for health (96.1%, 93.4%, and 94.6%, in the Czech, Russian, 
and Polish sample, respectively), while around 5% of participants thought eating fruits 
and vegetables had no effect on health (3.2%, 6.2%, and 4.7% in the Czech, Russian, 
and Polish sample, respectively), and the rest thought the effect was negative. 
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Table 47 Answers to ‘How does meat intake influence human health’ in three 
study samples 
View on 
meat intake 
Czech Republic        
(N=4992) 
Russia                        
(N=8783) 
Poland                     
(N=7611) 
N % N % N % 
Improve  1609 32.2 6022 68.6 4922 64.7 
No effect 2478 49.6 1931 22.0 1993 26.2 
Worsen 905 18.1 830 9.5 696 9.1 
 
 
Table 48 Answers to ‘How does fruit and vegetable intake influence human 
health’ 
View on 
fruit and 
vegetables 
intake 
Czech Republic      
(N=5012) 
Russia                      
(N=8787) 
Poland                     
(N=7627) 
N % N % N % 
Improve  4818 96.1 8206 93.4 7213 94.6 
No effect 159 3.2 548 6.2 359 4.7 
Worsen 35 0.7 33 0.4 55 0.7 
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Nutritional knowledge of meat intake was also examined in relation to some 
components of HDI scores, namely saturated fatty acids, protein, and cholesterol, 
which are the common nutrients in meat (see Table 49). In the Czech sample, 
participants who believed the meat intake worsens human health (the ‘worsen’ group) 
had higher score in saturated fatty acids (median: 4.2) compared to the ‘no effect’ 
group (median: 2.9) and the ‘improve’ group (median: 2.8). Moreover, participants in 
the ‘worsen’ group had slightly higher protein score (median: 7.4) than the ‘improve 
group’ (median: 7.1) and the ‘no effect group’ (median: 6.9). However, the median 
scores of cholesterol were 10 in all three groups. Compared with the Czech sample, 
Russians and Poles had lower scores for saturated fatty acids, protein, and 
cholesterol. In the Russian sample, participants in the ‘worsen’ group had higher 
saturated fatty acids score (median: 2.0) compared with those in the ‘no effect’ 
(median: 1.5) and ‘improve’ group (median: 1.1). On the protein score, the three 
Russian groups had very similar median scores (worsen: 7.6, no effect: 7.5, improve: 
7.5); while the cholesterol score was higher in the ‘worsen’ group (median: 2.5) 
compared with the ‘no effect’ (<0.1) and ‘improve’ group (median: 0). Polish sample 
had similar scoring pattern compared with the Russian ones: the ‘worsen’ group had 
higher median score in saturated fatty acids and cholesterol compare to the other 
groups, but very similar in protein score.   
Table 50 shows the nutrition knowledge of fruits and vegetable intake in relation to 
the score of fruit and vegetable in the HDI. In three study samples, the medians were 
similar in three knowledge groups, ranging from 8.5 (Russian ‘no effect’ group) to 10 
(Czech ‘improve’/‘worsen’ group or Polish ‘improve’).  
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Table 49 Nutrition knowledge of meat intake and selected HDI components (saturated fats, protein, and cholesterol) 
 
HDI 
components 
View on 
meat 
intake  
Czech Republic  Russia  Poland 
Mean SD Median  Mean SD Median  Mean SD Median 
Saturated 
fats score 
Improve 3.4 3.3 2.8  2.6 3.1 1.1  2.4 3.1 0.6 
No 
effect 
3.5 3.3 2.9 
 
2.8 3.2 1.5 
 
2.4 3.1 0.7 
Worsen 6.8 4.1 4.2  3.1 3.4 2.0  3.1 3.4 1.9 
Protein  
score 
Improve 6.7 2.6 7.1  7.1 2.4 7.5  6.5 2.3 6.7 
No 
effect 
6.7 2.6 6.9 
 
7.1 2.5 7.5 
 
6.6 2.3 6.9 
Worsen 7.3 3.9 7.4  7.1 2.6 7.6  6.6 2.5 6.9 
Cholesterol 
score 
Improve 6.8 4.1 10  3.3 4.2 0  4.6 4.4 3.7 
No 
effect 
7.0 2.5 10 
 
3.8 4.4 <0.1 
 
4.9 4.4 4.9 
Worsen 8.0 3.5 10  4.5 4.6 2.5  5.6 4.4 6.8 
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Table 50 Nutrition knowledge of fruit and vegetable intake and fruit and vegetable score  
 
 
HDI 
components 
View on 
fruit and 
vegetable 
intake  
Czech Republic Russia Poland 
Mean SD Median Mean SD Median Mean SD Median 
Fruit and 
vegetable 
score  
Improve 8.7 2.2 10 8.0 2.3 8.9 8.8 2.0 10 
No effect 7.8 2.7 9.5 7.8 2.3 8.5 7.9 2.4 9.1 
Worsen 9.0 2.1 10 8.6 1.7 9.0 8.5 2.1 9.7 
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In Table 51, nutrition knowledge of meat intake was examined in relation to risk of 
metabolic syndrome using chi square tests. In the Czech sample, around 50% of 
participants with or without metabolic syndrome thought meat intake had no effect on 
health, while around 32% thought it could improve health and the rest thought it had 
a negative effect on health. In the Russian sample, almost 70% of those with or 
without metabolic syndrome thought meat intake could improve human health, and 
around 20% thought it had no effect on health, and around 10% thought it worsens 
health. In the Polish sample, around 65% of those with or without metabolic syndrome 
thought meat intake improved people’s health, and around 25% thought ‘no effect’ 
and less than 10% thought ‘it worsens health’. The results from the chi square test 
showed that only in Russian sample, nutrition knowledge of meat intake was 
associated with risk of metabolic syndrome (P=0.013), but not in the Czech (P=0.136) 
or Polish sample (P=0.327). 
Table 52 shows the nutrition knowledge of fruit and vegetable intake in relation to risk 
of metabolic syndrome. In all three study countries, over 93% participants in the group 
of with or without metabolic syndrome believed that having fruit and vegetables could 
improve health. Results from the chi square tests showed that nutrition knowledge on 
fruit and vegetable intake was associated with risk of metabolic syndrome in the 
Czech sample (P=0.033) but not in Russian (P=0.442) and Polish sample (P=0.313). 
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Table 51 Nutrition knowledge of meat intake and metabolic syndrome 
View on meat 
intake 
Czech Republic 
N=4992 
Russia 
N=8783 
Poland 
N=7611 
No Yes P No Yes P No Yes P 
Improve 32.3 32.0 0.136 69.0 67.6 0.013* 64.8 64.4 0.327 
No effect 48.8 51.1 22.2 21.6 26.4 25.7 
Worsen 18.9 16.8 8.9 10.9 8.8 9.9 
*P<0.05 
 
 
 
Table 52 Nutrition knowledge of fruit and vegetable intake and metabolic 
syndrome  
View on fruit 
and vegetable 
intake 
Czech Republic 
N=5012 
Russia 
N=8787 
Poland 
N=7627 
No Yes P No Yes P No Yes P 
Improve 96.6 95.4 0.033* 
 
93.3 93.7 0.442 
 
94.5 94.8 0.313 
 No effect 2.7 4.0 6.4 5.9 4.9 4.3 
Worsen 0.8 0.6 0.3 0.5 0.7 0.9 
*P<0.05 
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In Table 53, nutrition knowledge of meat intake was examined in relation to HDI score. 
In the Czech sample, participants who believed meat intake worsened human health 
(mean: 49.4) had higher mean HDI total score compared to those thought meat had 
no effect (mean: 47.2) or could improve health (mean: 46.8). In the Russian and Polish 
samples, similar score pattern was found: participants in the ‘worsen’ group (mean: 
44.7 in Russia and 44.2 in Poland) had higher score than the ‘no effect’ (mean: 44.1 
in Russia and 42.6 in Poland) or ‘improve’ group (mean: 43.8 in Russia and 42.8 in 
Poland). The results from one-way ANOVA showed that nutritional knowledge on 
meat intake was associated with HDI score in all three study samples (P<0.001, 
P=0.003, and P<0.001, in the Czech, Russian, and Polish sample).  
In Table 54, nutrition knowledge of fruit and vegetable intake was examined in relation 
to HDI score. In the Czech sample, participants who believed fruit and vegetable had 
no effect on health (mean: 45.5) had lower HDI score than those in the ‘improve’ 
(mean: 47.5) and ‘worsen’ (mean: 48.2) groups. While in the Russian sample, the HDI 
scores were similar in all three groups (mean: 44.0 in ‘improve’, 44.3 in ‘no effect’, 
and 44.3 in ‘worsen’ group). In Poland, participants in the ‘improve’ group (mean: 
43.0) had higher score than the ‘no effect’ (mean: 41.6) and ‘worsen’ (mean: 42.2) 
group. Results from the one-way ANOVA showed that nutrition knowledge of fruit and 
vegetable intake was significantly associated with HDI score in the Czech and Polish 
samples (P<0.001), but insignificantly in the Russian sample (P=0.053).  
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Table 53 Nutrition knowledge of meat intake and HDI score 
View on 
meat intake 
Czech Republic 
N=4992 
Russia 
N=8783 
Poland 
N=7611 
Mean  SD P Mean  SD P Mean  SD P 
Improve 46.8 6.9 <0.001* 
 
43.8 6.8 0.003* 
 
42.8 6.5 <0.001* 
 No effect 47.2 6.9 44.1 6.8 42.6 6.5 
Worsen 49.4 6.8 44.7 7.2 44.2 7.0 
*P<0.05 
 
 
 
Table 54 Nutrition knowledge of fruit and vegetable intake and HDI score 
View on meat 
intake 
Czech Republic 
N=4992 
Russia 
N=8783 
Poland 
N=7611 
Mean  SD P Mean  SD P Mean  SD P 
Improve 47.5 6.9 0.001* 
 
44.0 6.8 0.053 
 
43.0 6.6 <0.001* 
 No effect 45.5 7.4 44.3 7.1 41.6 6.4 
Worsen 48.2 7.0 44.3 6.1 42.2 7.4 
*P<0.05 
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Based on previous analyses, nutrition knowledge of meat was associated with both 
risk of metabolic syndrome and HDI total score in the Russian sample only, which 
indicates that it could be a potential confounder in the association between HDI score 
and metabolic syndrome. Thus, in the sensitivity analyses, the fully adjusted model 
included nutrition knowledge on meat intake as an additional potential confounder 
(see Table 55). After adding nutrition knowledge on meat intake in the final model, the 
association between higher HDI total score and lower risk of having high blood 
pressure became significant, but the other results were similar. 
Nutrition knowledge of fruit and vegetable intake was also found associated with both 
risk of metabolic syndrome and HDI score in the Czech sample. Therefore, nutrition 
knowledge on fruit and vegetable intake was added into the final regression model for 
a sensitivity analysis (see Table 56). However, the associations were similar. 
 
 
 
 
 
178 
 
Table 55 The association between HDI and metabolic syndrome in Russia with 
nutrition knowledge of meat intake as a confounder 
a model 1: adjusted for age group, sex, country, smoking status, leisure activity hours per day, hours in 
engaging sports per day, working activity, education, medication for blood pressure, diabetes, or 
cholesterol, family history of diabetes, family history of stroke, alcohol intake, energy intake; added 
interaction terms between education and HDI, and energy intake and HDI 
b model 2: model 1+  nutrition knowledge on meat intake 
 
Table 56 The association between HDI and metabolic syndrome in the Czech 
Republic with nutrition knowledge of fruit and vegetable intake as a 
confounder  
a model 1: adjusted for age group, sex, country, smoking status, leisure activity hours per day, hours in 
engaging sports per day, working activity, education, medication for blood pressure, diabetes, or 
cholesterol, family history of diabetes, family history of stroke, alcohol intake, energy intake; added 
interaction terms between education and HDI, and energy intake and HDI 
b model 2: model 1+ nutrition knowledge on fruit and vegetable intake 
 Model 1a  Model 2b  
 OR (95% CI) P OR (95% CI) P 
HDI total score  (per-10 unit)    
Metabolic syndrome  1.03 (0.83,1.28) 0.804 1.00 (0.81,1.22) 0.974 
High blood pressure 0.83 (0.62,1.12) 0.225 0.77 (0.61,0.98) 0.030 
Central obesity 1.00 (0.80,1.25) 0.978 0.94 (0.77,1.16) 0.577 
High TG 1.01 (0.82,1.25) 0.913 0.99 (0.81,1.20) 0.889 
Low HDL-C 1.01 (0.77,1.32) 0.959 1.00 (0.77,1.30) 0.987 
High glucose 0.96 (0.78,1.18) 0.678 1.00 (0.81,1.22) 0.974 
 Model 1a  Model 2b  
 OR (95% CI) P OR (95% CI) P 
HDI total score  (per-10 unit)    
Metabolic syndrome  1.00 (0.78,1.28) 0.974 1.00 (0.78,1.28) 0.972 
High blood pressure 0.97 (0.74,1.28) 0.838 0.99 (0.75,1.31) 0.960 
Central obesity 1.11 (0.86,1.42) 0.425 1.13 (0.88,1.46) 0.332 
High TG 0.92 (0.72,1.16) 0.472 0.92 (0.72,1.17) 0.489 
Low HDL-C 0.88 (0.69,1.13) 0.312 0.87 (0.68,1.11) 0.265 
High glucose 0.95 (0.72,1.24) 0.708 0.94 (0.72,1.24) 0.667 
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5.7.3 Childhood SEP adjustment  
Childhood SEP is known to play an important role in diet and metabolic syndrome; 
however, due to the imperfect/imprecise childhood SEP measure in the HAPIEE 
study, the childhood SEP measure was only considered in sensitivity analyses. In the 
HAPIEE study, there was one measure of childhood SEP—household amenities in 
childhood. Participants were asked “Did you have any of the following items (cold tap 
water, hot tap water, radio, fridge, own kitchen, own toilet) in your house when you 
were a child (about 10 years old)”. In the analyses, the number of amenities was 
summed up from 0—6 items. Due to the different distribution of the answers in three 
study samples, for analytic purposes, the number of amenities in childhood was 
grouped differently in three study samples in order to achieve a balanced number of 
subjects in each group. The grouping details can be found in Table 57. 
 
Table 57 The distribution of childhood amenities at 10-year old  
Number 
of 
amenities 
Czech Republic 
(N=4914) 
Number 
of 
amenities 
Russia    
(N=8734) 
Number 
of 
amenities 
Poland             
(N=7481) 
N % N % N % 
0—3 1417 28.8 0 818 9.4 0—1 1399 18.7 
4 1471 29.9 1 2906 33.3 2 1582 21.2 
5 932 19.0 2 2240 25.7 3 1136 15.2 
6 1094 22.3 3 955 10.9 4—5 1770 23.7 
   4 589 6.7 6 1594 21.3 
   5 438 5.0    
   6 788 9.0    
 
 
180 
 
Analyses showed that number of childhood household amenities may be a potential 
confounder in the association between HDI and risk of metabolic syndrome, thus, the 
sensitivity analyses were conducted including this as a confounder (see Table 58). In 
the Czech and Polish samples, no association was found between HDI and risk of 
metabolic syndrome and its components before or after adjustment on childhood 
household amenities. While in the Russian sample, after adjusted for childhood 
household amenities, a ten-unit increase in HDI score was associated with 21% lower 
risk in having high blood pressure (P=0.047), other associations were similar.  
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Table 58 Association between HDIa and metabolic syndrome adding childhood 
SEP as an additional confounder  
aHDI per 10-unit increment  
b model 1: adjusted for age group, sex, country, smoking status, leisure activity hours per day, hours in 
engaging sports per day, working activity, education, medication for blood pressure, diabetes, or 
cholesterol, family history of diabetes, family history of stroke, alcohol intake, energy intake; added 
interaction terms between education and HDI, and energy intake and HDI 
c model 2: model 1+ childhood SEP 
 Model 1b  Model 2c  
 OR (95% CI) P OR (95% CI) P 
Czech Republic     
Metabolic syndrome  1.00 (0.78,1.28) 0.974 0.99 (0.77,1.27) 0.917 
High blood pressure 0.97 (0.74,1.28) 0.838 0.97 (0.74,1.29) 0.858 
Central obesity 1.11 (0.86,1.42) 0.425 1.15 (0.89,1.49) 0.276 
High TG 0.92 (0.72,1.16) 0.472 0.92 (0.72,1.17) 0.494 
Low HDL-C 0.88 (0.69,1.13) 0.312 0.87 (0.68,1.11) 0.271 
High glucose 0.95 (0.72,1.24) 0.708 0.93 (0.71,1.22) 0.598 
     
Russia     
Metabolic syndrome  1.03 (0.83,1.28) 0.804 0.98 (0.80,1.21) 0.875 
High blood pressure 0.83 (0.62,1.12) 0.225 0.79 (0.62,1.00) 0.047 
Central obesity 1.00 (0.80,1.25) 0.978 0.93 (0.76,1.14) 0.490 
High TG 1.01 (0.82,1.25) 0.913 0.97 (0.79,1.18) 0.751 
Low HDL-C 1.01 (0.77,1.32) 0.959 1.01 (0.77,1.32) 0.943 
High glucose 0.96 (0.78,1.18) 0.678 0.96 (0.79,1.17) 0.691 
     
Poland     
Metabolic syndrome  0.91 (0.73,1.14) 0.404 0.89 (0.72,1.11) 0.307 
High blood pressure 0.81 (0.62,1.04) 0.097 0.82 (0.64,1.05) 0.122 
Central obesity 0.85 (0.68,1.06) 0.140 0.86 (0.70,1.07) 0.177 
High TG 1.05 (0.85,1.30) 0.650 0.98 (0.80,1.22) 0.884 
Low HDL-C 1.04 (0.83,1.31) 0.710 0.98 (0.78,1.23) 0.862 
High glucose 0.92 (0.72,1.18) 0.526 0.93 (0.72,1.19) 0.539 
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5.7.4 Not adjusting for energy intake  
In order to exclude the possibility of over-adjustment of energy intake in the regression 
models, sensitivity analyses were conducted in which fully adjusted models were not 
adjusted for energy intake (see Table 59). Results from regression models without 
energy intake adjustment were similar to those from the main analyses. The general 
direction of the association stayed the same, and the magnitude of the effect size 
became slightly larger, especially in the Russian sample, a 10-unit increase in HDI 
score was significantly associated with 24% lower risk of having high blood pressure 
(P=0.020); however, the other associations between HDI and risk of metabolic 
syndrome and its components remained non-significant.   
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Table 59 The association between HDI and metabolic syndrome in the fully adjusted model but without energy intake as a confounder 
 Czech Republic   Russia   Poland  
 OR (95% CI) Pa  OR (95% CI) Pa  OR (95% CI) Pa 
Metabolic syndrome 0.97 (0.76,1.25) 0.839  0.98 (0.80,1.20) 0.834  0.89 (0.72,1.11) 0.293 
High blood pressure 0.95 (0.72,1.25) 0.71  0.76 (0.60,0.96) 0.020b  0.79 (0.62,1.01) 0.057 
Central obesity 1.08 (0.84,1.38) 0.548  0.95 (0.78,1.17) 0.635  0.87 (0.71,1.08) 0.198 
High triglycerides 0.91 (0.72,1.15) 0.421  0.99 (0.81,1.20) 0.881  1.00 (0.81,1.23) 0.977 
Low HDL-C 0.92 (0.72,1.17) 0.491  0.99 (0.76,1.29) 0.951  1.03 (0.83,1.28) 0.785 
High glucose 0.91 (0.69,1.18) 0.467  0.94 (0.77,1.14) 0.543  0.87 (0.68,1.12) 0.279 
a Logistic regression modelling: models were adjusted for age group, sex, country, smoking status, leisure activity hours per day, hours in engaging 
sports per day, working activity, education, medication for blood pressure, diabetes, or cholesterol, family history of diabetes, family history of stroke, 
alcohol intake; added interaction terms between education and HDI, bP<0.05 
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5.7.5 Menopausal status 
The prevalence of metabolic syndrome was examined by stratifying menopausal 
status among women (see Table 60). There were some missing data on menopausal 
status in three study samples (9, 3, and 38 cases in the Czech, Russian, and Polish 
sample respectively). In three study samples, the majority of female participants were 
postmenopausal (78.4%, 82.2%, and 75%, in the Czech, Russian, and Polish sample, 
respectively). Generally, the prevalence of metabolic syndrome and its components 
were higher among postmenopausal women compared to the premenopausal ones, 
except in Russian and Polish samples, there was no difference on the prevalence of 
having low HDL-C between the two menopausal status groups.  
Analyses showed that menopausal status may be a potential confounder in the 
association between HDI score and risk of metabolic syndrome, therefore, the 
sensitivity analyses of including menopausal status in the fully adjusted model among 
female participants were performed (see Table 61). The direction and the magnitude 
of the effect were similar before and after this adjustment. 
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 Table 60 Prevalence of metabolic syndrome among women stratified by menopausal status  
 
 Czech Republic  Russia  Poland  
 
PRMa 
(N=581) 
% 
PMPb  
(N=2115) 
% Pc 
PRMa 
(N=855) 
% 
PMPb 
(N=3958) 
% Pc 
PRMa 
(N=966) 
% 
PMPb 
(N=2894) 
% Pc 
Metabolic syndrome 123 21.2 839 39.7 <0.001 209 24.4 1,537 38.8 <0.001 141 14.6 961 33.2 <0.001 
Raised blood pressure 248 42.7 1,321 62.5 <0.001 436 51.0 2,716 68.6 <0.001 366 37.9 1,735 60.0 <0.001 
Central obesity 205 35.3 1,154 54.6 <0.001 448 52.4 2,485 62.8 <0.001 298 30.8 1,509 52.1 <0.001 
High triglycerides 149 25.6 881 41.7 <0.001 178 20.8 1,331 33.6 <0.001 188 19.5 1,020 35.2 <0.001 
Low HDI-C 164 28.2 706 33.4 0.019 174 20.4 801 20.2 0.940 234 24.2 771 26.6 0.138 
Raised blood glucose 62 10.7 410 19.4 <0.001 169 19.8 1,197 30.2 <0.001 61 6.3 516 17.8 <0.001 
aPRM: premenopausal  bPMP: postmenopausal cP-values from Chi-square tests 
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Table 61 The association between HDI and metabolic syndrome in women, adjusted for menopausal status 
 Czech Republic   Russia    Poland  
 OR (95% CI) Pa   OR (95% CI) Pa   OR (95% CI) Pa 
Metabolic syndrome 0.87 (0.65,1.17) 0.348   1.03 (0.79,1.36) 0.805   0.89 (0.67,1.18) 0.409 
High blood pressure 0.88 (0.64,1.21) 0.428   0.84 (0.59,1.20) 0.343   0.91 (0.66,1.26) 0.588 
Central obesity 1.04 (0.78,1.40) 0.778   0.97 (0.72,1.30) 0.817   0.89 (0.66,1.19) 0.414 
High TG 0.79 (0.60,1.05) 0.106   0.98 (0.75,1.27) 0.858   0.89 (0.68,1.17) 0.413 
Low HDL-C 0.80 (0.61,1.07) 0.131   1.01 (0.75,1.35) 0.967   1.03 (0.78,1.36) 0.844 
High glucose 0.84 (0.61,1.16) 0.288   1.03 (0.79,1.36) 0.808   0.89 (0.65,1.23) 0.483 
aLogistic regression modelling: models were adjusted for age group, sex, country, smoking status, leisure activity hours per day, hours in engaging 
sports per day, working activity, education, medication for blood pressure, diabetes, or cholesterol, family history of diabetes, family history of stroke, 
alcohol intake, energy intake, and menopausal status; added interaction terms between education and HDI, and energy intake and HDI 
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5.8 Summary  
In summary, the prevalence of metabolic syndrome was found to be high in all study 
samples—in the Czech Republic (37.1% in men and 35.7% in women), Russia (20.8% 
and 36.3%), and Poland (27.9% and 28.6%). Among the components of metabolic 
syndrome, raised blood pressure was the most prevalent (Czech Republic: 73.7% in 
men, and 58.2% in women; Russia: 62.4%, 65.5%; Poland: 66.1%, 54.5%).  
The average diet quality as determined by HDI was moderate to poor in the three 
countries investigated (Czech Republic: mean HDI total score=4.6 in men, 4.8 in 
women; Russia: 4.3 in men, 4.5 in women; Poland: 4.2 in men, 4.4 in women). The 
participants tended to have a healthier intake of polyunsaturated fatty acids, protein, 
fibre, and fruit and vegetables, and an unhealthier intake of other dietary 
components—especially saturated fatty acids, cholesterol, and sugar. Women 
generally had a healthier diet pattern compared with men.  
HDI was not associated with metabolic syndrome risk after adjusting for potential 
confounders in any of the three countries investigated (Czech Republic: 1.05 
(0.97,1.14); Russia: 1.11 (1.04,1.19); Poland: 1.18 (1.09,1.27)). In the pooled 
analyses, higher HDI score was associated with lower risk of having high blood 
pressure only (0.82(0.72,0.94)). However, some associations between HDI 
components and metabolic syndrome and its components were found. Higher score 
in saturated fats was associated with greater risk of having high blood glucose and 
high triglycerides level, but lower risk of having central obesity; higher score in 
polyunsaturated fatty acids was associated with lower risk of having high triglycerides; 
higher protein score was associated with lower risk of having high glucose, central 
obesity, and metabolic syndrome; high sugar score was associated with lower risk of 
HDL-C but greater risk of having high blood glucose; higher fruit and vegetable score 
was associated with higher risk of having high blood glucose; and higher cholesterol 
score was associated with higher risk of having metabolic syndrome and high blood 
glucose. Among these findings, the most consistent result among countries was the 
protective association between better adherence to protein intake and low risk of 
having high blood glucose (Czech Republic: 0.87 (0.80,0.94); Russia: 0.93 (0.88,0.99); 
Poland: 0.82 (0.75,0.89)).  
In sensitivity analyses, the results found in the imputed dataset was largely similar to 
the results based on the complete case sample except in Polish sample. Participants 
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with better knowledge of meat intake had healthier intake of saturated fatty acids, 
protein, and cholesterol. 
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Chapter 6  Discussion  
In this chapter, the main findings of the thesis will be summarised, and the 
methodological issues of the thesis will be discussed. In addition, the findings of the 
thesis will be compared with the existing literature. This will include estimates of 
metabolic syndrome prevalence, HDI scores in the Czech, Russian, and Polish 
samples, and the association between HDI and metabolic syndrome. The 
recommendation for the future research will be discussed, followed by the implications 
for public health.  
6.1 Summary of findings  
The first objective of this thesis was to examine the prevalence of metabolic syndrome 
and its components in the three samples. The results showed that the prevalence of 
metabolic syndrome was high in men and women in the Czech sample (37.1% among 
men and 35.7% among women), Russian sample (20.8% among men and 36.3% 
among women), and Polish sample (27.9% among men and 28.6% among women). 
Of the components of metabolic syndrome, raised blood pressure (systolic blood 
pressure≥130mmHg or diastolic blood pressure≥85mmHg) was the most prevalent 
component of metabolic syndrome in men and women: 73.7% and 58.2% in the 
Czech sample; 62.4% and 65.5% in the Russian sample; and 66.1% and 54.5% in 
the Polish sample, respectively. Other components of metabolic syndrome were also 
highly prevalent, especially central obesity (waist circumference ≥102 cm in men or 
≥88 cm in women) with 33.9% and 50.4% in the Czech sample, 25.1% and 60.9% in 
the Russian sample, 32.3% and 47.0% in the Polish sample. High triglycerides (≥ 
1.7mmol/L) was also highly prevalent, with 50.3% and 38.2% in the Czech sample, 
26.3% and 31.4% in the Russian sample, and 41.4% and 31.3% in the Polish sample. 
The prevalence of metabolic syndrome and its components were relatively high 
compared with estimates from Western European countries (eg, 25%),7 which 
supported the first hypothesis of this thesis (The prevalence of metabolic syndrome 
and its components is relatively high in the Czech Republic, Russia, and Poland 
compare with Western European countries). These findings will be discussed in more 
detail in Section 6.3.1. 
The second objective of this thesis was to examine whether the prevalence of 
metabolic syndrome was associated with age, sex, SEP, smoking status, and physical 
activity in the study countries. The results showed that as hypothesised (hypothesis 
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2) the prevalence of metabolic syndrome was consistently higher in older age in the 
three study samples. It was also proposed that the prevalence of metabolic syndrome 
was higher in men than in women in the Czech and Polish sample, but higher in 
women than men in the Russian sample. The results partially supported the second 
hypothesis with a slightly higher prevalence in men than in women in the Czech 
sample, and a more than 15% higher prevalence in women than in men in the Russian 
sample. However, contrary to expectation, the prevalence was slightly higher in 
women than in men in the Polish sample. In terms of SEP relations with metabolic 
syndrome, lower education was associated with higher risk of metabolic syndrome as 
hypothesis. It was also hypothesised that being a non-smoker or having higher 
physical activity would be associated with lower risk of metabolic syndrome, and this 
was supported by the findings in the Czech and Russian samples, while in the Polish 
sample higher physical activity was associated with slightly higher prevalence of 
metabolic syndrome.  
Objective three of the thesis was to characterise and compare the dietary quality in 
the three samples. The results showed that the overall diet quality as determined by 
HDI was moderate to poor in three study samples investigated. The participants 
tended to have moderate-good adherence to recommended intake of polyunsaturated 
fatty acids, protein, fibre, and fruit and vegetables, and a poor adherence to the 
recommended intake of other dietary components—especially, saturated fatty acids, 
cholesterol, and sugar. The findings of moderate dietary quality and variability of 
dietary quality scores partially supported hypothesis 3, except for the unexpected high 
score in dietary fibres (median: 7.7 in men, 8.8 in women in the Czech sample; 8.6 in 
men, 8.4 in women in the Russian sample; 10.0 in both men and women in the Polish 
sample) and protein intake (median: 6.7 in men, 7.5 in women in the Czech sample; 
7.3 in men, 7.7 in women in the Russian sample; 6.6 in men, 6.9 in women in the 
Polish sample). In addition, it was also found that Czechs had better adherence to 
cholesterol intake compared with the other two samples (median: 10.0 in both men 
and women in the Czech sample; 0 in men, 3.0 in women in the Russian sample; 1.6 
in men, 7.0 in women in the Polish sample). The overall dietary quality (in terms of 
HDI score) was found to be similar between countries (mean: 4.6 in Czech men, 4.8 
in Czech women; 4.3 in Russian men, 4.5 in Russian women; 4.2 in Polish men, 4.4 
in Polish women), while women generally had a significantly better adherence than 
men in all three countries (P<0.001); these findings supported hypothesis 3 (The 
study samples have on average a low HDI score, and women have better adherence 
to HDI compared with men).  
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The associations between dietary quality and risk of metabolic syndrome and its 
components were examined in response to objective 4. However, the results did not 
support the hypothesised finding (hypothesis 4: a higher HDI score would be 
associated with lower risk of metabolic syndrome and its components), because no 
statistically significant association was found between total HDI score and risk of 
metabolic syndrome or its components in any of the study samples after full 
adjustment (P>0.05).  
Objective 5 considered the associations between the separate dietary components of 
the HDI and risk of metabolic syndrome and its components. It was hypothesised that 
a better adherence to recommended levels of dietary components of HDI would be 
associated with lower risk of having metabolic syndrome and its components. 
However, associations between adherence to the HDI components and risk of 
metabolic syndrome components were mixed. On one hand, better adherence to 
some dietary components was significantly associated with lower risk of metabolic 
syndrome and its components: for example, a one unit increase in saturated fatty 
acids score was associated with 7% lower risk of having central obesity in the Polish 
sample; a one unit increase in polyunsaturated fatty acids score was associated with 
almost 10% lower risk of having high triglycerides in the Polish sample; and a one unit 
increase in sugar score was associated with a 7% lower risk of having low HDL-C in 
the Czech sample. Among all the dietary components, better adherence to protein 
intake was consistently and significantly associated with lower risk of having high 
glucose levels in three study samples: a one unit increase in protein score was 
associated with around 13% decreased risk among Czechs, 7% among Russians, 
and 18% in Poles; furthermore, in the Polish sample, a one unit increase in protein 
score was also associated with an 8% decreased risk in metabolic syndrome and 10% 
in central obesity. On the other hand, a better adherence to some HDI guidelines was 
significantly associated with increased risk of metabolic syndrome: for example, a one 
unit increase in saturated fatty acids score was associated with an 8% increased risk 
of having high blood glucose level in the Czech sample, and a 6% and 7% increased 
risk of having high triglycerides and high blood glucose in the Polish sample. A one 
unit increase in sugar score was associated with 10% increased risk of having raised 
blood pressure in the Russian sample, and it was also associated with 11%, 12%, 
and 23% increased risk of having high blood glucose in the Czech, Russian, and 
Polish samples respectively; a one unit increase in fruit and vegetable score was 
associated with 7% increased risk of having high blood glucose level in the Russian 
sample; a one unit increase in cholesterol intake was associated with 6% increased 
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risk of metabolic syndrome in the Russian sample, and 9% increased risk of having 
high blood glucose level in the Polish sample.  
The associations between HDI score and risk of metabolic syndrome and its 
components were evaluated again in analyses pooling the three countries (in 
response to objective 6). The results partially supported the hypothesised association 
(hypothesis 6) between higher HDI score and lower metabolic syndrome risk, and the 
magnitude of associations was similar to the country specific sample analyses. Similar 
to results of country-stratified analyses, the directions of the associations between 
diet quality and metabolic syndrome were not consistent. A better adherence to total 
HDI score, polyunsaturated fatty acids, and protein was significantly associated with 
lower risk of metabolic syndrome and its components: for example, a 10-unit increase 
in HDI score was associated with 18% lower risk of having raised blood pressure; a 
one unit increase in polyunsaturated fatty acids score was associated with a 7% lower 
risk of having low HDL-C; a one unit increase in protein score was associated with a 
6% lower risk of metabolic syndrome and obesity, and 13% lower risk of having high 
blood glucose level. In contrast, a one unit increase in sugar score was associated 
with a 4% increased risk of metabolic syndrome, a 7%  increased risk of raised blood 
pressure, and a 13% increased risk of high blood glucose; a one unit increase in fibre 
score was associated with a 4% increased risk of metabolic syndrome and an 8% of 
having high blood glucose; a one unit increase in fruit and vegetable score was 
associated with a 7% increased risk of having high blood glucose level; a one unit 
increase in cholesterol intake was associated with a 4% increased risk of metabolic 
syndrome and 7% in high blood glucose level.  
Finally, multiple imputation was conducted and the main analyses repeated using the 
imputed dataset (objective 7). The sample characteristics were very similar to the 
complete sample, supporting hypothesis 7. In the imputed analyses, a 10-unit 
increase in overall HDI score was associated with 12% reduced risk of having low 
HDL-C in the Czech sample and 9% reduced risk of having central obesity, while in 
the Polish imputed sample, a 10-unit increase in overall HDI score was associated 
with 18% and 22% increased risk of having metabolic syndrome and high glucose 
level, respectively. However, these associations were not found in the combined 
complete sample, and this did not support hypothesis 7.  
Overall, results found were mixed and there was little evidence for a strong 
association between HDI score (and its components) and metabolic syndrome (and 
its components). Before comparing the findings in this thesis with the literature, the 
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methodological issues in this thesis will be considered, and the roles of these issues 
may play in explaining the findings will be discussed.  
6.2 Methodological issues in the thesis 
The methodological issues that will be discussed are representativeness, 
misclassification, residual confounding, missing data, issues related to FFQ, potential 
over-adjustment, and the cross-sectional study design. 
6.2.1 Representativeness  
In the HAPIEE study, the participants were randomly selected from population 
registers in the Czech Republic and Poland, and the Russian sample was selected 
from electoral list, but the samples were only selected in the urban areas and the 
response rate was moderate, and these two issues may have affected study findings. 
The HAPIEE samples came from six cities in the Czech Republic, one city in Russia, 
and one city in Poland. The study participants were randomly selected from within the 
chosen urban areas, thus the study sample would likely be representative of the 
selected urban areas/communities. However, it could be argued that the study sample 
was not representative of all urban areas, nor of rural areas in these countries. As 
such, the prevalence of metabolic syndrome and diet quality reported in this thesis 
may not reflect the entire countries of Czech Republic, Poland, and Russia. This may 
be attributed to the urban/rural inequalities in the region;307 for example, people in 
urban areas would have better education and more advantage in accessing to health 
care system. 
Another issue related to representativeness is the response rates in the HAPIEE study. 
The response rates were moderate: 55% in Czech Republic, 61% in both Russia and 
Poland, and to other large population studies conducted in Western Europe.308;309 
Non-response might be partially due to participants moving homes or participants, but 
it is likely that a major reason for non-response is unwillingness to participate in the 
study. Moreover, non-response may be more likely for participants with worse health 
status.302 This would lead to underestimate the prevalence of metabolic syndrome, 
but would not alone affect the association between diet and metabolic syndrome. 
However, if non-responders also had a particularly unhealthy HDI, then the 
association between diet and metabolic syndrome would possibly be attenuated to 
null. 
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Data for metabolic syndrome (including waist circumference, blood pressure, 
triglycerides, HDL-C, and blood glucose) could not be measured for a number of 
participants particularly in the Czech Republic and Poland. In these two countries, 
participants were visited and questionnaires were administered at home, and they 
were subsequently invited to the local clinics for a medical examination. While in 
Russia, both the questionnaires and the examination were completed by the 
participants in the clinics. The missing data on metabolic syndrome of non-responders 
are discussed in more detail in section 6.2.4.  
6.2.2 Misclassification  
Measurement error is a common and important issue in epidemiological studies.310 It 
may be introduced into studies by factors including technical errors or fluctuations of 
the variable over time, leading to single measures incorrectly capturing long-term 
variables of interest. Measurement error can lead to misclassification, such that 
exposed persons are classified as unexposed and vice versa. There are two types of 
misclassification: non-differential and differential misclassification. In the following 
sections, the impact of these types of misclassification on the study findings will be 
discussed.  
Non-differential misclassification for exposures 
When non-differential misclassification occurs in the exposure, the subjects have 
been misclassified into different exposure group are independent on the outcome and 
other variables.310;311 When there is non-differential misclassification in the exposure, 
the association will be attenuated towards the null.310 In this thesis, the main 
explanatory variable was dietary intake, which was captured by FFQ and presented 
in the continuous form of HDI (1-70 points). FFQ has been commonly used in large 
epidemiological studies due to its inexpensive cost and easy administration in 
questionnaires. FFQs evaluate food intake within a specific period of time, for example, 
the past 3—6 months. However, long-term dietary intake is typically the risk factor of 
interest in association with outcomes, such as metabolic syndrome. Although 
compared with other dietary assessment methods, such as dietary reports within 24 
hours, FFQs capture a dietary intake for a longer time period; however, this may not 
reflect long-term dietary habits which take place over years and decades. Moreover, 
participants were asked the average intake of certain food over a period of time, which 
may be difficult to accurately recall. Therefore, the use of FFQs may introduce non-
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differential misclassification which would have attenuated the association between 
HDI and metabolic syndrome risk.  
Non-differential misclassification for outcomes 
When non-differential misclassification occurs in the outcome measure, the effect 
estimate tends to have wider corresponding confidence intervals and larger p-
values.310 Particularly when the outcome variable is binary, non-differential 
classification may bias results towards null.312 In this thesis, metabolic syndrome and 
its components were the main outcomes. The five components included high blood 
pressure, central obesity, low HDL-C, high triglycerides, and high blood glucose, all 
measured during clinic visits. Measurement error is likely to have occurred for each 
of these. For example, blood pressure is known to vary substantially during the day,313 
so the three measurements of blood pressure during the clinical examination would 
have imperfectly captured the true average blood pressure. Moreover, the values 
obtained would also fluctuate depending on the position of the cuff during 
measurement.314 Waist circumference was used to measure central obesity, and the 
use of trained nurses would have minimised measurement error. However, 
measurement error may have occurred. For example, different temperatures in the 
clinics may have affected measurement (eg, it would be easier to persuade 
participants wearing less layers of clothes to measure waist circumference if the room 
temperature was warmer). The other components of metabolic syndrome used 
laboratory measurements which differed in each country (see Section 4.3). Therefore, 
non-differential classification may be introduced in the interested outcome measures, 
and further affect the precision of the results/association. Several techniques have 
been adopted to reduce the measurement error and misclassification in plasma 
glucose level in the thesis (see Section 4.3.4). First, the capillary (Czech sample) and 
serum (Russian sample) blood glucose was recalculated to plasma equivalent values 
using recommended equation.279 Although the technique could reduce the 
measurement error in glucose measurements, there might be still some residual 
measurement error. Second, the standard plasma glucose was further calculated for 
the Czech and Polish sample using equation modelling to further reduce the 
measurement error between countries; however, this technique was not performed 
for the Russian sample because the only available glucose variable from Russian 
collaborators was binary. As explained in section 4.3.4, using CTSU glucose test 
results as ‘gold standard’, the sensitivity of the local laboratory measurements was 
81.2% and specificity was 82.3%. This showed that there were some misclassification 
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in the glucose values in the Russian sample, and this may make the results from 
Russian slightly difficult to compare with the other two samples. However, results from 
country specific samples did not show distinct difference between countries (see 
Sections 5.6.1 and 5.6.2). Moreover, in section 5.6.3 the pooled results (combining 
three study samples together) showed that the direction of the association in the 
pooled dataset was similar to the country-specific results; differences in results found 
may be attributed to both the different sample size and measurements used. 
Furthermore, the measurements of triglycerides, HDL-C, and blood glucose level 
differs depending on whether participants fasted before giving blood samples. 
Triglycerides and glucose are known to be sensitive to food intake, while research 
has suggested that HDL-C concentrations are not affected by food intake.91;315;316 In 
the study samples, only the Czech and Polish samples had available data on fasting 
status. In the Czech sample, 95% of participants fasted before blood sample was 
taken while only 57% in the Polish sample. Sensitivity analyses was performed by 
stratifying analyses by fasting status in these two samples. Similar results were found, 
suggesting that this source of error was unlikely to have substantially affected study 
findings (results are not shown in this thesis).  
Taken together, the above sources of measurement error in the outcomes may have 
introduced non-differential misclassification in categorising the binary outcomes used, 
contributing to further attenuation of the association between HDI and metabolic 
syndrome.  
Non-differential misclassification for covariates 
Non-differential misclassification could also occur in the covariates, which included 
smoking status, family history of diabetes, and family history of stroke. First, smokers 
could under-report their smoking status due to the social pressure. Second, in the 
thesis, participants had a mean age of 58 years; thus it could be difficult for them to 
recall clearly about their parents’ or even siblings’ medical conditions. This may further 
lead possible misclassification of family history of diabetes and stroke. These 
covariates were considered potential confounders in the thesis. Thus the non-
differential misclassification could have reduced the degree of the confounding control 
and potentially introducing bias in in adjusted analyses, Misclassification in 
confounding variables may have led to residual confounding, which will be discussed 
in more detail in section 6.2.3.  
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Differential misclassification  
The main form of differential misclassification in this thesis is likely to be information 
bias in the self-reported diet instrument used (FFQ) Recall bias is one of the important 
forms of information bias, and was likely to have affected  reported diet intake (over 
preceding 3 months). This is likely to have especially affected central obesity, as 
participants are less likely to be aware of the presence of the other components of 
metabolic syndrome. For example, participants who were obese may tend to report a 
healthier diet compared to true intake. Previous research has suggested that obese 
participants report a healthier diet with more fruit and vegetable and less sugar or fat 
intake, leading to energy under-reporting.183 This may have led to an underestimation 
of the true association between HDI and metabolic syndrome.  
6.2.3 Residual confounding  
Residual confounding is another issue which could have distorted some of the 
association between diet quality and metabolic syndrome risk. Normally there are at 
least two main causes of residual confounding. First, the confounding factors were 
not measured precisely enough; and second, misclassification occurred among the 
confounding variables.317  
In this thesis, the associations found between HDI and metabolic syndrome (though 
weak and inconsistent) could be attributed to residual confounding. For example, 
physical activity and alcohol intake were obtained by single measures from self-
reported questionnaires, which likely imprecisely measured these complex factors. 
These and other self-reported confounding factors examined, such as SEP and 
medical conditions, may have been misclassified (eg, due to genuine lack of 
awareness, or due to social desirability bias). The adjustment for these potential 
confounders in this thesis may therefore not have been sufficient to capture the full 
context of the confounding effects of other social and behavioural factors in the 
association between HDI and metabolic syndrome.  
In order to further investigate if misclassification in SEP have attenuated the finding 
in this thesis, results from sensitivity analysis including childhood SEP as an additional 
covariate showed a better adherence to HDI was borderline significantly associated 
with lower risk of having raised blood pressure in Russian sample, but not in the other 
two samples. This may imply that childhood SEP is an important factor in the 
association between HDI and metabolic syndrome. However, including it could also 
introduce recall bias in the study and further led to misclassification. 
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6.2.4 Missing data  
Missing data is an important factor that reduce the study power and worsen the 
precision of estimates, and may also bias associations found.301 In the HAPIEE study, 
many participants did not come to the clinics to the clinical examination (especially in 
the Czech and Polish samples), and this led to around 20% of the Czechs and 13% 
of the Poles having no metabolic syndrome measures. These subjects were excluded 
from the main analyses (see Section 4.7.1). However, multiple imputation was 
conducted in sensitivity analysis, under the assumption that the data were “missing at 
random” (see Section 4.7.1). These sensitivity analyses showed that the sample 
characteristics of the imputed dataset and the complete case sample were very similar 
(see Section 5.6.1 & 5.7.1). In the Czech and Russian samples, the direction and the 
magnitude of the association between HDI total score and metabolic syndrome risk 
was also largely similar—some differences found in the fully adjusted model in the 
imputed dataset could be due to the larger sample size compared to the complete-
case analyses. However, in the Polish sample, the results from fully adjusted-model 
in the complete sample (0.92 (0.72,1.18)) and imputed sample (1.22 (1.11,1.34)) were 
different. This may indicate that in the Polish sample, participants with missing data 
were possibly not “missing at random”. Possibly, participants with missing data were 
very unhealthy and had very unhealthy diet, thus excluding them had attenuate the 
association to null. 
6.2.5 FFQ 
FFQ was the dietary measure used in the HAPIEE study. It is one of the most 
commonly used methods for collecting dietary intake in the large population 
studies.318 However, there are some methodological issues related to the use of which 
may have affecting the results found in this thesis. First, in order to better capture 
country-specific food intake, the components of the FFQ differed slightly in the three 
countries investigated. This could make it difficult to compare the mean intake of 
certain food groups or nutrients, and therefore HDI comparisons between the 
countries. For example, Russians and Poles were found to have higher intake of 
cholesterol, but this may be related to the higher number of cholesterol-related items 
in the Russian and Polish FFQ compared with the Czech sample. However, the added 
items were approved by the local nutritionist in order to ensure that diet was 
appropriately measured in each country.  
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Second, participants completed the questionnaires in Russia with the assistance of 
nurses during clinic visits, while in the other two countries participants completed the 
questionnaire by themselves. Therefore, selective misclassification could have been 
introduced at the country level. Moreover, in Russia, although the nurses conducted 
interview on FFQs were trained and certified, it was the nurses’ decision on the length 
and depth of the interview according to the participants’ characteristics, which would 
result in differential misclassification for the recorded food intakes in participants. 
Third, there may be some seasonal variation in food intake which was not considered 
in the FFQ design of the HAPIEE study. The impact of seasonal differences may also 
differ in the different countries and cities investigated.  
Another methodological issue in dealing with FFQ would be the missingness of the 
answers. In this thesis, after excluding participants with more than 15 FFQs answers 
missing, missing data for a specific food item was assumed to reflect zero intake, 
rather than reflecting missing data. Although this approach has been long used in 
nutritional epidemiological studies, in order to preserve the analytic sample size, non-
responses may not necessarily always reflect no intake.183;290-292  Food items on an 
FFQ may be omitted because the food was not consumed or because of difficulties 
remembering the frequency and amount of intake, especially since there is no option 
of ‘Don’t remember’ in FFQs.183 Studies have showed that older adults tend to leave 
more FFQ items blank and this may be due to failing memory.290;319 Ultimately, if the 
assumption on item missingness was miss-specified, then the food intake might also 
be misclassified,290 which would further introduce non-differential misclassification in 
the study and may bias the association between HDI and metabolic syndrome. 
Additionally, some of the confounding factors such as dietary habits may act as 
underlying factors affecting diet quality. A systematic review showed that eating out 
of home was associated with higher energy intake, fat intake, and lower intake of 
vitamin C.320 Furthermore, a recent Norwegian study found the consistent results, and 
people constantly eating out had higher intake of sugar compared with those who do 
not regularly eat out.321 People are generally less aware of the ingredients they have 
when eating out, and the food may be less healthy than homemade food (eg, it may 
have more sugar and fat contents). However, there are no such variables on dietary 
habits in HAPIEE study to test these potential relationships. Moreover, dieting status 
is also an important factor when estimating food intake, specifically, women are more 
likely to be on a diet compare with men. Meal time is also an important factor of dietary 
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habit which could influence the diet quality. However, there are no such variables in 
the HAPIEE dataset to reflect the dieting status or dietary habits.  
6.2.6 Over-adjustment for energy intake 
Another issue regarding the dietary intake may be over-adjustment for energy intake 
which may lead to an artificial association between HDI and outcome, since the 
energy intake already has been taken into account while constructing HDI scores. 
Most of the scores of the HDI components were calculated into the percentage of the 
total energy intake per day. However, sensitivity analyses by excluding energy intake 
as a covariate was conducted, and the magnitude and significance of the association 
between HDI and metabolic syndrome remained the same; therefore, over-
adjustment for total energy intake does not appear to be a major explanation of the 
results found in the thesis.  
6.2.7 The cross-sectional study design 
Some unexpected results in relation to diet and metabolic syndrome could be 
attributed to the cross-sectional design of the study. It is not possible to determine the 
temporal nature of the relationship between HDI and metabolic syndrome using a 
cross-sectional study. For example, long-term exposure to an unhealthy diet (eg, a 
high intake of fats and sugars) would be expected to contribute to obesity and thereby 
type 2 diabetes. These patients are typically advised by doctors to change their diet 
(eg, to lower low fat and sugar intake). This may explain the unexpectedly higher 
sugar intake was associated with lower risk of having high blood glucose level (see 
Section 5.6.2). Studies with follow-up are required in order to better account for 
reverse causation in explaining an association between HDI and metabolic 
syndrome. .  
6.3 Comparison with other studies and explanation of findings  
In this section, the findings from this thesis will be compared with previous research 
in the order of the objectives stated in Chapter 3 (ie, prevalence of metabolic 
syndrome, HDI scores, and the association between HDI and metabolic syndrome 
and its components).  
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6.3.1 Prevalence of metabolic syndrome and its components (objective 1 & 2) 
The prevalence of metabolic syndrome in this study ranged from 20.8% (in Russian 
men) to 37.1% (in Czech men) in three study samples. There was little sex evidence 
for sex differences in the prevalence of metabolic syndrome in the Czech and Polish 
samples (Czech sample: 37.1% in men, 35.7% in women; Polish sample: 27.9% in 
men, 28.6% in women), while there was a relatively large difference in the Russian 
sample (20.8% in men compared with 36.3% in women). As shown below, both overall 
prevalence and sex differences in prevalence do not substantially differ from previous 
studies in Eastern Europe.  
Prevalence of metabolic syndrome in the Czech sample  
The slightly higher prevalence of metabolic syndrome among Czech men (37.1%) as 
compared with Czech women (35.7%) was consistent with other Czech estimates, 
but higher prevalence in both men than women (32.5% and 29.9% respectively).25 
Metabolic syndrome was defined using IDF in Vosatkova et al’s study, and previous 
research suggested that prevalence may be around 20% higher when using IDF 
compared with ATPIII as the definition.69 However, the prevalence was higher in this 
thesis compared with Vosatkova et al’s study, so the choice of definition of metabolic 
syndrome does not seem to explain the higher prevalence found in the thesis (using 
ATP III). The main reason for this difference may be that in Vosatkova et al’s study 
the participants were younger (aged from 18 to 65 years) than the sample used in this 
thesis (45 to 70 years). Previous studies have shown that the prevalence of metabolic 
syndrome increases with age,8;27 which was also found in this thesis. Moreover, 
women have higher risk of having metabolic syndrome and its components after 
transitioning through menopause.107;109;110 This may also explain the higher 
prevalence among women in the thesis compared with the findings in the Vosatkova 
et al’s sample. Indeed, sensitivity analyses in section 5.7.5 showed that the 
prevalence of metabolic syndrome among premenopausal women in the Czech 
sample was 21.2%, while among postmenopausal women was 39.7%. 
Similarly, it is possible to compare components of metabolic syndrome in the thesis 
with those from Vosatkova et al’s study. In this thesis, raised blood pressure (systolic 
blood pressure≥130 mmHg or diastolic blood pressure≥85 mmHg) was the most 
prevalent component of metabolic syndrome in the Czech sample (73.7% in in men 
and 58.2% in women). In Vosatkova et al’s study, the prevalence of having raised 
blood pressure (defined in the same way) was lower (45% in men, 20% in 
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premenopausal women, and over 50% in postmenopausal women), potentially 
explained by the younger age of the sample used.322 Apart from Vosatkova et al’s 
study, raised blood pressure using the same cut-points as this thesis has not been 
further investigated in other studies. However, the prevalence of hypertension 
(systolic blood pressure≥140mmHg or diastolic blood pressure≥90mmHg) was found 
to be 45.6% in men and 33.0% in women in year 2000/1 in the total population of the 
Czech MONICA study,78 compared with 71.9% in men and 51.9% in women in the 
thesis. Moreover, the average values of both systolic and diastolic blood pressure 
were higher in this thesis (systolic/diastolic: 144.2/90.8mmHg in men, 
134.3/87.0mmHg in women) compared with the Czech MONICA study 
(131.9/83.7mmHg in men, 125.9/79.3mmHg in women). The most likely reason again 
could be the younger age of the participants in the MONICA study (mean age: 45 
years). Moreover, in the MONICA study, the study sample was mostly from rural areas, 
while the HAPIEE study sample was selected from urban areas. This region difference 
may have also contributed to these differences (eg, if rural areas have lower salt 
intake and/or higher physical activity).323;324  
The second most prevalent component in the Czech sample found in this thesis was 
high triglycerides (ie, triglycerides≥1.7mmol/L) (50.3% and 38.2% in men and women 
respectively). These were higher than the findings in Vosatkova et al’s study, where 
prevalence of having high triglycerides (same definition as above) was 30% in men, 
12% in premenopausal women, and 30% in postmenopausal.25 A similar pattern was 
also found when comparing the prevalence of having low HDL-C between this thesis 
(27.4% in men and 32.4% in women) and Vosatkova et al’s study (20% in men, 3% 
in premenopausal women, and 20% in postmenopausal women).25 As triglycerides 
increase with age325 and HDL-C decreases with age,326 the difference in age between 
these two studies is again most likely reason for differences in prevalence of high 
triglycerides and HDL-C levels. In addition, the difference could also due to the 
differences in laboratory quality control: in the Czech sample, the laboratory was 
CDC-certified, while certification was not described in Vosatkova et al’s study. 
In Vosatkova et al’s study, prevalence of central obesity was 64% in men, 58% in 
premenopausal women, and 86% in postmenopausal women;25 and these were 
higher than the results from this thesis (33.9% in men and 50.4% in women). These 
results are however difficult to compare due to different cut-points in two studies. In 
Vosatkova et al’s study, the cut-points were waist circumference ≥94cm in men and 
≥80cm in women (compared to ≥102cm in men and ≥88cm in women in ATPIII 
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definition). Therefore, more subjects would fall into the central obesity category in the 
IDF definition. The prevalence of having high blood glucose was 25% in men, 6% in 
premenopausal women, and 27% in postmenopausal women using IDF definition 
(blood glucose≥5.6mmol/L) in Vosatkova et al’s study. With a higher cut-point in blood 
glucose in the thesis (≥6.1mmol/L), the prevalence found in this thesis was 25.9% in 
men and 17.5% in women. The prevalence of having high blood glucose was similar 
and slightly lower in this thesis (especially in women) which may also be due to the 
different definitions used. 
Apart from the Vosatkova et al’s, the prevalence of metabolic syndrome and its 
components in the Czech Republic were not systematically investigated in other 
studies to the author’s knowledge, but some individual components of metabolic 
syndrome were examined in the MONICA study, namely HDL-C.78 The HDL-C level 
was very similar to the findings in this thesis: it was 1.25mmol/L in men and 
1.49mmol/L in women in year 2000/1 in Cifkova et al’s study, and was 1.3mmol/L in 
men and 1.5mmol/L in women in the thesis.  
Prevalence of metabolic syndrome in the Russian sample 
In the thesis, the prevalence of metabolic syndrome in Russian women (36.3%) was 
similar to the prevalence in the Czech sample, and higher than Russian men (20.8%). 
These results were higher than previous study conducted in Russia but with different 
samples/cohorts.22 However, in a small sample study conducted by Jones et al, the 
prevalence of metabolic syndrome was 54.1% in the total sample. However, this study 
had a small sample size (N=146), and recruitment of the participants was not random, 
which led an over 90% of women in the study sample.20 Another previous study in 
Russia (Arkhangelsk) among 3705 participants aged 18-90 years found that women 
had higher prevalence of metabolic syndrome than men (11.5% in men and 19.8% in 
women).22 The lower prevalence found in this study could be due to the use of different 
biological metabolic measures. For example, the use of HbA1c (≥6.1%) (which 
equivalent to ≥7.1mmol/L in plasma glucose level) instead of plasma glucose could 
have resulted in lower prevalence of hyperglycaemia and thus an underestimate of 
the prevalence of metabolic syndrome.79 This study also reported a higher prevalence 
of other components of metabolic syndrome using the ATPIII definition compared with 
those found in this thesis.22 For example, the prevalence of central obesity was 37.1% 
in men and 82.4% in women in the Arkhangelsk study, compared with 25.1% and 
60.9% in the thesis respectively; and the prevalence of raised blood pressure, high 
triglycerides, and low HDL-C, were over 85% in men and women compared with lower 
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prevalence found in the thesis (raised blood pressure: 62.4% in men and 65.5% in 
women; high triglycerides: 26.3% in men and 31.4% in women; low HDL-C: 5.4% in 
men and 20.3% in women). Possible explanations for these differences include the 
use of a wider age range, differences in age-standardisation procedure, and/or 
regional differences in prevalence. In Russia, despite the much higher cardiovascular 
disease mortality in men compared with women, the prevalence of metabolic 
syndrome in women was found almost double that of men. This may due to the sex 
difference in alcohol intake, and/or due to the higher smoking prevalence in men.     
Prevalence of metabolic syndrome in the Polish sample 
In the Polish sample, the prevalence of metabolic syndrome was similar in men and 
women (27.9% in men and 28.6% in women). Only one previous study was found 
which examined the prevalence of metabolic syndrome among a Polish population 
using the ATPIII definition. This study reported a prevalence in men and women of 
16.2% and 20.9% respectively.23 The lower prevalence of metabolic syndrome may 
be due to the wider age range (25-97 years) compared with the HAPIEE sample (45-
70 years). The sample selection was also different: although a large sample size was 
used (N=40989), the participants were all patients who were not treated for diabetes 
or coronary artery disease. 
In two other Polish studies, different definitions of metabolic syndrome have been 
used. In the thesis, 66.1% of men and 54.5% of women were defined as having raised 
blood pressure, 41.4% of men and 31.3% of women with high triglycerides, and 18.8% 
of men and 26.1% of women with low HDL-C. In the PONS study, Janszky et al also 
reported a high prevalence of raised blood pressure (70%), but lower prevalence of 
high triglycerides (20%) and low HDL-C (16%). (Janszky et al. 2011) Moreover, in the 
study conducted by Ilow and colleagues,24 they found central obesity (94.8%) and 
high blood pressure (82.8%) were more common in women, while central obesity 
(87.5%), high triglycerides (80.9%), and high blood pressure (88.1%) were more 
common in man. This finding was consistent with the results found in this thesis. 
Furthermore, they also found that high blood pressure was the most prevalent 
component of metabolic syndrome in both men and women  
Prevalence of metabolic syndrome compared with to different regions 
The prevalence of metabolic syndrome was found to differ in the Czech, Polish and 
Russian samples in this thesis. Previous studies have consistently showed that the 
prevalence in the U.S. is very high compared with other countries, from 25% to 
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35%.8;72 In Europe, Grundy estimated a 25% prevalence of metabolic syndrome.7 
Other studies, using different definitions of metabolic syndrome, have reported 
prevalence ranges from 18% to 45%.7;69;70;73;74 
Restricted to the studies using ATPIII definition, the prevalence of metabolic 
syndrome found in the current study was higher than western European countries: in 
Ireland, the prevalence was 21.8% in men and 21.5% in women (aged 50-69 
years);327 in Sweden, the total prevalence among people aged 46-68 years was 
20.7%;73 in Germany, the prevalence was 22.7% in men and 18.0% in women among 
people aged 18-99 years;74 in Greece, the total prevalence was 24.5% among adults 
aged ≥18 years.69 As discussed in the previous sections, the lower prevalence found 
in these studies might be due to the study samples with a wider age range.69;74 
However, compared with the studies from Ireland and Sweden, which had quite 
similar aged population to this thesis (45-69 years old), the prevalence in this thesis 
(except among Russian man: 20.8%) was still higher.  
The comparisons between different studies are in general difficult. The differences 
may be real, and may be due to differences in lifestyle or even genetic differences. It 
is, however, likely that the differences are influenced by differences in study design, 
sample characteristics, and data collection. Age seems to be most influential factor 
because the individual components are mostly driven by the advancing age, which 
further would drive metabolic syndrome as a whole. It is also likely that the differences 
in results between studies are the combination of both real differences and differences 
in methodology.  
Prevalence of metabolic syndrome in relation to demographic factors  
In this thesis, results showed the prevalence of metabolic syndrome increased with 
increasing age in the three study samples, and this is consistent with previous studies 
as described previously.8;22;27;113;328 
It was also found that the prevalence of metabolic syndrome was slightly higher in 
men than in women in the Czech sample and this is supported by previous research.25 
While the prevalence was only a little higher in women than men in Polish sample, 
which was consistent with Szurkowska et al’s research, but not with the other two 
publications from Poland.23;24;80 In Russian sample, a more than 15% higher 
prevalence in women than in men was found and this was also supported by previous 
publications.21;22 
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Previous studies have consistently shown that lower education level is associated 
with higher risk of having metabolic syndrome in Western countries, and this was 
supported by the results found in this thesis.118;125;126 
In the Czech and Russian samples in the thesis, being a non-smoker or having higher 
physical activity was associated with lower risk of metabolic syndrome, and this was 
consistent with existing literature.27;113;137;139-141;143;144 However, in the Polish sample, 
a higher physical activity was associated with slightly higher prevalence of metabolic 
syndrome, which was not consistent with the literature. This could be explained by 
misclassification of the physical activity measure used, and/or reverse causality.  
6.3.2 HDI scores (objective 3) 
To the author’s knowledge, there is only one previous study which examined diet 
quality using HDI in these three countries, and the study used the same data as this 
thesis.37 However, in this study, the HDI score was defined following Huijbregts’ 
original suggestions which consisted of dietary components coded as dichotomous 
variables 203. The findings from this thesis therefore build on this study by examining 
diet quality in greater detail (by examining HDI scores across different age groups, 
education levels, and other healthy behaviours). 
Most previous studies have used the original dichotomous HDI scores, making it 
difficult to make valid comparison with the results in this thesis. A recent published 
paper by Jankovic et al (2014) however used a similar continuous version of HDI 289, 
in a sample of older women in a few European countries and the U.S. The median 
total HDI score ranged from 42 to 54 in studied countries, which was similar to the 
findings in the thesis (ie, Czech sample: 46 in men and 49 in women; Russian sample: 
43 in men and 44 in women; Polish sample: 41 in men and 43 in women). While the 
HAPIEE study was included in this paper, it used a sub-sample of older women from 
three study countries. The median scores in women aged ≥60 years were 48 in the 
Czech Republic, 42 in both Russia and Poland. This shows the score among Czechs 
had little difference compared with other countries, but the scores in Russians and 
Poles were lower.  
The studies that used dichotomous scores for HDI components are not perfectly 
compared with this thesis but they represent valuable source of information about 
dietary status in different populations. Huijbregts and colleagues found the overall HDI 
average score was the highest in Italy with values around 4 in different regions, 
followed by score of 2.5 in the Netherlands, and 1.8 in Finland (scoring range 0-9) 211. 
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Knoops and colleagues using the SENECA and FINE(Finland, Italy, The Netherlands, 
Elderly study) data showed that average HDI score in Europe was relatively low with 
range between 2 and 4 (scoring range 0-9) 208. Murray et al found the average HDI 
score was 3.3 in a small sample of non-diabetic Irish participants (scoring range 0-
9).217 Cade et al also found diet quality in the British cohort of women was similar to 
other European countries, with 55.1% of women having HDI score lower than 5 
(ranges from 0-10) 213. In Asian countries, the diet quality seemed healthier than in 
the Western Europe; for example, Kim et al found that the average HDI was 5 (with a 
range from 0-9) among Koreans 216. Because the number of HDI components was 
usually different in above reported studies compared to the current data in this thesis, 
and the scoring systems were different, it is important to be cautious when making 
comparisons using the HDI total score. Instead, it is necessary to compare the 
individual components score in these studies compared to the findings in the thesis.  
In the current study, participants had better adherence to recommended intake in 
polyunsaturated fatty acids (median: 10.0 in Czech and Russian men and women; 8.4 
in Polish men and 8.1 in Polish women), fruit and vegetables (10.0 in Czech and 
Polish men and women; 8.3 in Russian men and 9.4 in Russian women), and fibre 
intake (7.7 in Czech men and 8.8 in Czech women; 8.6 in Russian men and 8.4 in 
Russian women; 10.0 in Polish men and women), relatively good adherence to 
recommended intake in protein intake (6.7 in Czech men and 7.5 in Czech women;  
7.3 in Russian men and 7.7 in Russian women; 6.6 in Polish men and 6.9 in Polish 
women), but had worse adherence to recommended intake in saturated fatty acids 
(2.5 in Czech men and 3.5 in Czech women; 0.7 in Russian men and 1.7 in Russian 
women; 0.1 in Polish men and 1.3 in Polish women) and sugar intake (4.6 in Czech 
men and 2.6 in Czech women; 6.2 in Russian men and 5.1 in Russian women; 4.5 in 
Polish men and 2.9 in Polish women). In terms of the cholesterol intake, Czechs had 
better compliance to the recommended intake than Russian and Poles (10.0 in Czech 
men and women; 0 in Russian men and 3.0 in Russian women; 1.6 in Polish men and 
7.0 in Polish women).  
These results support some findings from previous research in some studies but not 
all. Huijbregts found that people aged between 50-70 years also had good compliance 
in polyunsaturated fatty acids and protein intake but bad compliance in saturated fatty 
acids, sugar, and cholesterol in the Netherlands, Finland, and Italy, however, all three 
countries showed a low fruit and vegetable intake compared to the WHO 
recommendation.203 In contrast to Huijbregts et al’s findings, Leite et al had found that 
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Italians had good compliance to fruit and vegetable intake among people over 65 
years old from rural towns, and this was consistent with the findings in this thesis.254 
Furthermore, the results were supported by Knoops and colleagues from the Healthy 
Ageing: a Longitudinal study in Europe (HALE).208 In Britain, Cade et al found all 
participants in the British cohort of women had the fruits and vegetable intake above 
400g/day.213 In South Korea, Kim et al found considering all the components, the 
greatest compliance in recommended intake for polyunsaturated fatty acids was 
found, but also in contrast to western populations described by Huijbregts, Koreans 
also had better compliance for sugar intake.216 
Compliance with WHO recommendations varied between regions, and sometimes 
differed within a country in different studies. This could be due to the demographic 
difference of the samples, for example, depending whether rural or urban area were 
included, what age range of participants was included, and in which year data were 
collected. However, it is possible to say the results in this thesis showed findings that 
generally agreed with majority of previous studies in Europe or even in Asia. 
6.3.3 HDI and metabolic syndrome and its components (objective 4, 5, 6 & 7) 
The weak and inconsistent association between HDI and metabolic syndrome found 
in the thesis was consistent with a study conducted in Luxembourg in 2012, which to 
the author’s knowledge is the only study that investigated the association between 
HDI and metabolic syndrome.224 The study was based on the data from ORISCAV-
LUX national survey in Luxembourg, and used 1349 men and women aged 18-69 in 
analyses.   
Several components of HDI were found to have a protective association with 
metabolic syndrome or its components in this thesis. The most consistent finding in 
three study samples was that higher protein score was associated with lower risk of 
having high blood glucose; furthermore, in Poland, the moderate intake of protein was 
also associated with lower risk of central obesity and metabolic syndrome. The 
protective association between moderate protein intake and metabolic syndrome was 
also found in the Luxembourg study, and was also the only component found to be 
associated with lower metabolic syndrome risk in the study.224 Dietary protein includes 
several food items, such as red meat, white meat, and dairy. A high intake of red meat 
in particular has long been discussed as being a potential risk to health.329;330 For 
example, studies have shown that increased intake of red and process meat was 
associated with higher risk of metabolic syndrome (among women)39 and among 
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those with a high risk of developing future cardiovascular diseases.40 Two large 
studies also investigated protein intake in relation to cardiovascular disease mortality. 
A recent study in the U.S using two large cohort studies and found that high red meat 
consumption was associated with increased cancer, cardiovascular, and total 
mortality.331 Recently, the EPIC study (UK) showed that high processed meat 
consumption (but not unprocessed red meat) was associated with increased risk of 
cardiovascular disease mortality.332 In this thesis, protein intake was associated with 
metabolic syndrome risk in one country only (Poland), but was associated with having 
high blood glucose in all three countries. However, total protein intake comes from 
multiple sources (eg, red meat, white meat, seafood, plant sources, or dairy products) 
which may have different effects on health and may differ by country. Therefore, the 
association between protein intake and metabolic syndrome requires in-depth 
investigation of the specific types of protein.  
There are some established underlying biological mechanisms which may explain the 
relationship between protein intake and blood glucose level. Protein is thought to have 
a minimal effect on glucose level, but this is only among people who have normal 
insulin function.333 However, among people with the insulin deficiency, 
gluconeogenesis (the conversion of protein to glucose) is much faster than in the 
normal population, which in turn would result an elevated glucose level. This could 
explain the association between better adherence to recommended protein intake (ie, 
moderate rather than low or high intake) and higher blood glucose level in this study.  
Better adherence to recommended saturated fatty acid intake was associated with 
lower risk of having central obesity in Poland. This association is consistent with that 
of another observational study in the Iran225 and could be explained by the effects of 
saturated fatty acids on plasma cholesterol levels, which may result in the 
development of metabolic syndrome and its components.181 However, this finding was 
only observed in the Polish sample, and not in the Russian or the Czech samples, 
suggesting that this may have been a chance finding. Better adherence to 
recommended saturated fatty acid intake was also associated with higher risk of 
having high glucose level in the Czech and Polish sample, and higher risk of having 
high triglycerides in the Polish sample; the findings were in line those from another 
observational study by Alkerwi’s paper.224 This found that higher adherence to 
recommended saturated fatty acids intake was associated with higher risk of 
metabolic syndrome. Another consistent finding in the thesis is that higher sugar score 
was associated with higher risk of having high blood glucose in all study samples. 
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This is also consistent with the findings by Alkerwi: participants with better adherence 
to recommended sugar intake had higher risk of metabolic syndrome.224 This at least 
in part is likely to be explained by the effects of glucose intake on plasma glucose 
level. This may also in part be due to limitations of the cross-sectional design 
(whereby those with metabolic syndrome improve their diet following medical advice) 
(see Section 6.2.7).  
A large number of studies have found that high fruit and vegetable intake is associated 
with lower risk of metabolic syndrome.42;45;46 However, in the thesis, contrary to 
expectation, better adherence to recommended fruits and vegetable intake was 
associated with higher risk of high glucose level and not with metabolic syndrome. 
This may be explained by the high sugar content of fruit, and/or due to those with 
impaired glucose metabolism increasing their fruit consumption following medical 
advice. The later may in part explain the lack of association found with metabolic 
syndrome. Compared to the existing studies, the sample used in the thesis was 
substantially larger (5060 in the Czech Republic, 8788 in Russia, and 7671 in Poland), 
suggesting that the study had sufficient power to detect any existing associations. 
Comparisons with these studies are difficult due to the different cut-points for fruit and 
vegetable intake used across the studies.  
Similarly, higher adherence to recommended cholesterol intake (ie, lower intake) was 
associated with higher risk of metabolic syndrome and high blood glucose level in the 
thesis. Interestingly, Alkerwi et al did not found any associations between cholesterol 
and metabolic syndrome in their paper.224 The finding may again be explained by 
reverse causality. 
6.4 Recommendations for future research  
Although the analysis of this thesis included large sample from three countries where 
such analysis has not been done before, there are still many recommendations for 
future studies. 
Because the present study was cross-sectional, and therefore unable to determine 
the temporal relationship between HDI and metabolic syndromes,311 future 
prospective analyses are required. Moreover, repeated dietary measures in 
longitudinal studies are also recommended to better measure diet and therefore its 
importance for metabolic health. In addition, since food availability and intake differs 
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according to season, repeated dietary measures may measure diet across multiple 
different seasons.  
Second, the validation of the FFQ should be further investigated, and its content 
modified in order to improve its validity in different contexts. For example, validation 
studies could focus on each food intake in relation to biological measures in different 
countries separately. One reason is that in the FFQ, even a subtle change of the 
question could affect the performance of the questionnaire and further affect the 
results found in association studies.334 Food consumption may also differ within 
countries by region, suggesting that FFQs may need to be tailored to account for 
regional differences.  
Third, some unmeasured factors may be important in the relation to diet quality and 
metabolic syndrome, such as, dieting status. Furthermore, social network and support 
could be important in determinant diet intake. For example, high frequencies of 
attending social activities was associated with high carotenoid level in older women;335 
and lack of transportation was associated with higher risk of nutritional risk.336 
HDI in its current form may not be a sufficient measure of diet quality to predict 
metabolic syndrome. In the future study, adapting HDI to the local context in the 
Eastern European countries, or developing a well-weighted scoring system for HDI, 
would be useful to see if the adjusted HDI would be associated with metabolic 
syndrome. Further studies could also investigate different diet quality scores which 
could relate more strongly to metabolic syndrome, such as the Mediterranean diet 
and diet quality index.  
Apart from the unmeasured factors, more precise measures of potential confounding 
variables should also be included in future studies. For example, objective measures 
on physical activity rather than self-reported physical activity level may better assess 
both physical activity level and cardiorespiratory fitness.45 This is important to 
measure in order to examine the independent effect of diet on metabolic syndrome 
risk.  
Additionally, the prevalence of having a high blood pressure was found especially 
high in the study population, this may due to high salt intake.337-339 However, salt 
intake was not measured precisely and is very challenging to measure precisely; for 
example, table and cooking salt are part of many meals, and difficult to distinguish 
when recalling diet intake. Future studies, with comprehensive measurements of salt 
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intake could further investigate if salt is the main explanation of the high prevalence 
of hypertension in this region.  
Finally, after using improved measures of both diet and confounding factors, 
modelling the risk factors together could be useful to examine the relative and 
independent importance of diet for metabolic syndrome. This may in turn help further 
explain the cardiovascular disease mortality gap between Eastern and Western 
Europe.  
6.5 Public health implications  
Previous studies have suggested that cardiovascular disease prevalence and 
mortality is high in Eastern Europe. Metabolic syndrome is thought to be an important 
risk factor for cardiovascular disease,100 and was found to be highly prevalent in the 
countries investigated in this thesis. This supports suggestions that tackling metabolic 
syndrome could reduce cardiovascular disease risk in Eastern Europe.  
This thesis also found that the dietary quality was in general moderate to poor in the 
countries investigated, especially a high intake of saturated fatty acids and cholesterol. 
Regardless of the relation between HDI and metabolic syndrome, improving diet in 
the region is likely to have multiple health benefits. Results also suggested that people 
with better nutrition knowledge had a healthier diet compared with their counterparts. 
These results indicate that improving the public understanding of diet could be one of 
the means in improving the population diet intake. 
Previous research (including both observational and intervention studies) has 
suggested that diet is a very important factor for tackling metabolic disorders.247;340;341 
However, results from this thesis did not find strong evidence that a healthy diet (as 
determined by HDI) is associated with lower risk of metabolic syndrome. However, a 
number of plausible methodological issues may explain these null findings (see 
section 6.2). 
Despite limited evidence for an association between HDI and metabolic syndrome, 
some findings have been identified may have potential public health implications. For 
example, a moderate protein intake was associated with lower risk of having 
metabolic syndrome and high blood glucose level. This suggests that better 
adherence to intake of protein may have health benefits in this region.  
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There are a number of potential means of improving diet quality in the population. 
Government and related institutions may act to improve nutritional knowledge in the 
community. Food consumption is also affected by its price and taxation, which also 
can be targeted to improve the population diet intake. Legislation and incentivisation 
may also be used such that unhealthy nutrients are reduced during production. For 
example, reduce salt and fat content in the package food from production. Finally, 
screening tests for metabolic health may also have a role in order to target those with 
metabolic disorders for intervention. 
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Chapter 7  Conclusion 
This thesis aimed to estimate the prevalence of metabolic syndrome and investigate 
the association between dietary quality and risk of metabolic syndrome and its 
components in three Eastern European countries: the Czech Republic, Russia, and 
Poland. The findings showed that metabolic syndrome and its components were 
highly prevalent in each country. HDI was moderate to poor, suggesting room for 
improvement. Healthy dietary quality (assessed by HDI) was not consistently 
associated with metabolic syndrome or its components although some findings, such 
as a moderate protein intake related to lower risk of high blood glucose, suggest 
potential importance of healthy diet for maintaining metabolic health. 
The findings suggest that preventing metabolic syndrome should be a target of public 
health intervention in Central and Eastern Europe, which in turn would likely contribute 
to the prevention of cardiovascular disease in this region. Although HDI was not 
consistently associated with lower risk of metabolic syndrome, there are likely to be a 
wide range of health benefits of improving diet quality in this region.  
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Appendices 
Appendix I Food Frequency Questionnaire  
 
Date of questionnaire filled 
 
 
 
 
 
 
 
 
 
Day 
 
Month 
 
Year 
 
 
Health and Life Style 
 
 
Dietary questionnaire 
 
 
 
 
Name: .........................................  Surname: ................................................... 
  
 
 
 
 
 
 
 
 
 
 
 
 
Study ID  
 
 
 
 
 
  
Interviewer code 
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1. We would like to ask you to estimate your average food use. Please cross the appropriate square in each row of 
the tables below a number indicating how often, on average, you have eaten the specified amount during the last 3 
months.  
 
 Amount 6+ per 
day 
4-5 per 
day 
2-3 per 
day 
1 per 
day 
5-6 per 
week 
2-4 per 
week 
1 per 
week 
1-3 per 
month 
Never or 
less than 
1 per 
month 
Bread and cereals 
White bread, rolls 
Medium 
slice, 1 roll 1 2 3 4 5 6 7 8 9 
Dark bread, rolls 
Medium 
slice, 1 roll 1 2 3 4 5 6 7 8 9 
Cereals  
Medium 
bowl 1 2 3 4 5 6 7 8 9 
Potatoes, rice, pasta, 
dumplings 
Potatoes boiled or mashed 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Potatoes fried (chips) or 
roasted 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Rice  
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Pasta (spaghetti, noodles) 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Pizza 
Medium 
slice 
 1  2 3 4 5 6 7 8 9 
Roll-dumplings 4 slices  1  2 3 4 5 6 7 8 9 
Potato-dumplings(CZ,RU) 4 slices  1  2 3 4 5 6 7 8 9 
Groats 
Medium 
serving 
 1  2 3 4 5 6 7 8 9 
Pirog with meat (RU) 4 slices  1  2 3 4 5 6 7 8 9 
Pirog with vegetables (RU) 4 slices  1  2 3 4 5 6 7 8 9 
Sweet pirog (RU) 4 slices  1  2 3 4 5 6 7 8 9 
Dairy products and fats           
Cream, sour cream 50 ml  1  2 3 4 5 6 7 8 9 
White yoghurt 
1 carton 
(100-150 
ml) 
 1  2 3 4 5 6 7 8 9 
Fruit yoghurt 
1 carton 
(100-150ml) 
 1  2 3 4 5 6 7 8 9 
Milk desserts 
1 carton 
(100-150 
ml) 
 1  2 3 4 5 6 7 8 9 
Soft cottage cheese 
Medium 
serving 
(about 30 g) 
 1  2 3 4 5 6 7 8 9 
Hard cottage cheese 
Medium 
serving 
(about 30 g) 
 1  2 3 4 5 6 7 8 9 
  
 
 
242 
 Amount 6+ per 
day 
4-5 per 
day 
2-3 per 
day 
1 per 
day 
5-6 per 
week 
2-4 per 
week 
1 per 
week 
1-3 per 
month 
Never or 
less than 
1 per 
month 
Low fat soft cheese 
(CZ,PL) 
Medium 
serving 
(about 30 g) 
 1  2 3 4 5 6 7 8 9 
High fat soft cheese 
Medium 
serving 
(about 30g) 
 1  2 3 4 5 6 7 8 9 
Hard cheese, processed 
cheese (CZ, PL) 
Medium 
serving 
(about 30 g) 
 1  2 3 4 5 6 7 8 9 
Hard semi fat cottage 
cheese (PL) 
Medium 
serving 
(about 30 g) 
 1  2 3 4 5 6 7 8 9 
Hard full fat cottage cheese 
(PL) 
Medium 
serving 
(about 30 g) 
 1  2 3 4 5 6 7 8 9 
Low fat cottage cheese 
(RU) 
Medium 
serving 
(about 30 g) 
 1  2 3 4 5 6 7 8 9 
High fat cottage cheese 
(RU) 
Medium 
serving 
(about 30 g) 
 1  2 3 4 5 6 7 8 9 
Low/med fat-not hard 
cheese like feta cheese 
(Brindza) (RU) 
Medium 
serving 
(about 30 g) 
 1  2 3 4 5 6 7 8 9 
Eggs 1 egg  1  2 3 4 5 6 7 8 9 
Margarine (on bread) 1 teaspoon  1  2 3 4 5 6 7 8 9 
Margarine (in food) 1 teaspoon  1  2 3 4 5 6 7 8 9 
Butter (on bread) 1 teaspoon  1  2 3 4 5 6 7 8 9 
Butter (in food) 1 teaspoon  1  2 3 4 5 6 7 8 9 
Mixture of margarine and 
butter (on bread) (PL) 
1 teaspoon  1  2 3 4 5 6 7 8 9 
Mixture of margarine and 
butter (in food) (PL) 
1 teaspoon  1  2 3 4 5 6 7 8 9 
Vegetable oil 
1 
tablespoon  1  2 3 4 5 6 7 8 9 
Lard (on bread)  1 teaspoon  1  2 3 4 5 6 7 8 9 
Lard (in food) 1 teaspoon   1  2 3 4 5 6 7 8 9 
Mayonnaise  
1 
tablespoon  1  2 3 4 5 6 7 8 9 
Light mayonnaise (PL) 
1 
tablespoon  1  2 3 4 5 6 7 8 9 
Soups, sauces and spreads 
Borsch, shiee, vegetable 
soup 
Medium 
serving 
(about 250 
ml) 
 1  2 3 4 5 6 7 8 9 
Bouillon 
Medium 
serving 
(about 250 
ml) 
 1  2 3 4 5 6 7 8 9 
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 Amount 6+ per 
day 
4-5 per 
day 
2-3 per 
day 
1 per 
day 
5-6 per 
week 
2-4 per 
week 
1 per 
week 
1-3 per 
month 
Never or 
less than 
1 per 
month 
Beetroot soup, white borsch 
(PL) 
Medium 
serving 
(about 250 
ml) 
 1  2 3 4 5 6 7 8 9 
Cabbage soup (PL) 
Medium 
serving 
(about 250 
ml) 
 1  2 3 4 5 6 7 8 9 
Bigo (PL) 
Medium 
serving 
(about 250 
ml) 
 1  2 3 4 5 6 7 8 9 
Tripe soup (PL) 
Medium 
serving 
(about 250 
ml) 
 1  2 3 4 5 6 7 8 9 
Goulash soup (PL) 
Medium 
serving 
(about 250 
ml) 
 1  2 3 4 5 6 7 8 9 
Other soups 
Medium 
serving 
(about 250 
ml) 
 1  2 3 4 5 6 7 8 9 
Ketchup 
1 
tablespoon  1  2 3 4 5 6 7 8 9 
Sauces with meat, pasta, 
groats (such as gravy or 
white sauces) 
Medium 
serving  1  2 3 4 5 6 7 8 9 
Marmalade, jam, honey 1 teaspoon  1  2 3 4 5 6 7 8 9 
Sweets and snacks 
Biscuits 1 medium  1  2 3 4 5 6 7 8 9 
Cakes, pies (sweet) 
medium 
slice  1  2 3 4 5 6 7 8 9 
Buns, pastries, doughnuts, 
muffins 
1 piece  1  2 3 4 5 6 7 8 9 
Sweets 1 bonbon  1  2 3 4 5 6 7 8 9 
Chocolate 1 bar  1  2 3 4 5 6 7 8 9 
Chocolate (pieces), 
chocolate bars (e.g. Mars) 
(PL) 
1 piece  1  2 3 4 5 6 7 8 9 
Ice cream one scoop  1  2 3 4 5 6 7 8 9 
Milk pudding 
medium 
serving  1  2 3 4 5 6 7 8 9 
Sweet rice 
medium 
serving  1  2 3 4 5 6 7 8 9 
Pancakes 1 pancake  1  2 3 4 5 6 7 8 9 
Sweet (fruit) dumplings 4 pieces  1  2 3 4 5 6 7 8 9 
Crisps, crackers and other 
packet-snacks 
1 small 
packet  (25 
g) 
 1  2 3 4 5 6 7 8 9 
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 Amount 6+ per 
day 
4-5 per 
day 
2-3 per 
day 
1 per 
day 
5-6 per 
week 
2-4 per 
week 
1 per 
week 
1-3 per 
month 
Never or 
less than 
1 per 
month 
Peanuts and other nuts 
1 small 
packet  (50 
g) 
 1  2 3 4 5 6 7 8 9 
Sugar into coffee, tea 1 teaspoon  1  2 3 4 5 6 7 8 9 
Sweetener into coffee, tea 
1 capsule, 1 
tablet  1  2 3 4 5 6 7 8 9 
Drinks 
Milk 2 dl  1  2 3 4 5 6 7 8 9 
Cocoa (RU,PL) 2 dl  1  2  3 4 5 6 7 8 9 
Fruit juice 2 dl  1  2 3 4 5 6 7 8 9 
Fizzy drinks (lemonade, 
coke, fanta) 
2 dl 
 1  2 3 4 5 6 7 8 9 
Diet/low calorie fizzy 
drinks 
2 dl  1  2 3 4 5 6 7 8 9 
Squash 
one 
tablespoon  1  2 3 4 5 6 7 8 9 
Unsweentened mineral 
water (CZ) 
2 dl  1  2 3 4 5 6 7 8 9 
Tap water, bottle non-
mineral water (CZ) 
2 dl  1  2 3 4 5 6 7 8 9 
Coffee 2 dl  1  2 3 4 5 6 7 8 9 
Tea 2 dl  1  2 3 4 5 6 7 8 9 
Wine 1 dl  1  2 3 4 5 6 7 8 9 
Beer 0.25 l  1  2 3 4 5 6 7 8 9 
Port, sherry, vermouth 1 dl  1  2 3 4 5 6 7 8 9 
Liqueurs 0.5 dl  1  2 3 4 5 6 7 8 9 
Spirits 0.25 dl  1  2 3 4 5 6 7 8 9 
Meat and fish 
Beef : roast, steak, mince, 
stew or casserole 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Lamb: roast, chops or stew 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Pork: roast, chops or stew 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Poultry 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Rabbit 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
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 Amount 6+ per 
day 
4-5 per 
day 
2-3 per 
day 
1 per 
day 
5-6 per 
week 
2-4 per 
week 
1 per 
week 
1-3 per 
month 
Never or 
less than 
1 per 
month 
Offals (heart, kidney, liver) 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Soft sausages 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Hard sausages 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Soft salami 50 g  1  2 3 4 5 6 7 8 9 
Hard salami (CZ,RU) 50 g  1  2 3 4 5 6 7 8 9 
Ham about 50 g  1  2 3 4 5 6 7 8 9 
Bacon 2 slices  1  2 3 4 5 6 7 8 9 
Lard from bacon (RU) 2 slices  1  2 3 4 5 6 7 8 9 
Pate 50 g  1  2 3 4 5 6 7 8 9 
Meat pie 
Medium 
serving  1  2 3 4 5 6 7 8 9 
Luncheon meat (CZ,PL) 50 g  1  2 3 4 5 6 7 8 9 
Canned meat 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Meat ravioli (RU) 
Serving (10 
pieces)  1  2 3 4 5 6 7 8 9 
Polish meat dumplings (CZ, 
PL) 
4 pieces  1  2 3 4 5 6 7 8 9 
Fish – fresh, frozen or 
canned (not in oil) 
          
Fresh water fish (e.g. carp, 
pike) 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Salt water white fish (e.g. 
cod of haddock) 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Oily fish (e.g. mackerel, 
tuna, salmon, sardines, 
herring, kippers) 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Other fish           
Fish canned in oil 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Fish fingers, fish Afilé 
(RU,PL) 
Medium 
serving 
 1  2 3 4 5 6 7 8 9 
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 Amount 6+ per 
day 
4-5 per 
day 
2-3 per 
day 
1 per 
day 
5-6 per 
week 
2-4 per 
week 
1 per 
week 
1-3 per 
month 
Never or 
less than 
1 per 
month 
(about 100 
g) 
Salted fish (RU,PL) 25 g  1  2 3 4 5 6 7 8 9 
Crab, prawns, mussels (sea 
food) 
Medium 
serving  1  2 3 4 5 6 7 8 9 
Fresh fruit 
Apples 1 medium  1  2 3 4 5 6 7 8 9 
Pears 1 medium  1  2 3 4 5 6 7 8 9 
Oranges 1 medium  1  2 3 4 5 6 7 8 9 
Grapefruit ½ medium  1  2 3 4 5 6 7 8 9 
Mandarins 1 medium  1  2 3 4 5 6 7 8 9 
Lemons ½ medium  1  2 3 4 5 6 7 8 9 
Peaches 1 medium  1  2 3 4 5 6 7 8 9 
Apricots 1 medium  1  2 3 4 5 6 7 8 9 
Plums about 100 g  1  2 3 4 5 6 7 8 9 
Cherries about 100 g  1  2 3 4 5 6 7 8 9 
Strawberries 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Raspberries 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Red currant 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Black currant 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Blueberries 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Gooseberry 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Kiwi 1 medium  1  2 3 4 5 6 7 8 9 
Melon 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Pineapple (CZ,RU) Medium 
serving 
 1  2 3 4 5 6 7 8 9 
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 Amount 6+ per 
day 
4-5 per 
day 
2-3 per 
day 
1 per 
day 
5-6 per 
week 
2-4 per 
week 
1 per 
week 
1-3 per 
month 
Never or 
less than 
1 per 
month 
(about 100 
g) 
Bananas 1 medium  1  2 3 4 5 6 7 8 9 
Grapes 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Tinned or bottled fruit 
medium 
serving 
(about 
100g) 
 1  2 3 4 5 6 7 8 9 
Dried fruit (e.g. raisins, 
apricots, apples) 
medium 
serving 
(about 50g) 
 1  2 3 4 5 6 7 8 9 
Vegetables 
Green salad (lettuce) 
Medium 
serving  1  2 3 4 5 6 7 8 9 
Spinach 
Medium 
serving  1  2 3 4 5 6 7 8 9 
Brussels sprouts (RU,PL) 5 sprouts  1  2 3 4 5 6 7 8 9 
Parsley, dill (RU) 1 medium  1  2 3 4 5 6 7 8 9 
Cabbage 
Medium 
serving  1  2 3 4 5 6 7 8 9 
Beans 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Lentils 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Dried peas 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Green beans 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Green peas (CZ,RU) 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Turnips, swedes, parsnips 
(CZ,PL) 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Radish 4 radishes  1  2 3 4 5 6 7 8 9 
Celeriac 50 g  1  2 3 4 5 6 7 8 9 
Parsley 1 medium  1  2 3 4 5 6 7 8 9 
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 Amount 6+ per 
day 
4-5 per 
day 
2-3 per 
day 
1 per 
day 
5-6 per 
week 
2-4 per 
week 
1 per 
week 
1-3 per 
month 
Never or 
less than 
1 per 
month 
Cauliflower 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Broccoli 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Carrots 1 medium  1  2 3 4 5 6 7 8 9 
Onion ½ medium  1  2 3 4 5 6 7 8 9 
Leeks ½ medium  1  2 3 4 5 6 7 8 9 
Garlic 1 clove  1  2 3 4 5 6 7 8 9 
Peppers 1 medium  1  2 3 4 5 6 7 8 9 
Tomatoes 1 medium  1  2 3 4 5 6 7 8 9 
Cucumbers 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Aubergine 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Courgette/marrow 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Corn 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Beet-root cooked Russian 
salad (RU,PL) 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Sauerkraut 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
Pickled vegetables, 
gherkins 
Medium 
serving 
(about 50 g) 
 1  2 3 4 5 6 7 8 9 
Mushrooms 
Medium 
serving  1  2 3 4 5 6 7 8 9 
Soya meat 
Medium 
serving 
(about 
100g) 
 1  2 3 4 5 6 7 8 9 
Mixed frozen vegetables 
Medium 
serving 
(about 100 
g) 
 1  2 3 4 5 6 7 8 9 
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2. Are the foods and drinks listed in the previous table representative of the foods and drinks that you consumed in 
the last 3 months? 
   
 1. Yes 
 2. No 
 
3. Are there any other foods, which you ate more than once a week?  
 
   
 1. Yes 
 2. No 
 
4. If yes, please list below 
  
 
Food name 
 
 
Usual serving size 
 
 
Number of times 
eaten each week 
   
   
   
    
 
5. What type of milk did you most often use? 
 
 1. Full cream (3% of fat and more)             
 2. Semi- skimmed (2% of fat)     
 3. Skimmed (about 0.5% of fat)    
 4. Soya milk     
 5. Cream into coffee, tea                
 6. I do not use milk                  
 7. I do not know                               
 
6. How much milk do you drink each day, including milk with tea, coffee, cereals etc.? 
 
 1. None      
 2. Less than 250 ml                                
 3. More than  250, less than 500 ml       
 4. More than 500 ml, less than 1000 ml 
 5. More than 1000 ml                     
 
 
